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2 ABBREVIATIONS 
ABCD Trial  the Alternans Before Cardioverter Defibrillation Trial 
APD   action potential duration 
AV    atrioventricular 
BMI   body-mass index 
cAMP   cyclic adenosine monophosphate 
CHD   coronary heart disease 
CI    confidence interval 
DAP   diastolic arterial pressure 
DI    diastolic interval 
ECG   electrocardiography 
EF    ejection fraction 
FINCAVAS  Finnish Cardiovascular Study 
HF    high frequency 
HR    hazard ratio 
HRV   heart rate variability 
ICD    implantable cardioverter-defibrillator 
ICD-10 tenth revision of the international classification of diseases 
LF    low frequency 
MET   metabolic equivalent of task 
MI    myocardial infarction 
MMA   Modified Moving Average 
NN50   percentage of difference between N-N intervals that exceed 50ms 
pcSD   standard deviation of Poincare plot 
pNN50   proportion of NN50 by the total number of N-N intervals 
RMSSD   square root of the mean squared differences in
 
N-N intervals 
RPP   rate-pressure product 
RR    risk ratio 
SAP   systolic arterial pressure 
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SCD   sudden cardiac death 
SCD-HeFT   the Sudden Cardiac Death in Heart Failure Trial 
SD    standard deviation 
SDANN standard deviation of the mean value of all 5-minute segments of N-N 
intervals 
SDNN   standard deviation of N-N intervals 
TWA   T-wave alternans 
ULF   ultra low frequency 
VLF   very low frequency 
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3 ABSTRACT 
The more than 20,000 cardiovascular deaths per year in Finland have made the identification of 
individuals at risk for cardiovascular death a pressing public challenge. The clinical exercise test 
and exercise-based ST segment deviation are widely accepted methods for diagnosing coronary 
heart disease (CHD). However, beyond ST segment analysis, a clinical exercise test provides much 
more information when estimating a patient’s risk for future cardiovascular events. As a part of the 
Finnish Cardiovascular Study (FINCAVAS), the present study was designed to investigate the 
prognostic power of single and multiple variables derived from a clinical exercise test.  
The FINCAVAS population includes all patients scheduled for an exercise stress test due to 
clinical reasons using a bicycle ergometer at Tampere University Hospital and willing to participate 
in the study between October 2001 and December 2008. The follow-up lasted until September 
2009. The final number of participants was 4,568 (1,765 women), but smaller study populations 
were created after shorter follow-up periods. In addition to repeated measurement of standard 
parameters such as heart rate and blood pressure, digital high-resolution ECG at 500Hz was 
recorded continuously during the entire exercise test, including the resting and recovery phases. T-
wave alternans (TWA) was analyzed continuously with the time-domain Modified Moving Average 
(MMA) Method.  
During the follow-up (55±26 months) 321 patients died, including 138 cardiovascular deaths 
and 63 sudden cardiac deaths (SCD). The prognostic power of exercise-test-based variables was 
determined by means of Cox multivariate regression analysis after adjustment for common coronary 
risk factors. Diminished heart rate variability (HRV) during the pre-exercise phase was associated 
with an increased risk of all-cause mortality according to several parameters (log VLF power, log 
LF power, log LF power n.u, log HF power%, pcSD2, log RMSSD), but during peak exercise HRV 
did not predict worse prognosis. At peak exercise TWA predicted worse prognosis both as a 
categorized variable (≥60 µV) and a continuous variable, especially in lead V5. During the recovery 
after exercise TWA ≥60 µV predicted worse prognosis. A prolonged PR interval and first-degree 
atrioventricular (AV) block during recovery were associated with increased risk of cardiovascular 
death. Abnormal heart rate recovery (≤18 bpm) after exercise was a significant predictor of all-
cause death and cardiovascular mortality. The combination of abnormal heart rate recovery and 
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TWA ≥60 µV was a significant predictor of all-cause and cardiovascular mortality when TWA was 
measured either during peak exercise or during recovery. A decreased recovery of rate-pressure 
product (RPP) was significantly associated with an increased risk of SCD, cardiovascular mortality 
and all-cause death.  
 An exercise test utilising the bicycle ergometer has unused prognostic potential when 
evaluating patients’ risk for future all-cause and cardiovascular mortality as well as for SCD. To 
enhance the prognostic power of the exercise test, the test should be considered as a continuum 
from rest via peak exercise to the recovery phase. Combinations of single parameters can increase 
the accuracy of the exercise test by reflecting cardiovascular health from several perspectives. 
However, more studies are needed before universal recommendations for exercise testing in risk 
stratification can be constructed. 
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4 TIIVISTELMÄ 
Kliinistä rasituskoetta ja sen aikaisia ST-segmentin muutoksia käytetään yleisesti 
sepelvaltimotaudin diagnostiikassa. Diagnostiikan lisäksi kliinistä rasituskoetta voidaan käyttää 
myös arvioitaessa potilaan ennustetta sekä sydäntapahtumien riskiä tulevaisuudessa. 
Riskinarviointiin kliininen rasituskoe tarjoaa ST-segmentin muutosten lisäksi useita muita 
muuttujia. Osana Finnish Cardiovascular Study (FINCAVAS) -tutkimusta tämän 
väitöskirjatutkimuksen tarkoituksena oli tutkia sekä yksittäisten rasituskokeen aikaisten muuttujien 
että eri muuttujien yhdistelmien kykyä ennustaa tulevaisuuden kuolleisuutta. 
FINCAVAS -tutkimusaineisto sisältää rasituskokeen aikaiset tiedot potilailta, jotka tulivat 
vuoden 2001 lokakuun ja vuoden 2008 joulukuun välisenä aikana kliiniseen rasituskokeeseen 
Tampereen Yliopistolliseen Sairaalaan ja olivat halukkaita osallistumaan tutkimukseen. Seuranta-
aika oli syyskuun 2009 loppuun asti. Kokonaisuudessaan tutkimusaineisto sisältää tiedot 4568 
potilaasta (1765 naista), mutta pienempiä aineistoja otettiin analysoitavaksi lyhyempien seuranta-
aikojen jälkeen. Säännöllisen sykkeen ja verenpaineen mittaamisen lisäksi rekisteröitiin digitaalinen 
EKG 500Hz:n taajuudella koko kokeen ajan. T-aallon vuorottelu (T-wave alternans, TWA) 
analysoitiin Modified Moving Average (MMA) -metodilla. 
Seuranta-aikana (55±26 kuukautta) kuoli 321 potilasta. Kuolemista 138 oli sydän- ja 
verisuoniperäisiä, joista edelleen 63 oli sydänäkkikuolemaa (sudden cardiac death, SCD). 
Rasituskokeen aikaisten muuttujien yhteys seuranta-ajan kuolleisuuteen määritettiin Coxin 
monimuuttuja-analyysilla, jossa muina muuttujina käytettiin tunnettuja sydän- ja verisuonitautien 
riskitekijöitä. Rasitusta edeltävän lepovaiheen aikana vaimentunut sydämen sykevaihtelu (heart rate 
variability, HRV) oli yhteydessä huonoon ennusteeseen usean muuttujan osalta (log VLF power, 
log LF power, log LF power n.u, log HF power%, pcSD2, log RMSSD). Maksimirasituksen 
aikainen HRV ei ennustanut kuolleisuutta. Maksimirasituksen aikainen TWA oli yhteydessä 
kuolleisuuteen sekä luokiteltuna (≥60 µV) että jatkuvana muuttujana, erityisesti kytkennässä V5. 
Rasituksen jälkeisen palautumisvaiheen aikana TWA ≥60 µV oli yhteydessä huonoon ennusteeseen. 
Myös pidentynyt PR-intervalli sekä ensimmäisen asteen eteiskammiokatkos (AV-katkos) ennustivat 
sydän- ja verisuoniperäistä kuolleisuutta rasituksen jälkeisen palautumisvaiheen aikana. Hidastunut 
sykkeen palautuminen (≤18 bpm) rasituksen jälkeen oli yhteydessä niin kokonaiskuolleisuuteen 
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kuin sydän- ja verisuoniperäiseen kuolleisuuteenkin. Poikkeuksellisen suuri TWA (≥60 µV) 
yhdistettynä hidastuneeseen sydämen sykkeen palautumiseen oli yhteydessä huonoon ennusteeseen, 
kun TWA oli määritetty joko rasituksen tai palautumisvaiheen aikana. Hidastunut syke-paine-tulon 
(rate-pressure product, RPP) palautuminen rasituksen jälkeen ennusti merkitsevästi kaikkia kolmea 
kuoleman luokkaa. 
Kliininen rasituskoe tarjoaa merkittävästi tietoa riskinarviointiin. Rasituskoe tulisi nähdä 
kokonaisuutena, johon kuuluvat lepovaihe, rasitus sekä rasituksen jälkeinen palautumisvaihe. 
Yhdistämällä yksittäisiä muuttujia voidaan rasituskokeen ennustearvoa lisätä ja samalla vähentää 
virheellisiä riskiarvioita. Kuitenkin tarvitaan vielä uusia ja laajempia tutkimuksia suurilla 
potilasaineistoilla, ennen kuin voidaan tehdä yleisiä suosituksia rasituskokeen käytöstä 
riskinarvioinnissa. 
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5 INTRODUCTION 
In 2008, there were over 20,000 cardiovascular deaths in Finland, with 58% of them attributed to 
CHD. (Laatikainen et al. 2005, http://www.stat.fi/til/ksyyt/tau.html, referred 25.9.2010). Besides 
CHD, several other causes can lead to cardiac death as well, including structural abnormalities of 
the heart, inherited arrhythmia syndromes, hypertrophic and dilated cardiomyopathy, various 
valvular diseases, and acute illnesses such as myocarditis. SCD is usually defined as a natural death 
due to cardiac causes, heralded by an abrupt loss of consciousness within an hour of the onset of 
acute symptoms. If the death is unwitnessed and the victim is known to have been alive and 
functioning normally prior to being discovered, the time limit has been settled as 24 hours. Pre-
existing heart disease may or may not have been previously diagnosed, but the time and mode of 
SCD are unexpected. (Priori and Zipes 2006.) Despite the fact that many patients have anatomic 
and functional cardiac substrates that predispose them to developing ventricular arrhythmias, only a 
small percentage of these patients will face SCD or cardiac death. In addition to the underlying 
arrhythmia
 
mechanisms, a chain of events leading to SCD usually requires a transient event that 
perturbs the physiological balance of the cardiovascular system. Because of this complex and 
diverse background of cardiac death, identifying patients at high risk for SCD or cardiac death due 
to other causes has been a challenge. The assessment of conventional risk factor burden is necessary 
but may not accurately estimate the risk of future cardiovascular events. (Brindle et al. 2006.)  
Therefore, there is a need for easily available non-invasive methods to detect individuals at high 
risk for future cardiovascular events and who would benefit the most from preventive measures. 
(Laukkanen 2005.)  
 Exercise is the most common form of physiologic stress for the body and requires a 
controlled adaptation of the cardiovascular system to various physiological conditions between rest 
and maximal exercise. Exercise can elicit such cardiovascular abnormalities that are not evident at 
rest. During the clinical exercise test, these changes in the cardiovascular system are measured 
under rigorously controlled and reproducible conditions. Previously, the main focus in exercise 
testing has been on electrocardiogram (ECG) recordings and chest pain during the exercise for 
screening CHD and evaluating its severity in a medium-risk population. The clinical usefulness of 
the exercise test as a diagnostic tool has been limited, however, by deficient sensitivity of visual ST 
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segment analysis but also by false positive outcomes. (Froelicher et al. 1998, Fowler-Brown et al. 
2004, Kligfield and Lauer 2006.) Therefore, increased attention has been focused on the exercise 
test as a prognostic modality. The ST segment has proven to be a relatively minor predictor of risk, 
but beyond ST segment analysis, a modern exercise test provides several indices that are strong 
predictors of cardiovascular outcomes such as blood pressure, heart rate and exercise capacity. 
TWA is a relatively new variable, reflecting repolarisation abnormalities in the heart, and its 
prognostic power in risk stratification has been under thorough investigation during recent years. 
The method is yet to spread to wide clinical use. Because the factors leading to a cardiac death are 
complex, a single test is unlikely to predict the risk reliably. In improving the prediction of 
cardiovascular events, multiple variables have been shown to perform better than single variables. 
(Redwood et al. 1997.)  
An exercise test is inexpensive, it is performed in most cases without the presence of a 
cardiologist, and it offers the highest predictive accuracy of any of the non-invasive tests for CHD. 
(Ashley et al. 2000.) Identifying high-risk patients should lead to aggressive prevention and 
treatment with optimized drug or revascularization therapy, and the patients who are at high risk of 
ventricular fibrillation or ventricular tachycardia should be considered as to whether they would 
benefit from an implantable cardioverter-defibrillator (ICD) to prevent potentially fatal 
tachyarrhythmias. Lower-risk patients should be guided with primary prevention methods. The 
present study was designed to investigate and identify those single and multiple variables derived 
from an exercise test that can be used in clinical risk stratification for future mortality. 
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6 BACKGROUND 
6.1 Clinical exercise test 
6.1.1 History 
In 1908 William Einthoven documented ST segment changes in the ECG during exercise, but it was 
not until 1932 when Goldhammer and Scherf proposed ECG during exercise as a diagnostic tool for 
angina pectoris. (Ashley et al. 2000.) At the same time, A. M. Master presented the first 
applications of the exercise test for diagnosing symptomless patients who were suspected to have 
CHD. Master developed a two-step exercise test which was first used as a means of estimating 
cardiovascular function by determining the response of the blood pressure and heart rate to a 
standardized form of exertion by using trips up and down nine-inch steps. (Wener et al. 1953.) In 
the 1940s Master included ECG in the exercise test to obtain objective evidence of the presence of 
ischemia. (Wener et al. 1953.) In the single two-step exercise test, the workload of the heart was 
increased by a standard amount of work in 1.5 minutes. In the patients who were suspected of 
having CHD, the work imposed upon the heart was found to be insufficient to produce the ECG 
changes characteristic of coronary insufficiency. The double two-step test was introduced for those 
patients whose single two-step test was normal. In the double two-step test the patient performed 
twice the amount of work in twice as long a time as in the single test. (Wener et al. 1953.) The first 
criteria for positive exercise testing were a depression of the RS-T segment of more than 0.5 mm in 
any lead with or without flattening, or the inversion of a previously upright T-wave, even though 
these criteria led to 16–39% of the false-positive and 12–49% of the false-negative results. (Thomas 
1951, Davis et al. 1953, Friedberg et al. 1962.)  
Master’s two-step test was in clinical use for many decades, although it provided little 
information about the patient’s physical working capacity. During the 1960s multi-stage tests were 
designed to satisfy both of the requirements; provoking ECG abnormalities and other symptoms and 
signs of CHD, as well as providing quantitative information of the patient’s physical working 
capacity. Treadmill and bicycle ergometer tests were performed in parallel with the Master two-step 
test because of their better ability to provide information about patients’ physical working capacity. 
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At the time, a large number of different stress protocols were used, including continuous tests with 
stepwise load increment every one to three minutes; continuous tests with an initial rapid increase in 
work load and subsequent adjustment of the workload level to reach a predetermined heart rate 
which was then maintained for two to three minutes; as well as five to six minutes of exercise at 
each level in a series of progressively heavier workloads interspersed with rest periods. (Blomqvist 
1971.) In 1967 Mason and Likar introduced a multiple lead system for exercise ECG to decrease the 
distortion of the ECG signal due to muscular activity, respiration and electrode artefacts. In the 
Mason-Likar modification, the ECG limb leads of the arms and legs are placed on the shoulders and 
on the hip. (Mason et al. 1967.)  
6.1.2 Methods 
Today, an exercise test is usually performed as a treadmill or bicycle test. Walking on a treadmill 
provides a greater diagnostic ability to detect CHD than cycling. (Hambrecht et al. 1992.) However, 
it is more expensive, requires more space in the testing room, and might be inappropriate for those 
patients who are severely obese or have problems with extended periods of walking (Lear et al. 
1999). In the United States the treadmill test according to Bruce’s protocol is the preferred modality 
for exercise (Palatini 2008). The Bruce’s protocol begins with the treadmill set to a low speed and a 
10% incline, with an increase in the speed and incline every three minutes. The test continues for a 
maximum of 27 minutes, or until the patient stops or develops signs or symptoms of ischemia or 
arrhythmias. (Miller 2008.) Despite the wide use of the Bruce’s protocol, there are disadvantages, 
such as too large or rapid work-rate increments lowering the sensitivity for detecting CHD, a 
tendency to overestimate exercise capacity, and poor reliability in testing the effects of therapy 
(Ashley et al. 2000). In addition, unfit patients may not be able to complete even the first stage, 
corresponding to 5 metabolic equivalents of task (MET), in the Bruce’s protocol. An alternative to 
the Bruce’s protocol is ramp testing where the patient is exercising from rest to maximum exercise 
through a linear increase in workload over approximately 10 minutes. Focusing on total workload 
rather than on exercise time, and avoidance of fatigue are the benefits of this protocol.    
In Finland exercise tests are mainly performed by bicycle ergometer (Table 1). Usually, the 
exercise test begins with the workload of 25–50 W, which is then increased every three minutes by 
25–50 W. The exercise protocol varies between hospitals, depending on the indication for the 
exercise test and the adopted practice. A bicycle exercise test produces lower peak oxygen uptake in 
comparison to a treadmill test, because untrained subjects usually terminate the bicycle exercise at a 
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peak work rate that is 10–20% lower due to leg muscle fatigue. (Hambrecht et al. 1992.) Heart rate 
increase as a response to exercise is significantly higher in treadmill exercise than in bicycle 
exercise, and the drop in heart rate after the exercise is significantly lower in treadmill than in 
bicycle exercise. In addition, abnormal responses to exercise are more frequent in treadmill exercise 
than in bicycle exercise. (Rahimi et al. 2006.) The maximal heart rate for ruling out CHD should be 
at least 90% of the age-related maximum heart rate during the exercise test to avoid false-negative 
test results due to a too low level of exercise. The advantages of using bicycle exercise as a test 
mode are the fact that the population is, particularly in Europe, quite familiar with the bicycle, in 
addition to lower costs, better quality of ECG tracings and higher accuracy of blood pressure 
measurements due to reduced upper body movement. (Rahimi et al. 2006.) The comparisons 
between treadmill and bicycle exercise have shown that these tests are, in fact, testing different 
stressors leading to different haemodynamic and clinical responses (Hambrecht et al. 1992, Klein et 
al. 1994). Therefore, the results of treadmill and bicycle exercise tests may not be intercomparable.  
The patient’s symptoms are controlled for the entire duration of the exercise test. In addition 
to the symptoms, numerous ECG-based and haemodynamic variables could be measured. The 
ECG-based variables include all variables that are measured from normal resting ECG and the 
changes in those variables between rest and exercise, with the ST segment as an example. The 
haemodynamic variables include heart rate, heart rate response to and recovery after exercise as 
well as blood pressure. The mechanical function and local hypokinesias of the heart muscle can be 
estimated using echocardiography before and after the exercise test. Maximal working capacity and 
the duration of the test describe the patient’s general fitness and, on occasion, also the co-operation 
between the tester and testee. An ortostatic test could be performed before exercise. During the 
ortostatic test, ECG and haemodynamic variables, such as heart rate and blood pressure, are 
measured at rest and during 3–8 minutes of standing. 
Roughly 20–40% of patients with suspected CHD are unable to perform the maximal 
exercise test due to orthopaedic, vascular or pulmonary disease, or poor physical condition or 
motivation (Sovijärvi et al. 2003). If the clinical exercise test cannot be performed, the 
pharmacologic stress test combined with isotope perfusion imaging is a possible alternative stress 
method. Other suggested alternative test methods, although rarely used, are arm ergometry, 
inotropic stimulation, handgrip test, right atrial pacing and a cold pressure test (Niemeyer et al. 
1992, Sovijärvi et al. 2003). 
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Table 1. Exercise test in Finland. 
Rest (Ortostatic test) Exercise Recovery 
10 min 3-8 min Usually 3 min steps  5-10 min 
ECG 
 
ECG 
 
ECG 
 
ECG 
 Heart rate 
 
Heart rate Heart rate Heart rate 
Blood pressure 
 
Blood pressure Blood pressure Blood pressure 
Breathing frequency Breathing frequency Breathing frequency Breathing frequency 
Sa02 
 
Sa02 
 
Sa02 
 
Sa02 
 PEF/FEV1     Subjective feeling of exertion PEF/FEV1 
 
ECG= electrocardiography; FEV= forced expiratory volume; PEF= peak expiratory flow;  
Sa02= oxygen saturation.  
6.1.3 Exercise test a s a diagnostic tool for coronary heart disease 
Because only a limited proportion of patients undergo coronary angiography after exercise testing, 
the diagnostic accuracy of the exercise test is difficult to determine. In a large meta-analysis the 
sensitivities of the exercise test varied from 23% to 100%, with a mean of 68%, while the 
specificities varied from 17% to 100%, with a mean of 77% (Gianrossi et al. 1989, Gibbons et al. 
1997). However, a marked work-up or verification bias existed in the majority of the studies 
(Gibbons et al. 1997). In the study where work-up bias was avoided by having patients agree to 
undergo both coronary angiography and an exercise test, the approximate sensitivity of 1mm ST 
segment depression was 33–50%, with a specificity of 84–96% (Morise and Diamond 1995).  In the 
meta-analysis, the sensitivity of the exercise test in diagnosing CHD was found to be significantly 
decreased when equivocal tests were considered normal and when the exercise test was compared to 
other tests (publication bias; Gibbons et al. 1997). 
When the exercise test is used as a purely diagnostic tool, a positive exercise test result is 
much more likely to be false-positive than true-positive for asymptomatic subjects, which may lead 
to unnecessary testing, overtreatment and labelling (Fowler-Brown et al. 2004). According to 
Bayes’ theorem, the probability of a patient having CHD after a test is the product of the CHD 
probability before the test and the probability that the test provided a true result. If the pre-test 
possibility for CHD is low, an exercise test is not recommended for detecting underlying CHD 
because of the high occurrence of false-positives test results. In contrast to this, in screening higher-
risk groups, such as persons with one or more risk factors for CHD, an exercise test will probably 
perform better. (Fowler-Brown et al. 2004.) However, typical or definite angina makes the pre-test 
probability of disease so high that the test result does not change the probability dramatically. If the 
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pre-test possibility for CHD is >75%, guidelines suggest proceeding directly with coronary 
angiography. (Gibbons et al. 2003.) For diagnostic purposes, an exercise stress test is most valuable 
in the intermediate pre-test probability category, because the test result has the largest potential 
effect on diagnostic outcome.  
6.1.4 Exercise test as a prognostic tool for cardiovascular events 
Although the diagnostic accuracy of the exercise test depends greatly on the prevalence of CHD in 
the population studied, exercise testing has been suggested to be valuable and less dependent on the 
patient’s pre-test possibility for the purpose of risk stratification (Lauer 2007, Gibbons 2008). The 
results regarding the prognostic accuracy of ST segment deviation have demonstrated only limited 
predictive utility
 
for this purpose (Gordon et al. 1986, Rautaharju et al. 1986, Okin et al. 1991, Okin 
et al. 1996). The limited sensitivity of ST segment deviation has been attributed to the 
pathophysiology behind the cardiac events. Acute cardiac events frequently occur secondarily to a 
rapid transformation of an atherosclerotic lesion, such as plaque rupture or thrombosis. The risk of 
plaque disruption may not be related to the pre-existing severity of coronary artery stenosis, which 
is detected in an exercise stress test. (Coplan and Fuster 1990.) Symptomatic obstructive plaques 
that typically result in exercise-mediated ischaemia may be less relevant with regard to infarction 
and SCD than less obstructive unstable plaques (Libby and Theroux 2005). 
Heart-rate-adjusted indexes of ST segment deviation, such as the ST/HR index
 
and the 
ST/HR slope, have been developed to improve the performance of the exercise ECG. Other 
variables received during the exercise test – such as exercise hypotension or hypertension, 
chronotropic incompetence and heart rate recovery – also carry prognostic value. (Gibbons et al. 
2000, Lauer et al. 2005, Miller 2008, Laukkanen et al. 2009, Scott 2009.) One of the strongest 
prognostic markers identified in exercise testing is maximum exercise capacity, which is influenced 
by the extent of resting left ventricular dysfunction and the amount of further left ventricular 
dysfunction induced by exercise. Several exercise parameters are used to reflect exercise capacity, 
including exercise duration, maximum MET level achieved and maximum workload achieved. 
Maximum heart rate, blood pressure response to exercise as well as the combination of heart rate 
and systolic arterial pressure (SAP), namely double product or RPP, are other markers used in 
exercise-test-based risk stratification. (Gibbons et al. 1997.)  
Several studies have attempted to determine exercise test scores that incorporate clinical and 
demographic risk factors not based on the exercise test itself. An example of such is the Duke 
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Treadmill Score, adding exercise duration and the presence and test-limiting severity of angina to 
ST segment depression, and the method is well-validated and clinically useful for risk assessment in 
younger (<75 years) patients with either established or suspected CHD for whom the desirability of 
additional invasive testing must be determined (Mark et al. 1991, Kwok et al. 2002). In 
asymptomatic women, however, the predictive value of the Duke Treadmill Score has been stated to 
be entirely due to the exercise capacity component of the score, because exercise time is part of the 
score and essentially reflects exercise capacity (Gulati et al. 2005). 
6.2 Haemodynamics during exercise test and prognosis 
6.2.1 Overview of the autonomic nervous system 
The autonomic nervous system is a part of the peripheral nervous system that functions to regulate 
the processes needed for the maintenance of body homeostasis. Its effects include controlling heart 
rate and contraction of the heart, the constriction and dilation of blood vessels, the contraction and 
relaxation of smooth muscle in various organs, and glandular secretion, all independently of 
voluntary control. (Freeman et al. 2006.) The autonomic nervous system consists of three parts: the 
sympathetic and parasympathetic divisions as well as the enteric nervous system. These three parts 
of the autonomic nervous system function between the central nervous system and peripheral 
organs, controllig each other via a feedback system. The sympathetic and parasympathetic nerve 
fibres mainly secrete one of two synaptic transmitter substances, acetylcholine by cholinergic nerve 
endings or noradrenalin by adrenergic nerve endings. The sympathetic nervous system has synapses 
in peripheral ganglias which constitute paravertebral sympathetic chains to both sides of the 
vertebral column.  Parasympathetic ganglias are located in the wall of the organ that is to be 
controlled. The enteric nervous system controls the gastrointestinal system. It consists of the 
myenteric and submucous plexus, both of which are embedded in the wall of the digestive tract and 
extend from the oesophagus to the anus. The enteric nervous system can function on its own, but 
stimulation of the sympathetic or parasympathetic nervous system can further activate or inhibit 
gastrointestinal functions, because both the myenteric and the submucosal plexuses connect with 
the sympathetic and parasympathetic nerve fibres.  
 The Prognostic Power of the Clinical Exercise Test  -  21 
6.2.1.1 Parasympathetic nervous system 
All parasympathetic preganglionic neurons are cholinergic neurons with nicotinic acetylcholine 
receptors, while most of the parasympathetic postganglionic neurons are cholinergic neurons with 
muscarinic receptors. The cholinergic nerve endings contain high concentrations of 
acetylcholinesterase, and therefore the transmitter acetylcholine does not diffuse into the 
bloodstream, making the cholinergic effects discrete and very short-lived. (Levy 1997.) Because of 
the very short duration of action, the swift and accurate regulation by the parasympathetic nervous 
system is possible, enabling, for example, beat-to-beat regulation of heart rate (Levy 1971). The 
main effects of acetylcholine are vasodilatation in essentially all vascular beds, negative 
chronotrophy, deceleration in conduction velocity, or negative dromotrophy in the sinoatrial node, 
AV node and the His-Purkinje system, and negative inotrophy especially in atrial muscle. (Higgins 
et al. 1973, Kent and Cooper 1974, Feigl 1998, Brodde and Michel 1999.) 
6.2.1.2 Sympathetic nervous system  
At exercise the sympathetic nervous system prepares the body for activity, constituting a major 
mediator of the fight or flight response. Preganglionic neurons are cholinergic also in the 
sympathetic nervous system, while postganglionic neurons are adrenergic. Adrenergic activation 
increases the heart rate, blood pressure and cardiac output, and dilates large muscular arteries and 
bronchioles. (Curtis and O’Keefe 2002.) Noradrenalin is synthesized at adrenal medulla where 
approximately 80% of the noradrenalin is methylated to form adrenaline. There are two types of 
adrenergic receptors: α and β receptors. Noradrenalin mainly excites α receptors, causing the 
constriction of essentially all the blood vessels of the body, increased activity of heart, the inhibition 
of the gastrointestinal tract, and so forth. Adrenaline excites both α and β receptors approximately 
equally, having greater effect on cardiac stimulation and lesser effect on blood vessels in muscles 
than noradrenalin. Secreted noradrenalin and adrenaline are removed from the secretory site in three 
ways: reuptake into adrenergic nerve endings, diffusion into blood and other bodily fluids, and 
destruction by tissue enzymes. Noradrenalin and adrenaline secreted directly into the tissue remain 
active for a few seconds, while the activity can last from one to several minutes when secreted into 
the blood. From the blood noradrenalin and adrenaline diffuse into tissue where they are destroyed 
by catechol-O-methyl transferase occurring mainly in the liver. Chronic sympathetic hyperactivity 
is common in the conditions that require increased vascular tone and it leads to an increase in the 
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cardiovascular workload. It is one of the factors predisposing to endothelial dysfunction, coronary 
spasm, left ventricular hypertrophy and serious arrhythmias. (Metra et al. 2000.)  
6.2.1.3 Regulation of cardiovascular function by the autonomic nervous system 
Cardiovascular autonomic reflexes help to control blood pressure and heart rate in particular. All 
blood vessels except for the capillaries, pre-capillary sphincters and most of the metarterioles are 
innervated by sympathetic nerves. The sympathetic stimulation of the small arteries and arterioles 
increases the resistance of the blood flow, decreasing the rate of blood flow into the tissues. In the 
large veins, sympathetic stimulation decreases the volume of the vessels, translocating blood into 
the heart and regulating heart’s function as a pump. Cardiac sympathetic effects are mainly 
mediated by β receptors; most of the effects of α receptors are indirect. Sympathetic stimulation of 
the heart both increases the heart rate and enhances the strength of pumping. The parasympathetic 
nervous system plays a more minor role than the sympathetic one in regulating circulation. Its main 
effects are a decrease in heart rate and heart muscle contraction as mediated by the vagus nerve.  
The principal relation between mean blood pressure, stroke volume and total peripheral 
resistance is parallel to Ohm’s law (Form. 1): 
 
Blood pressure = cardiac output ∙ total peripheral resistance  
= stroke volume ∙ heart rate ∙ total peripheral resistance     (1) 
 
Long-term regulation of blood pressure mainly involves the regulation of extracellular fluid volume 
by the kidneys via the renin-angiotensin system. The most important factor in long-term regulation 
is the balance between intake and output of fluid and electrolytes. The main regulator of short-term 
regulation of arterial blood pressure is the baroreceptor reflex. In the aortic arch and internal carotid 
arteries are stretch receptors called baroreceptors. Baroreceptors transmit a signal of heightened 
arterial pressure to the vasomotor centre in the brain stem when they become stretched. The 
vasomotor centre starts to inhibit sympathetic impulses to the heart and blood vessels and to excite 
the vagal parasympathetic centre. The net effects are the vasodilatation of veins and arterioles as 
well as a decrease in heart rate and the strength of heart contraction, leading to a decrease in blood 
pressure. Heart rate, discussed more in the next section, is mainly determined by the balance 
between parasympathetic inhibitory influences and sympathetic excitatory actions on the rate of 
impulses discharged from the pacemaker cells comprising the sinoatrial node. The relationship 
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between vagal and adrenergic action is also dependent on the existing level of basal autonomic 
activity. (Mason 1968.) The stroke volume of the heart is determined by the degree of filling of the 
heart, and hence also the venous return according to Frank-Starling’s law; the greater the volume of 
blood entering the heart during diastole, the greater the volume of blood ejected during systolic 
contraction. Total peripheral resistance is directly proportional to the length of the vessel and the 
viscosity of the blood, and inversely proportional to the radius to the fourth power. The resistance is 
controlled by vasoconstriction and vasodilatation, mediated mainly by the sympathetic nervous 
system. 
6.2.2 Overview of hemodynamic parameters received from exercise test and 
prognosis 
Impaired autonomic modulation has been shown to be a key factor in the development of a cardiac 
arrest (Exner 2009). Several haemodynamic measures received during the exercise test are 
independent predictors of adverse cardiovascular events. Heart rate during and after exercise as well 
as blood pressure and RPP are often quoted as markers reflecting sympathovagal balance. 
Chronotropic incompetence reflects the inability of heart rate to increase as a response to exercise. 
Whether these measures reflect a primary abnormality of the autonomic nervous system or a 
pathological end organ response to normal autonomic nervous system input has not been elucidated. 
(Freeman et al. 2006.)  
6.2.3 Heart rate during and after exercise 
6.2.3.1 Physiology behind heart rate regulation 
Heart rate is regulated from the sinoatrial node by both intrinsic and extrinsic mechanisms. Intrinsic 
regulation establishes the diastolic depolarisation in the sinoatrial node regulated by voltage-
sensitive pacemaker-currents, particularly the hyperpolarisation-activated ―funny‖ current If, which 
is Na
+
-K
+
-current-regulated by cyclic adenosine monophosphate (cAMP). (DiFrancesco and Borer 
2007, Verrier and Tan 2009, DiFrancesco 2010.) The name of the current is due to its atypical 
property of being an inward current slowly activating upon hyperpolarisation and causing the 
membrane potential to begin to depolarise spontaneously, thereby initiating the diastolic 
depolarisation. When at the end of a sinoatrial action potential, the membrane potential is at a very 
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low level, roughly -60 mV; the If current is then activated and responsible for initiating the diastolic 
depolarisation phase. After the membrane potential has reached approximately -50 mV, Ca
++ 
channels also open, supplying the inward Ca
++
 current. The opening of these channels causes 
depolarisation, which continues until the action potential threshold level is reached, usually at 
between -40 and -30 mV. The other atypical features of If are its dual activation by voltage and 
internal cAMP, which binds directly to channel proteins and acts as a second messenger, and a very 
small single-channel conductance. (DiFrancesco 2006.) Sympathetic stimulation raises the level of 
cAMP molecules which bind to f channels and shift the If activation range to more positive 
voltages, leading to an increase in the current at diastolic voltages and, therefore, to an increase in 
the steepness of diastolic depolarisation and heart rate acceleration. Parasympathetic stimulation 
reduces cAMP and decreases the heart rate by the opposite action – that is, by shifting the If 
activation curve towards more negative voltages. Selective inhibition of the If current can be caused 
pharmacologically by ―heart-rate-reducing‖ drugs, such as ivabradine, and it has therefore been 
suggested to offer a better prognosis in, for example, patients with CHD. (DiFrancesco 2006.) The 
intrinsic heart rate of healthy individuals is approximately 100 bpm as observed during complete 
autonomic blockade (Katona et al. 1982). 
Extrinsic regulation consists of the influence of the sympathetic and the parasympathetic 
nervous system as well as circulating hormones and reflex regulation associated with 
cardiorespiratory and baroreceptor inputs (Verrier and Tan 2009). Sympathetic stimulation via 
noradrenalin alters membrane permeability to Na
+
 and Ca
++
 ions causing more positive resting 
potential in the sinus node, thus accelerating the self-excitation. Increased permeability to Na
+
 ions 
also leads to decreased conduction time in the AV node when the impulse is proceeding from the 
atria to the ventricle. Acetylcholine, as a transmitter of the parasympathetic nervous system, alters 
the membrane permeability to K
+
 ions, allowing the rapid leakage of K
+
 ions out of the conductive 
fibres, in addition to causing hyperpolarisation and reducing the self-excitation in the sinus node.  
The main mechanisms for heart rate acceleration during exercise are a steepening of the 
slope of spontaneous diastolic depolarisation and a decrease in the resting potential as a result of a 
release of noradrenalin and adrenaline (Colucci et al. 1989, Verrier and Tan 2009). Even during 
peak high-intensity exercise, the parasympathetic system has a small, but significant effect on heart 
rate, indicating that parasympathetic withdrawal is not complete under such conditions 
(Kannankeril et al. 2004). In normal asymptomatic subjects, there is a rapid fall in heart rate during 
the first 30 seconds after exercise, followed by a shallower fall. An attenuated heart rate recovery 
immediately after exercise is thought to be a marker of reduced parasympathetic activity, with vagal 
activity via acetylcholine release from the efferent vagal nerve in particular. (Huang et al. 2005.) 
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One minute after the cessation of exercise the β-adrenergic effect of the sympathetic nervous system 
starts to withdraw. Interestingly, after both β-adrenergic and parasympathetic blocking, heart rate 
recovery prevails, indicating a non-autonomic component at play, although in a lesser role, in heart 
rate recovery. (Sundaram et al. 2008.) 
6.2.3.2 Heart rate and mortality 
A low resting heart rate is associated with high levels of parasympathetic nervous system tone, and 
it is typically seen in athletes (Lauer 2009). An elevated heart rate at rest is a risk factor for future 
cardiovascular disease as well as all-cause and cardiovascular mortality according to many 
epidemiological investigations (Dyer et al. 1980, Cook et al. 2006, Fox et al. 2007, Palatini 2007, 
Palatini 2009). In most epidemiologic studies, patients have been defined to be tachycardic if they 
have belonged to the top quintile of the heart rate distribution, which has been approximately 80–90 
bpm (Palatini 1999). Increased resting heart rate is considered to be a sign of increased sympathetic 
tone, which in turn is associated with metabolic disorders such as increased glycaemia, 
triglycerides, body-mass index (BMI) and total cholesterol (Perret-Guillaume et al. 2009). 
Maximal heart rate during exercise generally declines with age. Other known factors 
affecting maximal heart rate include the mode of exercise and general level of fitness. Vagal 
withdrawal can result in an increase of 30 to 50 bpm in heart rate, but further increases are thought 
to be due to sympathetic activation. Chronotropic incompetence refers to the inability of heart rate 
to increase appropriately during exercise and it is present in 11% to 26% of healthy middle-aged 
adults, but it has been associated with greater risk of adverse cardiac events in asymptomatic men 
and in symptomatic referral populations. (Lauer et al. 1996, Lauer et al. 1999, Curtis and O’Keefe 
2002, Eldenhy et al. 2003, Jouven et al. 2005, Savonen et al. 2006, Savonen et al. 2008.) Abnormal 
chronotropic response has been hypothesized to be related to abnormal autonomic balance because 
of decreased sympathetic sensitivity of the sinus node, resulting from cardiac disease and 
compensatory parasympathetic hyperactivity due to inappropriate vagal activation during exercise 
(Colucci et al. 1989, Townend 2006). The association between chronotropic response during 
exercise and non-sudden death from myocardial infarction (MI) is low, indicating that this risk 
factor is directly associated with a particular susceptibility to cardiac arrhythmia and does not 
reflect the development of atherosclerosis (Jouven et al. 2005). For healthy persons with an 
abnormal heart rate profile during exercise, a possible therapeutic approach might be the correction 
of the autonomic imbalance, because autonomic imbalance precedes the symptoms of 
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cardiovascular disease and aid in the early identification of patients with increased risk for SCD 
(Jouven et al. 2005). However, chronotropic incompetence may also reflect the inability of end 
organs such as the heart to respond appropriately to normal autonomic nervous input.   
Abnormal heart rate recovery after exercise has been studied among different patient 
populations, including heart failure patients (Imai et al. 1994, Sheppard et al. 2007), left ventricle 
dysfunction patients (Watanabe et al. 2001), CHD patients (Diaz et al. 2001), and the healthy 
population including important subgroups, namely the elderly, women, patients with a normal 
chronotropic response during exercise, and those taking β-blockers (Cole et al. 1999). An attenuated 
heart rate recovery after maximal as well as sub-maximal exercise has been shown to indicate worse 
prognosis (Cole et al. 1999, Cole et al. 2000), but for angiographic CHD, heart rate recovery is a 
poor diagnostic test with a sensitivity of only 31% and a specificity of 76% (Vivekananthan et al. 
2003). However, heart rate recovery has proven to be more predictive in non-cardiovascular than 
cardiovascular mortality (Cole et al. 1999). Cardiac rehabilitation has improved heart rate recovery 
by reviving the parasympathetic activation (Oldbridge et al. 1988). If there is a cool-down period 
after exercise, 12 bpm is usually defined as an abnormal heart rate recovery one minute after 
exercise (Cole et al. 1999, Nishime et al. 2000). If the exercise test is stopped abruptly, a heart rate 
recovery of ≤18 bpm in the first minute after exercise is considered to be abnormal (Watanabe et al. 
2001, Bilsel et al. 2006). Although heart rate recovery is usually defined one minute after the 
cessation of exercise, heart rate recovery at two minutes after exercise surpassed other time points 
in predicting of death, and the limit of 22 bpm at two minutes after exercise identified the high-risk 
group of patients (Shetler et al. 2001). 
Of all the heart rate parameters measured during the exercise and recovery, the heart rate 
increase from resting level to peak exercise has been found to be the most powerful predictor of 
cardiovascular prognosis after adjustment for potential confounders during treadmill exercise 
testing (Leeper et al. 2007). Heart rate and heart rate recovery are simple and non-invasive methods 
for evaluating sympathovagal balance, in addition to being provably independent risk factors for 
cardiovascular deaths, but the association with cardiovascular death may also be secondary via 
other cardiovascular risk factors. As a limitation, heart rate only communicates the net effect of the 
autonomic inputs of the sinus node, providing no direct information regarding either sympathetic or 
parasympathetic input individually. (Lahiri et al. 2008.) 
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6.2.4 Blood pressure during and after exercise 
6.2.4.1 Physiology behind blood pressure during exercise 
In the beginning of exercise, sympathetic activity predominates over vagal tone, increasing heart 
rate and cardiac output. As a result of increased cardiac output, mean arterial pressure increases by 
approximately 40% with a progressive increase in SAP. (Myers 1994.) Diastolic arterial pressure 
(DAP) exhibits little or no change (<10 mmHg) during exercise because of peripheral vasodilatation 
(Kharabsheh et al. 2006). Dysfunction in endothelium-dependent vasodilatation also plays an 
important role in abnormal SAP increase during exercise (Chang et al. 2004). Abnormally low 
blood pressure during exercise is associated with severe CHD, reduced ejection fraction (EF), or 
both (Le et al. 2008). Compared to blood pressure measurements at rest, blood pressure recordings 
during exercise are less influenced by nervousness and external factors such as noise or talking 
(Lund-Johansen 2002). SAP recording during bicycle exercise is reasonably practicable by means 
of the cuff method, while DAP may be grossly over- or underestimated (Lund-Johansen 2002). The 
rise in SAP can exceed the normal level if there is decreased aortic distensibility resulting from 
aging or aortic atherosclerosis, or increased left ventricular mass amplifying the effect of increased 
sympathetic tone (Le et al. 2008). Increased arterial stiffness increases pulse wave velocity along 
the aorta during systole, and the velocity of the later-arriving reflected pulse wave from the 
periphery also increases. The accelerated velocity of the reflected pulse wave causes a reflected 
wave from peripheral reflecting sites to the heart during systole when the ventricle is still ejecting 
blood. This phenomenon can be expressed in absolute terms (augmented pressure) or as a 
percentage of pulse pressure (augmentation index). Increased augmented pressure and augmented 
index at rest have been previously associated with higher cardiovascular mortality, in most cases 
because of underlying CHD, but among the Framingham study population the augmentation index 
was not associated with the risk of cardiovascular events in models
 
that included standard risk 
factors (Mitchell et al. 2010). The augmented systolic and pulse pressures, an effect that increases 
arterial wall stress, potentiates the development of atherosclerosis, elevates left ventricular 
afterload, and increases left ventricular mass and oxygen demand while decreasing stroke volume. 
Movement of the reflected wave from diastole
 
to systole diminishes coronary perfusion pressure 
and has
 
been shown to produce ischaemia in 29 dogs both with and without
 
epicardial coronary 
stenoses. (Buckberg et al. 1972.) Because this wave reflection does not contribute positively to the 
ejection of blood, the effect of the extra workload is wasted energy (Peterson et al. 2003, Weber et 
al. 2004). During exercise the augmented pressure is reduced with the increasing intensity of 
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exercise, persisting for up to 60 minutes into recovery. This reduction could be due to altered heart 
rate or ventricular ejection characteristics, large artery stiffness or pulse wave velocity, or a change 
in the tone of muscular arteries influencing pressure wave reflection. (Munir et al. 2008.) 
Upon recovery after exercise, SAP usually normalises quickly due to a reduction in 
sympathetic output and an increase in vagal tone, leading to a decrease in heart rate and peripheral 
resistance (Le et al. 2008). Diminished SAP recovery after exercise reflects the over-activity of the 
sympathetic nervous system and attenuated vagal reactivation (Laukkanen et al. 2004, Ushijima et 
al. 2009). Impaired chronotropic response in the later phase of exercise leads to diminished SAP 
recovery, reflecting the sympathetic hyperactivity which may suppress parasympathetic reactivation 
(Ushijima et al. 2009). Peripheral vasoconstriction may occur during exercise as a compensatory 
response to ischemic-induced left ventricular systolic dysfunction, and this compensatory 
vasoconstriction may well persist during the first few minutes of recovery, preventing normal SAP 
recovery (McHam et al. 1999). Catecholamine levels continue to increase during the first three 
minutes after the cessation of exercise, thus having an inverse correlation with the SAP level 
(Dimsdale et al. 1984). It is biologically plausible that without metabolic needs, the increasing level 
of catecholamines leads to SAP elevations beyond the normotensive range (Laukkanen et al. 2004). 
The catecholamine response could be a reflex effort to maintain SAP at a level set during the peak 
exercise, but this has not been verified. There is a relationship between attenuated heart rate 
recovery and noradrenalin desensitization (Ushijima et al. 2009). Under continuous sympathetic 
excitation, the sympathetic down-regulation is a possible cause for the desensitization to 
noradrenalin, and this may cause SAP to remain above normal until several hours post-exercise (Le 
et al. 2008, Ushijima et al. 2009). An attenuated decrease in SAP after exercise has also been 
suggested to be caused by structural changes such as poor arterial compliance together with 
underlying vascular smooth muscle hypertrophy and subclinical arteriosclerotic changes (Morrow et 
al. 1993). Nitroglycerin-induced vasodilatation of muscular arteries demonstrates that reduction in 
pressure wave reflection is an independent mechanism underlying exercise-induced changes in 
pulse waveform morphology. Reduced pressure augmentation after exercise could be one 
mechanism contributing to the phenomenon known as warm-up angina, where an initial period of 
exercise in patients with CHD limits subsequent angina. (Munir et al. 2008.) 
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6.2.4.2 Exercise blood pressure and mortality 
Exercise hypotension is most frequently defined as a drop in exercise SAP below the resting value, 
or an initial increase followed by a drop of 20 mmHg or greater while exercising (Le et al. 2008). In 
the general population the prevalence of exercise hypotension is between 5% and 8% and among 
persons with known CHD the prevalence rises up to 8–10% (Le et al. 2008). Exercise hypotension 
reflects a failure of cardiac output to increase during exercise and it is associated with severe CHD, 
aortic stenosis or left ventricular systolic dysfunction – therefore it is also associated to an increased 
risk of death, especially when associated with a prior MI or exercise-induced ischemia (Dubach et 
al. 1988). However, the increased risk has not been observed in patients with no prior MI or 
ischemia during exercise testing (Dubach et al. 1988).  
There is no widely accepted normal blood pressure response to exercise, making the 
estimation of exaggerated blood pressure response to exercise difficult (Le et al. 2008). In most 
cohort-based studies, the prevalence of exaggerated SAP, with varying definitions, during exercise 
has been shown to be 3–4%, with one in three subjects having normal resting values (Le et al. 
2008). In the Framingham study population, an abnormal rise in SAP or DAP to a level greater than 
or equal to the 95
th
 percentiles of sex- and age-specified blood pressures in patients with a normal 
resting blood pressure predicted an increased risk for future sustained hypertension (Singh et al. 
1999a). The same results were also seen in a Finnish population where patients with a SAP 
response to exercise of ≥30 mmHg or a DAP response of ≥15 mmHg were at a nearly four-fold risk 
of becoming hypertensive in comparison to the patients with lower blood pressure response to 
exercise (SAP response <10 mmHg, DAP response, <5 mmHg) (Everson et al. 1996). When the end 
point was cardiovascular or all-cause mortality, neither submaximal nor maximal blood pressure 
during exercise yielded additive prognostic information on blood pressure at rest in a study of 143 
hypertensive men (Fagard et al. 1991). Resting blood pressure has been found to have a stronger 
association to cardiovascular death than maximal blood pressure during exercise (Weiss et al. 
2010). On the contrary, exercise hypertension has been found an important independent risk factor 
for all-cause long-term mortality among patients with known or suspected peripheral artery disease 
(De Liefde II et al. 2008), but also among healthy patients (Allison et al. 1999). Some studies have 
stated that the ability of exercise blood pressure to predict mortality has been attenuated when blood 
pressure has been measured at maximum capacity, and therefore the early and steep rise in SAP 
during the exercise should be considered as a warning sign (Mundal et al. 1994, Laukkanen et al. 
2006). 
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On the other hand, a higher SAP during exercise has been associated with lower rates of 
SCD (Irving et al. 1977), cardiovascular mortality (Morrow et al. 1993, Gupta et al. 2007) and all-
cause mortality (Bouzas-Mosquera et al. 2010). Among chronic heart failure patients and those with 
a previous MI, low SAP response to exercise is a significant predictor of worse prognosis, because 
the SAP response reflects an increase in cardiac output (Hedberg et al. 2009, Nishiyama et al. 
2010). A weaker SAP rise during exercise has also been suggested to be a result of a more powerful 
reduction in systemic vascular resistance (Hedberg et al. 2009). In a healthy population, a higher 
exercise blood pressure may indicate hypertension or prehypertension, instead of normal vascular 
function, and it is therefore associated with worse long-term prognosis. In a population with a high 
burden of heart disease, the highest-risk subjects with the most extensive cardiac disease may not be 
capable of generating pressure or workload to allow the manifestation of exercise systolic 
hypertension. By comparison, therefore, those with exercise hypertension have a better prognosis. 
(Smith et al. 2009.) The association between exercise blood pressure and worse prognosis is 
supposed to have a J curve shape (Le et al. 2008). 
Abnormal SAP recovery is usually defined as a ratio of SAP after a certain time of recovery 
versus SAP during peak exercise or earlier during the recovery (Le et al. 2008). Abnormal SAP 
response to recovery has been demonstrated to be a significant prognostic factor for future 
hypertension (Singh et al. 1999a, Lund-Johansen 2002), CHD and cerebrovascular disease, as well 
as acute MI (McHam et al. 1999, Laukkanen et al. 2004, Yosefy et al. 2006), but contradictory 
results have also been reported (Ellis et al 2004). The differences in blood pressure during recovery 
from exercise between healthy people and patients with severe CHD have been thought to result 
from rapid amelioration of left ventricular asynergy, leading to an improvement in cardiac output as 
well as increased levels of circulating catecholamines, which in turn causes the increased peripheral 
vascular resistance (McHam et al. 1999). 
Even though several investigations have published imposing results about the association 
between abnormal SAP during exercise and during recovery, among middle-aged adults 
participating in the Framingham Heart Study, DAP was a significant predictor of cardiovascular 
disease during exercise and recovery, while SAP was not (Lewis et al. 2008). As large-artery 
stiffness increases in elderly subjects,
 
especially during CHD, SAP begins to rise and DAP fall, 
causing increments in pulse-pressure but no effect
 
on mean arterial pressure. The fall in DAP in the 
elderly signals a preponderance of
 
large artery stiffness as the cause of further rise in SAP. Franklin 
and colleagues showed that when assessed individually,
 
increments in pulse-pressure at a fixed SAP 
were associated with a greater
 
risk for CHD than were increments in SAP at a fixed pulse-pressure 
(1997). Based on
 
these findings, the authors hypothesized that CHD risk is related
 
more to the 
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pulsatile stress caused by large-artery stiffness
 
during systole than to the steady-state stress due to 
small-vessel
 
resistance during diastole. The same elevation in
 
SAP does not lead to the same CHD 
risk; those with lower DAP, and therefore wider pulse-pressure, have greater CHD risk, possibly 
due to greater pulsatile
 
stress. (Franklin et al. 1997) These facts about the decrease in DAP among 
clinical and subclinical CHD patients may explain the results from the Framingham Heart Study. In 
any case, the significance of DAP during the recovery was diminished when resting blood pressure 
was taken into account (Lewis et al. 2008). 
In summary, in populations with a high risk of CHD, a relatively low SAP at peak exercise 
is independently associated with severe CHD and cardiovascular events. In contrast, despite strong 
evidence to the effect that exaggerated SAP among an apparently healthy population is associated 
with a risk of cardiovascular events, partially contradictory findings exist to confuse the issue (Le et 
al. 2008).  
6.3 Prognostic ECG markers during exercise test  
6.3.1 Overview of ECG parameters received from exercise test and prognosis 
The most frequently used parameter for diagnostic estimation received from the exercise stress test 
is ST segment depression. However, exercise ECG offers a considerable amount of information 
beyond the ST segment. Various non-invasive tools for evaluating conduction abnormalities and 
vulnerability to arrhythmias are received during exercise testing. The number of leads showing 
changes in the ST segment as well as the duration of ST deviation into recovery after exercise have 
been demonstrated to associate with poor prognosis (Gibbons et al. 1997). Heart-rate-adjusted ST 
segment depression (ST/HR) analysis improves the prognostic capacity of standard
 
exercise ECG 
(Elamin et al. 1980, Kligfield et al. 1987, Bigi et al. 2005). Analysis could be represented by the 
ST/HR index utilising only the information from the exercise phase or by ST/HR hysteresis which 
represents a heart-rate-corrected average difference in the ST segment depression between the 
recovery and the exercise phase of the exercise test (Lehtinen et al. 1997, Svart et al. 2010).  
Ventricular premature beats occur in both healthy and unhealthy hearts. Premature 
ventricular complexes have been observed among heart failure–free patients during or after exercise 
in more than half of the individuals (Jouven et al. 2000, Dewey et al. 2008). During recovery the 
occurrence of frequent ventricular ectopy (ventricular premature beats ≥7/min) – including 
ventricular bigeminy, ventricular trigeminy, ventricular couplets, ventricular triplets, sustained or 
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nonsustained ventricular tachycardia, ventricular flutter, torsade de pointes, or ventricular 
fibrillation – has been stated to be strongly predictive of an increased risk of death from all causes, 
whereas the occurrence of frequent ventricular ectopy only during exercise is not connected with an 
increased risk of death (Frolkis et al. 2003). In suitable settings ventricular premature beats can 
reflect a damaged myocardium, constituting a marker of the presence of an arrhythmogenic 
substrate and thus acting as a trigger of ventricular tachycardia (Tapanainen 2003). During recovery 
after exercise, premature beats can reflect the attenuated vagal reactivation (Frolkis et al. 2003).  
During the repolarisation, the myocardial cell transmembrane potential returns to its baseline 
level following a passing depolarising electrical impulse. Repolarisation takes place in wide areas 
simultaneously. (Tapanainen 2003.) The heterogeneity of repolarisation is present in various 
pathological cardiac disorders, creating a substrate for ventricular arrhythmias (Tapanainen 2003). 
The arrhythmogenic mechanism is probably due to the facilitation of re-entry (Spargias et al. 1999). 
The first variable representing the heterogeneity of cardiac repolarisation was QT dispersion, but 
later it was considered to be nothing more than an approximate and simplistic expression of 
repolarisation abnormality, and the reliability of both automatic and manual measurement of QT 
dispersion was low and significantly lower than that of the QT interval (Malik and Batchvarov 
2000). Dynamic repolarisation measures, such as QT variability and TWA provide more 
information on risk than static measures, such as QT dispersion, because of the unpredictable nature 
of most cardiac arrests (Exner 2009). TWA, reflecting the ventricular repolarisation, is discussed 
more thoroughly later.    
Other ECG markers that have been linked to poorer prognosis include HRV and PR interval. 
HRV is the parameter representing beat-to-beat alternation in heart rate, which reflects 
cardiovascular responses to autonomic activity. HRV is one of the investigated parameters in the 
present study and it is discussed more thoroughly in the next section. PR interval, representing 
atrium-ventricle conduction, is also discussed in more detail later.   
 
6.3.2 Heart rate variability 
6.3.2.1 Physiology behind heart rate variability 
HRV, or differences in beat-to-beat interval (R-R interval) between successive heart rate cycles, is a 
tool for assessing cardiovascular responses to autonomic activity. The clinical relevance of HRV 
 The Prognostic Power of the Clinical Exercise Test  -  33 
was first appreciated in 1965
 
when Hon and Lee noted that foetal distress was preceded by 
alterations
 
in interbeat intervals before any perceivable change occurred
 
in heart rate itself. (Task 
Force of the European Society of Cardiology and the North American Society of Pacing 
Electrophysiology 1996). In 1981 the power spectral analysis of heart rate fluctuations was 
introduced for the quantitative evaluation of beat-to-beat cardiovascular
 
control (Akselrod et al.).
 
The clinical importance of HRV became appreciated
 
in the late 1980s, when the relationship 
between HRV and cardiovascular mortality was discovered (Kleiger et al. 1987, Malik et al. 1989, 
Bigger et al. 1992). 
HRV is predominantly dependent on extrinsic regulation of the heart rate, including 
respiration, baroreflexes and thermal regulation (Malpas 2002, Perini and Veicsteinas 2003). The 
degree of HRV provides information about the functioning of the nervous control on the heart rate 
and the ability of heart to respond, namely the balance between the sympathetic and 
parasympathetic nervous system (Acharya et al. 2006). The parasympathetic nervous system has the 
main response of high frequency (HF) HRV, while the sympathetic nervous system affects low 
frequency (LF) HRV, due to the physiological features of the autonomic nervous system described 
earlier (Malpas 2002, Acharya et al. 2006). Considering this, it is surprising that it has been found 
in many studies that HF-HRV increases gradually during exercise, whereas LF-HRV decreases 
during exercise (Dixon et al. 1992, Perini et al. 1993, Pichon et al. 2004). The results of a study on 
1,297 male veterans who were exercise-tested at the Palo Alto Veterans' Affairs Hospital indicated 
that LF-HRV, namely normalized LF power, was greater in the two-minute period immediately 
after exercise than in the last two minutes during the exercise. At the same time, normalised HF 
power was found to be lower during the recovery than in the last two minutes of exercise. This 
supports the supposition that, in addition to sympathetic and parasympathetic function, there are 
additional mechanisms, such as baroreceptor function, accounting for HRV during exercise and 
HRV is probably best explained by the complex interplay of multiple inputs to the heart, rather than 
simply autonomic imbalance. (Freeman et al. 2006.)  
6.3.2.2 Measurement of heart rate variability 
Time domain analysis calculates a number of variables that describe beat-to-beat changes in heart 
rate. These changes include the standard deviation (SD) of all normal R-R intervals (N-N intervals) 
in the entire 24-hour ECG-recording (SDNN), the SD of the mean value of all five-minute segments 
of normal R-R intervals (SDANN) and the percentage of difference between adjacent normal R-R 
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intervals that exceed 50 ms (NN50) as well as the proportion derived
 
by dividing NN50 by the total 
number of N-N intervals (pNN50) and the square root of the mean squared differences of 
successive
 
N-N intervals (RMSSD). (Barron and Lesh 1996.) Other time domain measurements that 
can be used are variations
 
in instantaneous heart rate secondary to respiration, tilt, the Valsalva
 
manoeuvre, or phenylephrine infusion. All HRV variables are dependent on the length of the 
recording period, and therefore the recordings of different durations are not directly comparable.  
Spectral analysis of HRV allows the assessment of frequency-specific fluctuations in heart 
rate behaviour and provides prognostic information beyond the time-domain measures (Bigger et al. 
1993). In the spectral analysis, power spectral density of the R-R intervals is calculated and then 
analyzed by calculating powers and peak frequencies for different frequency bands. The HF (0.15-
0.4 Hz) band is thought to represent the parasympathetic component of the autonomic nervous 
system. The LF (0.04-0.15 Hz) component is mediated by both the parasympathetic and the 
sympathetic nervous system and is influenced by the baroreceptor system. The very low frequency 
(VLF, 0.0033-0.04 Hz) and ultra low frequency (ULF <0.0033 Hz) bands are influenced by many 
factors, including thermoregulation and the renin-angiotensin system. (Barron and Lesh 1996.) The 
VLF peak is generally quoted in absolute units and as a percentage of total power (the total area 
under the HRV spectrum curve), whereas the LF and HF peaks are usually quoted in absolute units, 
as a percentage of total power, and in units that are normalized to total power (after subtracting the 
contribution of the VLF component). The Poincaré plot is a geometric method for dynamic analysis 
of HRV where each R-R interval is plotted as a function of the previous R-R interval. The SDs of 
the Poincare plots are referred to as pcSD1 and pcSD2, respectively. PcSD1 is related to the fast 
beat-to-beat variability in heart rate, while pcSD2 describes the longer-term variability. Measures 
derived from different frequency bands of heart period variability are especially attractive 
candidates for predictors of mortality after MI, because certain frequency bands of the heart period 
power spectrum have been associated with autonomic nervous system control of sinus node period. 
(Pomeranz et al. 1985, Pagani et al. 1986.) A recent study has shown that HRV measurements, 
particularly those in the frequency domain, may vary largely and unpredictably from day to day in 
the same subject, making the assessment difficult (Maestri et al. 2009). 
6.3.2.3 Heart rate variability and mortality 
Reduced HRV has been suggested to be a reflection of elevated sympathetic activity which is 
known to attenuate baroreceptor reflexes, presumably decreasing the threshold for ventricular 
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fibrillation and predisposing an individual to life-threatening arrhythmias. Lower HRV may also 
reflect an intrinsic impairment in the physiological regulatory and adaptive mechanisms that 
regulate heart rate, causing the individual to be less able to tolerate a perturbation such as an 
ischemic event or more routine rhythm disturbances. Heritable factors may explain a substantial 
proportion of the variance in heart rate and HRV. (Singh et al. 1999b.) It has been shown in several 
studies that HRV alters before ventricular tachyarrhytmias (Vybiral et al. 1993, Valkama et al. 
1995, Huikuri et al. 1996, Shusterman et al. 1998) and during balloon angioplasty created acute 
coronary occlusion (Airaksinen et al. 1993, Airaksinen et al. 1999). 
Depressed HRV has been shown to be associated with increased mortality among the 
Framingham cohort (Tsuji et al. 1994), among survivors of acute MI (Kleiger et al. 1990, Zuanetti 
et al. 1996, Bulleccetti et al. 2009), among women (Janszky et al. 2004) and among diabetics 
(Kataoka et al. 2004). Depressed HRV has also been associated with an increased risk of new 
cardiac events (Tsuji et al. 1996) and cardiovascular mortality in subjects without CHD (Dekker et 
al. 2000). Impaired HRV has been associated with heart failure and the progression of 
atherosclerosis (Huikuri et al. 1999), a greater risk for developing hypertension (Singh et al. 1998) 
as well as high plasma glucose levels (Singh et al. 2000).   
In the CARISMA study, ECG was recorded six weeks after an acute MI. SDNN, VLF and 
HF were significant predictors of fatal or near-fatal arrhythmias during the two-year follow-up 
(Huikuri et al. 2009). In the REFINE study, measured either two to four weeks or 10 to 14 weeks 
after an acute MI, depressed SDNN had no prognostic power as regards future cardiovascular 
events, though the later recordings were nearly significant (Exner et al. 2007). Reduced HRV after 
MI is more powerful in predicting SCD and symptomatic ventricular tachycardia than EF <35%, 
indicating that reduced HRV probably reflects the lack of an autonomic defence against ventricular 
fibrillation, which indentifies those patients who are at high risk of SCD or arrhythmic 
complications (Malik and Camm 1994, Copie et al. 1996). Reduced EF is more likely to reflect a 
liability to cardiac failure and thus identify patients who are at risk of non-sudden death. Survivors 
of MI probably constitute the population of patients who may benefit most from HRV assessment. 
According to both the CARISMA and the REFINE study, measurement of cardiovascular 
autonomic function late (over six weeks) after an MI provides more powerful information on the 
risk of fatal or near-fatal arrhythmic events than do measurements performed early after MI. (Exner 
et al. 2007, Huikuri et al. 2009.) 
The prognostic power of HRV during exercise has not been adequately studied. On the 
contrary to the results concerning HRV at rest, greater short-term HRV during peak exercise and 
recovery have been associated with all-cause and cardiovascular mortality (Dewey et al. 2007). It 
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has been postulated that non-neuronal mechanisms such as the mechanical effect of increased 
respiratory activity dominate the HRV spectrum at increasing workloads (Bernardi et al. 1990, 
Pichon et al. 2006), and the prognostic findings during peak exercise may be caused by this non-
neuronal stimulus and its differences between patients.  
6.3.3 T-wave alternans 
TWA is a specific form of ECG alternans that is related to repolarisation abnormalities. 
Macroscopic TWA was first time reported as early as 1908 by H.E. Hering and it has always been 
associated with poor prognosis (Garcia 2008). In 1948 H.H. Kalter published a review of 48 
patients with macroscopic TWA. Among this relatively small patient group, the 24-hour mortality 
was 60% (Osman and Gold 2002). The microscopic TWA was first reported in the 1980s by 
Richard Cohen and his colleagues (Adam et al. 1984). They found that reducing the ventricular 
fibrillation threshold level in 20 dogs resulted in the development of TWA. TWA was calculated 
from the power spectrum of the T-wave fluctuations. Ventricular fibrillation has been indicated as a 
manifestation of repolarisation heterogenetics in cardiac muscle (Nearing and Verrier 2003, Weiss 
et al. 2000). During the 21
st
 century, TWA has been investigated in numerous patient groups, 
including dilated cardiomyopathy patients (Hohnloser et al. 2003a, Verrier et al. 2003a, 
Klingenheben et al. 2005, De Ferrari and Sanzo 2009), hypertrophy cardiomyopathy patients 
(Momiyama et al 1997, Kuroda et al. 2002, Puntmann et al. 2010), ischemic cardiomyopathy 
patients (Chow et al. 2006, Chan et al. 2008), patients with Brugada syndrome (Chinushi et al. 
2001, Ikeda et al. 2001, Morita et al. 2002, Ohkubo et al. 2003), patients with congenital heart 
disease (Alexander et al. 2006, Schmitt et al. 2009), patients with reduced left ventricular EF 
(Hennesdorf et al. 2000, Kondo et al. 2001, Hohnloser et al. 2003b, Huikuri et al. 2003, Bloomfield 
et al. 2004, Cantillon et al. 2007), diabetics (Molon et al. 2007, Martin et al. 2009), CHD patients 
(Ikeda et al. 2000, Krittayaphong and Chotinaiwatarakul 2002) and healthy subjects (Garcia et al. 
2009). Microscopic TWA has been associated with an increased risk of life-threatening arrhythmias 
and some of the TWA researchers have regarded TWA as a bifurcation point preceding ventricular 
fibrillation (Narayan 2006). On the other hand, in some study populations TWA has not been a 
prognostic factor for ventricular tachyarrhytmias (Chow et al. 2008), SCD or ICD discharge, though 
it has been associated with all-cause mortality (Gold et al. 2008). 
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6.3.3.1 Physiology behind T-wave alternans 
In primary TWA, repolarisation alternans is present without concurrent fluctuations in other ECG 
components. In secondary TWA, the QRS complex also alternates in bigeminal rhythm and in 
response to conduction changes, such as fusion beats, MI or heart failure. Most of the clinical 
studies are based on primary TWA, although the distinction between these two phenomena is not 
always clear. The physiology behind TWA is based on beat-to-beat alternation of action potential 
duration (APD) at the level of the cardiac myocytes. There are two major conceptual frameworks 
which have been proposed to explain the cellular mechanisms of TWA; APD restitution and 
calcium cycling dynamics (Armoundas et al. 2002). 
According to the first proposal, APD alternans by the mechanism of steep restitution is the 
primary event in a series of events linked to TWA and arrhythmogenesis. Action potential 
restitution means the relationship between APD and the diastolic interval (DI). (Narayan 2006, 
Narayan 2008; Fig 1.) In the case of a steep restitution curve (>1), the shortening of DI produces a 
short APD in the next cycle and, given that cycle length is constant, a long DI. This in turn gives 
rise to a long APD with an associated short DI, leading to concordant alternation. (Myles et al. 
2008; Fig 2.)  
 
                       
Fig. 1. Action potential restitution 
is the interval separating the 
current action potential from the 
prior one. If the restitution is steep 
(slope >1), diastolic interval (DI) 
shortening abruptly shortens action 
potential duration (APD), which 
lengthens the next DI and APD 
leading to APD alternans.  
CL= cycle length 
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At an ionic level, action potential alternans may be caused by alternans of cytosolic Ca
2+
 
(Hirayama et al. 1993). Intracellular Ca
2+
 modulates the magnitude of ionic currents during the 
repolarisation phase of the action potential. Under normal conditions the amount of Ca
2+
 released 
from the sarcoplasmic reticulum in the ventricular myocyte equals the sarcoplasmic reticulum 
reuptake by Ca
2+ 
-adenosine triphosphatase (SERCA2a). Repolarisation alternans can occur 
whenever the myocyte’s capabilities to maintain the balance between the release and reuptake are 
compromised, such as when heart rate is elevated. (Verrier et al. 2009.)  
Cardiac alternans may be spatially concordant or disconcordant. In the spatially concordant 
alternans, all the tissue regions alternate in the same phase. In the spatially discordant case, some 
regions of tissue alternate in a long-short-long pattern, whereas other regions alternate in a short-
long-short pattern. These regions are separated by a nodal line, in which no alternans
 
is present. At a 
nodal line, the spatial gradients in APD or
 
Ca
2+
 transient amplitude are the steepest, predisposing to 
localized
 
conduction block. (Weiss et al. 2006.) 
Highly arrhythmogenic conditions occur when TWA progresses from concordant to 
discordant, namely when the alternation in one area is out of phase with an adjoining area. This 
situation is conductive to re-entry and wave break. (Karma 1993, Pastore et al. 1999, Weiss et al. 
1999, Weiss et al. 2006.) Among the most significant anatomical barriers leading to gradients in 
APD is myocardial scar resulting from MI, or abnormal myocardial fibre orientation or fibrosis in 
patients with hypertrophy.  
Fig. 2. Temporal dispersion of repolarization. Action potential duration (APD) alternates between 
cycles, either from alternans of cytosolic calcium or steep APD restitution. DI=diastolic interval 
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6.3.3.2 Measurement of T-wave alternans 
Microvolt TWA is generally too small to be detected by visual inspection of the ECG, but it can be 
measured using several distinct computer analysis methodologies. The two most common and most 
investigated methods are the Spectral Method and MMA Method. In 1988 Smith and colleagues 
developed the Spectral Method which allowed the measurement of alternans at the level of 1 µV 
(1988). A slightly modified version was presented in 1994 (Rosembaum et al.). In the Spectral 
Method, sequential ECG cycles are aligned to their QRS complex and the amplitude of the ST 
segments and T-waves at a predefined point are measured. Thereafter, this beat-to-beat series of 
amplitude fluctuations is divided into 128 segments and processed with Fast Fourier transform to 
generate a separate spectrum for each point. These spectra are averaged to produce a composite 
spectrum. The peaks in the composite spectrum correspond to respiratory variation, pedalling if 
bicycle exercise is performed, and noise. The peak at 0.5 beats is due to TWA, if present. The 
alternans voltage in microvolts represents the square root of alternans power and it is defined as the 
voltage difference between the overall mean beat and the even or odd numbered mean beats. The 
alternans ratio represents the ratio of the alternans amplitude to the SD of the background noise. 
(Osman and Gold 2002.) An alternans level of >1.9 µV with an alternans ratio of >3 sustained over 
two minutes is defined as a positive test result. Test results below this level are negative. The 
Spectral Method has been the most prolific one and has been reported in all clinical populations 
involved in TWA screening. (Garcia 2008.) It is also included in commercial equipments, such as 
CH2000 and Heartwave (Cambridge Heart Inc, Bedford; MA). One of the strengths of the Spectral 
Method is its ability to differentiate between true alternans and non-specific noise in the ECG signal 
(Armoundas and Cohen 1997). The major limitation is that it requires stationary data, which is 
achieved by elevating and stabilising heart rate at a predetermined level by atrial pacing or exercise. 
This process, together with unsustained TWA, ventricular ectopy and noise during the exercise, 
increases the number of indeterminate tests, which occur in 20–40% of cases. (Kaufman et al. 
2006.) Therefore, the Spectral Method is not compatible for ambulatory ECG monitoring during 
patients’ daily activities. Because of the large number of indeterminate test results, a test 
classification of ―abnormal due to patient factors‖ has been introduced. This classification includes 
excessive ectopies, the lack of capacity to reach target heart rate, and non-sustained TWA. 
Abnormal test results due to patient factors carry the same risk level than positive test results. 
(Kaufman et al. 2006.) Technically indeterminate test results have no prognostic power (Kaufman 
et al. 2006). Atrial fibrillation typically leads to irregulations in R-R intervals and prevent controlled 
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heart rate elevations. Therefore, atrial fibrillation patients are typically excluded from TWA 
analysis with the Spectral Method.  
Nearing and Verrier developed the MMA Method to allow TWA measurement in freely 
moving individuals (2002, Verrier et al. 2003b, Verrier et al. 2005). The MMA Method allows 
microvolt TWA measurements during routine exercise testing and ambulatory ECG monitoring by 
circumventing the heart rate stationarity requirements. In this time-domain method the MMA 
algorithm reports TWA as the maximum difference in T-wave morphology between successive 
beats.  It separates odd beats from even beats, creates median complexes of both the odd and even 
beat streams separately, and the maximum difference between odd and even median complexes at 
any JT segment is reported as a TWA value. Results are updated every 10–15 seconds by an update 
factor, usually 1/8, which is the fraction of morphology change that an incoming beat can contribute 
to the median complex. (Nearing and Verrier 2002.) The MMA Method is included in commercial 
equipment such as the CASE-8000 by GE Medical Systems. Because the MMA Method generates 
high-resolution templates of superimposed QRS-aligned complexes showing the alternation pattern, 
the method permits visual examination to verify the presence and magnitude of TWA (Minkkinen et 
al. 2009, Slawnych et al. 2009).
 
If the cut-off point for positive TWA results is used, TWA values 
above the cut-off point should be reread for verification. If numerical values are reported, they 
should be reread down to 20 μV.  For exercise testing, the MMA Method employs the TWA cut-off 
point of ≥60 μV to indicate significantly enhanced risk of SCD when used as a single screening test 
(Minkkinen et al. 2009), and for ambulatory monitoring, TWA values ≥46 μV indicate increased 
risk (Verrier et al. 2003b, Sakaki et al. 2009, Slawnych et al. 2009). The precise cut-off points for 
different patient populations remain to be determined.   
The comparisons between time-domain and frequency-domain TWA methods have shown 
that TWA magnitude measured by the Spectral Method is smaller than that derived with the MMA 
Method (Hostetler et al. 2005, Selvaraj and Chauhan 2009). The Spectral Method reports one half 
of the average TWA magnitude across the entire JT interval for 128 beats, whereas the MMA 
Method reports the peak TWA level at any point within the JT interval for a 15-second interval. 
Furthermore, the update factor can account for a several-fold difference in the detected TWA level. 
The MMA Method can detect short-term TWA better than the Spectral Method (Hostetler et al. 
2005), but the MMA Method also falsely detects or overestimates TWA in the presence of noise 
(Selvaraj and Chauhan 2009). The Spectral Method can better distinguish physiologic signals, for 
example T-wave amplitude modulation by respiration, from real TWA, because frequency-domain 
analysis is more robust at discriminating 0.5 cycles per beat TWA signal from periodic noise at 
lower frequencies (Selvaraj and Chauhan 2009). After Selvaraj and Chauhan published their results 
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concerning TWA and noise, prefiltering has became an essential part of TWA measurements by 
means of the MMA Method. Even though prefiltering probably improves the MMA Method, noise 
has been considered to be one of the fundamental problems with the method. 
6.3.3.3 The autonomic nervous system and T-wave alternans 
TWA is a heart-rate-dependent property of the heart and it typically occurs at elevated heart rates. 
In comparison to heart rate, sympathetic stimulation does not have similar effect on the amplitude 
of TWA. (Kaufman et al. 2000.) Above a specific heart rate threshold, TWA increases 
monotonically independently of the autonomic state and TWA is therefore usually measured at 
heart rates above rest but below rates likely to cause false positives (Kaufman et al. 2000). The 
optimal heart rate for the measurement of TWA is between 100 and 120 bpm (Kavesh et al. 1998). 
When the Spectral Method is used, sustained TWA has been settled to occur at heart rates <120 
bpm to be considered abnormal. When the MMA Method is used, it is suggested that TWA values 
above the cut-off points be reread for verification, or if numerical values are reported, they should 
be reread down to 20 μV to verify the presence and magnitude of TWA. However, the 
investigations about the heart rate limit and the MMA Method are still ongoing. For patients at risk 
for SCD, TWA develops at lower heart rates as compared to the healthy population. (Kaufman et al. 
2000.) Too excessive and too rapid increase in heart rate would cause an overshoot of heart rate into 
ranges that could induce TWA also in low-risk individuals (Cutler and Rosembaum 2009a). Both 
exercise and pacing have been used for accelerating heart rate, but bicycle exercise has been shown 
to be superior to pacing in clinical risk stratification (Rashba et al. 2002a, Tanno et al. 2004). On the 
other hand, simultaneous atrial and ventricular pacing significantly more rarely leads to 
indeterminate test results than bicycle exercise and atrial pacing (Raatikainen et al. 2005). Atropine 
has been used for accelerating heart rate, but the effect of atropine on the T-wave has not been 
studied enough yet (Rashba et al. 2002b). 
The results concerning the influence of the sympathetic nervous system on TWA are 
contradictory. There is strong evidence that an increase in sympathetic activity plays a critical role 
in triggering ventricular tachyarrhythmias (Schwartz and Malliani 1975, Kavesh et al. 1999, Harada 
et al. 2003, Murata et al. 2003). β-blocking also reduces arrhythmic events and TWA magnitude 
and, in some cases, this may cause false negative TWA values (Klingenheben et al. 2001, Rashba et 
al. 2002b, Chan et al. 2010). Furthermore, β-blocking might prevent patients from reaching an 
adequate heart rate during the study. Based on these assumptions, it has been suggested that β-
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adrenergic therapy should not be continued during TWA testing. On the contrary, Zacks et al. have 
provided evidence that oral β-blocker therapy has no effect on the predictive value of TWA in 
patients with CHD, diminished left ventricular function or a history of non-sustained ventricular 
tachycardia (Zacks et al. 2007). However, acute and intravenous β-blocker therapy cannot be 
compared with the chronic oral therapy (Zacks et al. 2007).  
6.3.3.4 T-wave alternans and mortality 
The prognostic power of TWA has been evaluated in many large clinical studies during the last 
decade (Table 2). At the same time, when TWA has been associated with an increased risk of life-
threatening arrhythmias, the most hopeful researchers have expected TWA to be a new guide when 
selecting patients for ICD therapy. Though several TWA studies have used cut-off points when 
dividing the study population into high-risk and low-risk groups, MMA-based TWA studies support 
the concept that TWA represents a continuum of risk – the higher the level of TWA, the greater the 
risk. (Nearing et al. 1994, Minkkinen et al. 2009, Slawnych et al. 2009.) In 2003 the ATRAMI 
researchers published results concerning the association between TWA measurement from 
ambulatory 24-hour ECG and cardiac events in 1,284 post-MI patients. Using the MMA Method for 
detecting TWA, they found the odds ratios of cardiovascular events during 21±8 months’ follow-up 
to fall between 4.2 and 7.9 (p<0.01) for  patients who have TWA above the 75
th
 percentile at 2 to 25 
days following an MI, as compared to patients with lower levels of TWA. (Verrier et al. 2003b.) In 
2004 the results from the MADIT II study were published revealing out that in 1,232 post-MI 
patients with impaired EF, the increased TWA during an exercise test, as measured by the  Spectral 
Method, yielded the hazard ratio (HR) of 4.8 (p=0.020) for two-year mortality, when compared to 
the patients with normal TWA (Bloomfield et al.). 
In the REFINE study, 322 post-MI patients underwent a submaximal exercise test including 
TWA measurements with the Spectral Method. At two to four weeks after the MI, the exercise-
based TWA was not predictive of long-term outcomes, but when the test was performed 10 to 12 
weeks after the MI, the HR for non-negative TWA was 2.75 (95% confidence interval [CI] 1.08–
7.02, p=0.034) as compared to those with negative TWA. (Exner et al. 2007.) The first results 
concerning TWA in FINCAVAS indicated an association between TWA ≥65 µV and all-cause and 
cardiovascular mortality as well as SCD during 45 months’ follow-up in 1,037 low-risk patients 
referred to a clinical exercise test. The main indications for exercise testing in FINCAVAS were 
suspicion of CHD (46%), adequacy of CHD treatment (24%), vulnerability to arrhythmia during 
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exercise (18%), evaluation of working capacity (19%), obtaining an exercise test profile prior to an 
invasive procedure (13%) and obtaining an exercise test profile after an MI (10%) (Table 2) 
(Nieminen et al. 2007). In the EPHESUS study, abnormal TWA (≥47 µV), measured from the 
ambulatory ECG at 2 to 10 days after an MI using the MMA Method, was a powerful predictor of 
SCD for 493 patients with left ventricular dysfunction (Table 2) (Stein et al. 2008).  
Contradictory evidence on TWA as a prognostic marker was received from the MASTER 
Trial and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). In the MASTER Trial, the 
association between TWA and ICD discharge was tested with 575 post-MI patients who met the 
MADIT-II criteria. Non-negative (including 81% positive and 19% indeterminate) TWA by the 
Spectral Method during a treadmill exercise test was not associated with ventricular tachyarrhytmic 
events, although it was associated with total mortality (HR 2.04 [95% CI 1.10-3.78], p=0.02) 
(Chow et al. 2008). In the SCD-HeFT study, 490 patients with symptomatic heart failure were 
TWA-tested with the Spectral Method (Gold et al. 2008). During the approximately 30 months of 
follow-up, there were no differences between TWA-positive and TWA-negative patients in SCD, 
ventricular arrhythmias, or ICD discharge. Although TWA was a significant predictor of 
arrhythmias in a study of 286 patients with left ventricular dysfunction, the event rate in the TWA-
negative group did not differ from the TWA-non-negative group, suggesting that TWA alone may 
not be capable of identifying a sufficiently low-risk subset in that particular population to obviate 
the need for ICD implantation (Cantillon et al. 2007). The Alternans Before Cardioverter 
Defibrillation (ABCD) trial is the only study so far where TWA has been used as one of the criteria 
for ICD implantation. In the study of 566 patients with ischemic cardiomyopathy and low left 
ventricular EF, the primary end point (appropriate ICD discharge or SCD) rates were significantly 
higher among patients with either a positive TWA (HR 2.1, p=0.03) or a positive electrophysiologic 
study (HR 2.4, p=0.007) than in those whose TWA and electrophysiologic tests were non-positive 
at one year. Patients with negative results for both of these tests had significantly lower event rates 
than those with two positive tests (2% vs. 12%; p=0.017). In the ABCD study TWA predicted 
endpoint events at one year but not at two years of follow-up, suggesting a time-dependent nature of 
TWA predictivity. (Constantini et al. 2009, Amit et al. 2010.)  
The discussion on TWA testing and its prognostic power has been intensive in recent years, 
and the clinical utility of TWA remains controversial. As a marker of areas predisposed to 
arrhythmias, TWA has been suggested to aid in decision-making as regards the patients’ need for 
and benefits from ICD (Cutler and Rosembaum 2009b). Many studies have found that the rate of 
ventricular tachyarrhythmic events among patients who test TWA negative is exceedingly low,
 
suggesting that ICD therapy may not benefit such patients
 
(Klingenheben et al. 2000, Ikeda et al. 
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2002, Kitamura et al. 2002, Hohnloser et al. 2003b, Armoundas et al. 2005, Bloomfield 2006,  
Chow et al. 2007, Ikeda et al. 2006, Salerno-Uriarte et al. 2007). Therefore, TWA has been 
proposed as a means of guiding ICD therapy in patients with risk factors for SCD but no prior 
history of sustained ventricular tachyarrhythmic events, namely primary prevention patients. The 
negative results from the MASTER and SCD-HeFT studies were controversial in regard to this 
hypothesis. The controversy in the results has been suggested to arise from diverse patient 
populations, testing protocols and endpoint definitions in the various studies. (Bansal and Berger 
2010.) In the SCD-HeFT trial, the amount of indeterminate TWA tests were 2- to 4-fold greater 
than in other studies. The survival rates of TWA-positive versus TWA-negative patients in the 
study population examined in the SCD-HeFT sub-study began to diverge from each other after 14 
to 28 months of follow-up, which was precisely the period of time when the SCD phenotype 
emerged in the main SCD-HeFT study population. Therefore, this study population was proposed to 
characterise the late-appearing SCD phenotype which has a strong correspondence with the TWA 
signal. (Rosenbaum 2008.) The predictive accuracy of ICD discharge has been strong in the TWA 
studies enrolling relatively few patients with ICDs, as compared to the studies with high ICD use 
(Hohnloser et al. 2009). Recently, it has been theorised that TWA may be dependent on T-wave 
amplitude, but there are no studies to date to prove or reject this statement. The TWA index, by the 
amplitude of corresponding T-waves-adjusted TWA, could provide some advantage over maximum 
TWA value (Madias 2009a-e).  
In summary, TWA is a promising marker of ventricular arrhythmias and SCD, and therefore 
it may also be valuable when deciding on patients’ ICD therapy (Gehi et al. 2005). The applications 
of signal procession techniques to quantify TWA clinically have generated a sizeable literature of 
prognostic clinical studies enrolling a total of more than 12,000 patients. The strength of TWA is its 
up to 97% negative predictivity value for cardiovascular mortality and SCD (Gehi et al. 2005). 
However, many questions remain to be addressed, including the connection between heart rate and 
TWA as well as TWA’s reflection on the surface ECG. (Cutler and Rosembaum 2009) Moreover, 
uniform guidelines about the measurement and interpretation of TWA are yet to be determined. 
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Table 2. Clinical studies of T-wave alternans with the Modified Moving Average Method 
Study Patient population LVEF 
Follow-
up 
period 
Recovery 
time after 
MI 
HR for end-point 
      
Verrier et al. 
2003b 
1284  post-MI patients in 
ambulatory ECG 
moderately depressed 
(42±3%) 
21 
months 
15±10 days Maximal TWA: 7.9 (1.9-33.1) 
for cardiac arrest due to VF or 
arrhythmic death in lead V5 
Exner et al. 
2007 
322 post-MI patients in 
ambulatory ECG 
moderately depressed 
(38-48%) 
47 
months 
2-4 weeks NS 
    10-14 
weeks 
TWA ≥5 µV: 2.94 (1.10–7.87) 
for CVD or resuscitated cardiac 
arrest 
Nieminen et 
al. 2007 
1037 patients in routine exercise 
testing 
preserved (65±15%, 
529 patients) 
45 
months 
 TWA ≥65 µV: 3.3 (1.8-6.3) for 
all-cause death 
     TWA ≥65 µV: 6.0 (2.8-12.8) 
for CVD 
     TWA ≥65 µV: 7.4 (2.8-19.4) 
for SCD 
Stein et al. 
2008 
493 post-MI patients in 
ambulatory ECG 
depressed (34±5%) 16 
months 
2-10 days TWA ≥65 µV: 5.5 (2.2-13.8) 
for SCD in lead V3 
Sakaki et al. 
2008 
295 cardiomyopathy patients in 
ambulatory ECG 
depressed (34±6%) 1 year  TWA ≥65 µV: 17.1 (6.3-46.6) 
for CVD 
     TWA ≥65 µV: 22.6 (2.6-193.7) 
for witnessed SCD 
Minkkinen et 
al. 2009 
2119 patients in routine exercise 
testing 
preserved (60-66%) 47 
months 
 TWA  ≥90 µV: 6.4 (2.0-21.2) 
for CVD 
     TWA  ≥60 µV: 4.6 (1.7-12.3) 
for SCD 
Slawnych et 
al. 2009 
322 post-MI patients, 681 CAD 
patients 
moderately 
depressed, preserved 
(38-63%) 
48 
months 
 TWA  ≥60 µV: 2.5 (1.1-6.0) for 
CVD 
     TWA  ≥20 µV: 2.5 (1.2-6.1) for 
CVD 
Maeda et al. 
2009 
21 controls, 21 post-MI with VT 
and 21 post-MI without VT in 
ambulatory ECG 
depressed (36-43%) 
for post-MI group 
6 years  TWA ≥65µV: 6.1 (1.1-34.0) for 
sustained VT or VF 
Stein et al. 
2010 
general population patients (49 
cases, 98 controls) in ambulatory 
ECG 
assumed preserved 14 years  TWA ≥37µV: 4.8 (1.5-15.8) for 
SCD 
 
CVD=cardiovascular death; LVEF=left ventricular ejection fraction; MI=myocardial infarction; 
SCD=sudden cardiac death; VF=ventricular fibrillation; VT=ventricular tachycardia;
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6.3.4 PR interval 
The PR interval is determined by the conduction time from the sinus node to the ventricles. 
Therefore, it integrates information about a number of sites in the conduction system of the heart. 
The situation where the PR interval exceeds 200 ms is known as first-degree AV block. This block 
may result from conduction delay in the atrium, the AV node or the His-Purkinje system. More than 
one site of conduction delay is often present. (Cheng et al. 2009.) First-degree AV block has been 
considered a benign and functional phenomenon since recently (Mymin et al. 1986, Cheng et al. 
2009). Among healthy adults of 20–40 years of age, 1–2% have a prolonged PR interval, and the 
prevalence of first-degree AV block increases to 3–4% by the age of 60 years (Packard et al. 1954, 
Perlman et al. 1971, Rose et al. 1978). 
6.3.4.1 Physiology behind the PR interval 
The PR interval represents the time required for an electrical impulse from the sinoatrial node to 
conduct through the atria, the AV node, the bundle of His, bundle branches, and Purkinje fibres. 
Prolongation of the PR interval may be due to a conduction delay within any of these sites or a 
combination of several sites. AV nodal dysfunction accounts for the majority of cases. (Zipes 
1997.) A conduction delay in the His-Purkinje system is often associated with bundle-branch block. 
As early as in 1982, the possible mechanisms of conduction delay were detailed as follows: a 
decrease in adrenergic and increase in vagal tone; local liberation of metabolites (such as adenosine) 
in response to ischemia; structural changes in the AV node or the vicinity thereof, giving rise to 
complete or partial bypass of the impulses which normally pass through the AV node; and changes 
in AV conduction brought on by altered autonomic nervous activity as elicited by myocardial 
ischemia (Erikssen et al.). Structural changes appear in the cardiac skeleton after 40 years age, and 
responses to catecholaminergic or inotropic stimuli are blunted in older age. Therefore, one of the 
early ECG manifestations of these abnormalities representing advanced physiological age may be 
the prolongation of the PR interval, which may be related to progressive alterations in the 
conduction system or cardiac structure, or both.  
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6.3.4.2 PR interval and mortality 
Isolated first-degree AV block has generally not been associated with an increased risk of SCD, 
syncope or progression to higher degrees of AV block. In a 30-year longitudinal study of 3,983 
Royal Canadian Air Force Pilots, moderate first-degree AV block was concluded as a benign 
phenomenon, suggesting that first-degree AV block does not convey prognostic information among 
young, healthy men (Mymin et al. 1986). In the Tecumseh Community Health Study there was no 
excess incidence of cardiovascular disease or mortality among the persons with long PR intervals 
(>210 ms) during a 4-year observation of 4,678 adult men and women (Perlman et al. 1971). After a 
7-year follow-up, a moderate but significant association was observed between prolonged PR 
interval and lower incidence of CHD in a study on 1,832 healthy males aged 40 to 59 years 
(Erikssen and Otterstad 1984). Similar results were found when 18,403 middle-aged male civil 
servants collected from the National Health Service Register were investigated. Among 366 men 
with prolonged PR intervals (>220 ms), the CHD mortality rate was slightly lower than among the 
study group as a whole, though the difference was within chance limits. (Rose et al. 1978)  
First-degree AV block has been associated with CHD over a 5-year follow-up (Blackburn et 
al. 1970). Last year, Cheng and colleagues showed an association between abnormal AV 
conduction at rest and the outcomes including atrial fibrillation (approximately 2-fold risk) and all-
cause mortality (approximately 1.4-fold risk) among 7,575 individuals from the Framingham Heart 
Study population with a follow-up period of 20 years (Cheng et al. 2009).  
According to these results, prolonged PR interval is rarely an indicator of more severe 
conduction disturbances during a follow-up of less than five years. Exceptions to these results 
include patients with non-isolated first-degree AV block, where intra-atrial conduction delays prone 
to atrial fibrillation, acute MI, or bundle branch disease offer a possibility of developing a higher 
degree of AV block. 
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7 AIMS OF THE STUDY 
The aim of the present dissertation, including five sub-studies, was to investigate the prognostic 
power of the exercise test in predicting mortality. The more detailed aims of each study are listed 
below.  
 
STUDY I: To investigate the prognostic power of HRV measured during the exercise test and the 
recovery phase after the exercise for mortality.  
 
STUDY II: To evaluate the hypothesis that the change from the peak to recovery values in SAP and 
RPP can be used to predict all-cause and cardiovascular mortality as well as SCD in patients 
referred to a clinical exercise test. 
 
STUDY III: To evaluate the association between future cardiovascular mortality and the PR interval 
measured at rest and during the recovery phase after exercise.  
 
STUDY IV: To determine whether the combined analysis of heart rate recovery and TWA enhances 
the predictive power for cardiovascular and all-cause mortality over the independent assessment of 
either variable, and to compare their predictive strength to other standard risk factors.  
 
STUDY V: To take a more thorough look to the appearance, magnitude and prognostic power of 
TWA in precordial leads. Is TWA in some specific precordial lead or leads associated with poorer 
prognosis than in others? Is it more dangerous to have high values of TWA in one lead or low TWA 
in several leads?    
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8 MATERIALS AND METHODS 
8.1 The Finnish Cardiovascular Study (FINCAVAS) 
The purpose of the FINCAVAS project is to construct a risk profile using ECG as well as 
haemodynamic and genetic markers of individuals at a high risk of cardiovascular diseases, events 
and deaths (Nieminen et al. 2006). The second objective is to elucidate the effects and interactions 
of exercise, commonly used cardiovascular medications and a variety of candidate genes in people 
with no cardiac diseases as well as patients with CHD.  
8.1.1 Study population 
A detailed description of the FINCAVAS population is presented in Table 3. The total study 
population consists of patients who were referred to a clinical exercise test at Tampere University 
Hospital between October 2001 and December 2008 and were willing to participate in the study. 
Patients with technically successful storage of exercise test data were included. The exercise test 
was considered technically adequate if the hemodynamic data and continuous digital ECG signal 
were stored successfully. The duration of total follow-up was until September 2009 (Data 3), but 
smaller data (Data 1, 2) were gathered after shorter follow-up periods. At the end of follow-up, the 
survival status of each patient was checked and the causes of death were gathered from the Causes 
of Death Register maintained by Statistics Finland; this source has been determined to be reliable 
(Pajunen et al. 2005.) The certificates included causes of death using the tenth revision of the 
International Classification of Diseases (ICD-10). The diagnosis numbers and certificate texts were 
used to classify the deaths as all-cause, cardiovascular or SCD (defined as a cardiac death within 24 
hours after the onset of symptoms). The classification of deaths was assessed by blinded 
adjudication to the results of exercise test findings. Data 2 was used in the first four sub-studies 
(Studies I, II, III and IV). In the fifth study (Study V), all data for 4,568 patients (Data 3) were 
available. Of these, 1,352 (30%) patients had a diagnosis of CHD before the exercise testing (Data 
3). After the exercise testing, coronary angiography was performed on 755 (17%) patients, and over 
50% stenosis was found in 291 (6.4%) of these patients (Data 3).   
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8.1.2 Exercise protocol 
Before the exercise test, each patient signed an informed consent, after which the medical history of 
each patient was collected with a computer-based questionnaire form. Prior to the exercise test, the 
patient lay down in the supine position for 10 minutes, and the resting ECG was recorded digitally. 
The upright routine exercise test was performed using a bicycle ergometer with electrical brakes. 
The lead system was the Mason-Likar modification of the standard 12-lead system. The initial 
workload varied from 20 W to 30 W, and the load was increased stepwise by 10–30 W every 
minute. Continuous ECGs were digitally recorded at 500 Hz with the CardioSoft exercise ECG 
system (Versions 4.14, 4.2 and 6.51, GE Healthcare, Freiburg, Germany). During the test, heart rate 
was continuously registered on the ECG, while SAP and DAP were measured manually with a 
brachial cuff every two minutes. Most of the tests were sign- and symptom-limited maximal tests, 
but some tests on special occasions (for example, after an MI) had an upper limit of 120–130 bpm 
for heart rate. 75% of the patients reached the maximal heart rate of over 130 bpm (Data 3). The 
main reasons for discontinuing the exercise testing were fatigue (42%), difficulty in breathing 
(6.9%) and chest pain (3.7%) (Data 3). The recovery phase after the exercise was at least five 
minutes. In the post-exercise phase, heart rate and blood pressure were defined in the sitting 
position at one to four minutes after the cessation of exercise.  
For HRV analysis (Study I), R-R interval data during the pre-exercise phase, first and last 
minute of exercise as well as during the first two minutes of recovery were analysed using HRV 
Analysis Software (version 1.1, Biosignal Analysis and Medical Imaging Group, University of 
Kuopio, Kuopio, Finland). The following time domain HRV variables were analysed: mean R-R, 
SDNN and RMSSD. In addition, the Poincare plot analysis (pcSD1, pcSD2) was run. For the 
frequency domain HRV variables, the R-R interval data was resolved into HF (>0.15 Hz), LF (0.04-
0.15 Hz) and VLF (<0.04 Hz) components including absolute power of each bandwidth (pow), 
power in normalised units (pow n.u.) and percentage power (powprc) using nonparametric Fast 
Fourier transform. The baseline trend in heart rate was removed using the smoothness priors 
method (Tarvainen et al. 2002.) After detrending, all the R-R intervals of the frequency domain 
HRV variables were re-sampled with cubic interpolation at a rate of 4 Hz. 
TWA was measured using the time-domain FDA-cleared MMA Method by GE Healthcare. 
In Study IV, peak TWA values were analysed at the heart rates of <125 bpm, whilst in Study V, 
TWA values were analysed with no regard to the exercise heart rate. In Study V, TWA values of 
≥46 µV were reread by a physician investigator and corrected if necessary, or discarded based on 
noise or baseline wander. The cut-off point 46 µV were chosen based on previous study where this 
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cut-off point, coinciding with the 75
th
 percentile, was used to predict cardiac arrest and arrhythmic 
death. (Verrier et al. 2003b) The investigators who analysed the TWA test results were blinded to 
the events. 
PR intervals were assessed to the nearest millisecond one minute before the start of exercise 
and two minutes after the cessation of exercise using the CASE Workstation (version 1.82, GE 
Healthcare). The software composed a spatial ECG vector from the 12 standard ECG leads. An 
average complex was calculated based on the normal cardiac cycles. In the averaged cycle, P-onset 
and QRS-onset were defined. The first deflections from the 0 lines of the P-wave and the QRS 
complex were used for measurement of the PR interval. All extreme PR interval values (>250 ms or 
<90 ms) were reread by a physician investigator and corrected if necessary. Manually and 
automatically measured PR intervals at the pre- and post-exercise phases were compared in a subset 
of 100 randomly chosen ECGs. The PR intervals in lead II were reread by a physician, and three 
random measurements were averaged. Bias between manually and automatically derived values was 
defined as the mean difference between the paired PR intervals, and limits of agreement were 
calculated as bias ±2 SD of the measurement pairs. The bias for the pre-exercise phase was 4 ms 
(limits of agreement −10 ms to 18 ms) and for the post-exercise phase 5 ms (−17 ms to 26 ms).  
  
 
Table 3. The FINCAVAS population  
 
Period of data 
collected 
End of follow-
up 
Study 
population 
Female 
Age 
(Mean± SD) 
Follow-up 
(Months) 
Mortality Indication for exercise test 
Data 1 October 2001– 
January 2003 
January 2006 1037 364 (35.1%) 58±13 44±7 All-cause death 59 (5.7%) suspicion of CHD 46% 
      
CV death 34 (3.3%) evaluation of work capacity 19% 
       
SCD 20 (1.9%) vulnerability to arrhythmia during exercise 18% 
        
adequacy of CHD treatment 24% 
        
obtaining an exercise test profile prior to an invasive procedure 13% 
        
obtaining an exercise test profile after an MI 10% 
Data 2 October 2001– 
December 2004 
May 2007 2431 867 (35.7%) 57±13 47±13 All-cause death 142 (5.8%) suspicion of CHD 44% 
      
CV death 69 (2.8%) evaluation of work capacity 18% 
       
SCD 36 (1.5%) vulnerability to arrhythmia during exercise 21% 
        
adequacy of CHD treatment 16% 
        
obtaining an exercise test profile prior to an invasive procedure 13% 
        
obtaining an exercise test profile after an MI 8% 
Data 3 October 2001– 
December 2008 
September 2009 4568 1765 (38.6%) 56±13 55±13 All-cause death 321 (5.4%) suspicion of CHD 45% 
      
CV death 138 (3.0%) evaluation of work capacity 18% 
       
SCD 63 (1.4%) vulnerability to arrhythmia during exercise 21% 
        
adequacy of CHD treatment 16% 
        
obtaining an exercise test profile prior to an invasive procedure 13% 
        
obtaining an exercise test profile after an MI 8% 
 
CHD= coronary heart disease; CV=cardiovascular; MI=myocardial infarction; SCD=sudden cardiac death; SD=standard deviation; 
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8.1.3 Ethical aspects 
The study protocol was approved by the Ethics Committee of the Tampere University Hospital 
District, Finland, and all patients gave informed consent prior to the interview and measurements as 
stipulated in the Declaration of Helsinki. 
8.2 Statistical analysis 
Statistical analyses were made using SPSS release 14.0 (Studies I, II, IV) or release 16.0 (Studies 
III, V) for Windows (SPSS, Inc., Chicago, IL, USA). All statistical tests were two-tailed and used 
an α-level of <0.05. The t-test for independent samples and Mann-Whitney U-test were used to 
compare continuous parameters, and the χ2-test was applied for dichotomous variables. Before 
statistical analysis, patients with atrial fibrillation and atrial flutter were excluded. HRs were 
analysed for all-cause and cardiovascular mortality as well as for SCD by Cox regression analysis. 
In the multivariate Cox analysis, we used standard coronary risk factors as covariates, namely sex, 
age, BMI, smoking, hypercholesterolemia, diabetes, use of β-blockers, prior MI, prior diagnosis of 
CHD, heart rate and QRS complex width. The exact combination of covariates varied, to a degree, 
between studies because of the progression of the FINCAVAS data and for the purposes of 
developing our analysis. The physiology of the investigated parameter had an effect on selected 
covariates as well. The proportionality assumption for all covariates was checked by using the 
correlations of the survival rankings with the Schoenfeld residuals. The significance of mortality 
rates by quintiles was determined with Poisson regression (Studies III and V). In Study IV Harrell’s 
C indices were calculated by STATA 10.1 for Windows (StataCorp LP, College Station, TX, USA). 
Harrell’s C index is a generalisation of the area under the receiver operator curve for survival data 
with censored cases. 
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9 RESULTS 
9.1 Heart rate during and after exercise 
The mean of the achieved percentages of age-adjusted expected heart rate during the exercise was 
84±14% (mean±SD). The maximum heart rate reached during the exercise and heart rate recovery 
one minute after exercise were significantly higher among survivors than non-survivors in Study IV 
(Fig. 3). To evaluate the heart rate recovery one minute after the cessation of exercise as a 
categorised variable, we used the cut-off point of 18 bpm, because of the abrupt end of the exercise 
(Studies II, IV). After adjustment for common coronary risk factors (sex, age, BMI, smoking, use of 
β-blockers, reached maximum heart rate, prior MI, CHD, diabetes and hypercholesterolemia), heart 
rate recovery was a significant predictor of all-cause mortality (HR 2.5, 95% CI 1.6-3.7, p<0.01 
[Study IV], HR 2.4, 95% CI 1.6-3.6, p<0.01[Study II]) and cardiovascular mortality (HR 2.3, 95% 
CI 1.3-4.2, p=0.01 [Study IV], HR 2.4, 95% CI 1.3-4.3, p<0.01 [Study II]) when applying the cut-
off point of 18 bpm. For SCD heart rate recovery with the cut-off point of 18 bpm was not a 
significant predictor of mortality (Study II). (Table 5.) As a continuous variable, heart rate recovery 
produced statistically significant HR for all-cause mortality (0.97, 95% CI 0.95-0.99, p<0.01), but 
not for cardiovascular mortality or SCD (Study II).  
The differences in maximal heart rate during the exercise might have an influence on the 
prognostic power of heart rate recovery. Therefore, we also tested the prognostic power of heart rate 
recovery separately to the patients with maximal heart rate ≤130 bpm (N=1141) and the patients 
with maximal heart rate >130 bpm (N=3427) (Data 3). Among patients with maximal heart rate 
≤130 bpm, heart rate recovery with the cut-off point of 18 bpm was a significant predictor of all-
cause mortality (HR 2.3, 95% CI 1.6-3.4, p<0.01) and cardiovascular mortality (HR 2.8, 95% CI 
1.6-5.1, p<0.01), but not for SCD (Data 3). Among patients with maximal heart rate >130 bpm, 
heart rate recovery with the cut-off point of 18 bpm was a significant predictor of all-cause 
mortality (HR 2.2, 95% CI 1.6-3.1, p<0.01), but not for cardiovascular mortality or SCD (Data 3). 
 
 
The Prognostic Power of the Clinical Exercise Test  -  55 
 
0
20
40
60
80
100
120
140
160
180
Maximum heart rate 
during the exercise
Heart rate recovery at 
1 min after exercise
H
ea
rt
 r
a
te
 / 
h
ea
rt
 r
a
te
 r
ec
o
v
er
y
 (
b
p
m
)
Survivors
Non-survivors
 
Fig. 3. Maximum heart rate±standard deviation (SD) during the exercise and heart rate 
recovery±SD after exercise among survivors and non-survivors. The differences between the groups 
were statistically significant (p<0.01). (Study IV.) 
 
9.2 Blood pressure during and after exercise 
SAP did not differ significantly between survivors and non-survivors during the pre-exercise phase, 
while DAP was significantly (p<0.05) higher among survivors (80 mmHg [Study I, IV, V]) than 
non-survivors (75 mmHg [Study I], 76 mmHg [Study IV], 78 mmHg [Study V]). During the 
exercise SAP as well as DAP were significantly higher among survivors than non-survivors (Fig 4.) 
(Study IV). As a predictor of mortality, SAP during peak exercise was not associated with any 
classes of mortality, although for all-cause mortality it reached near significance (HR 0.99, 95% CI 
0.98-1.00, p=0.01) after adjustment for common coronary risk factors. SAPrecovery (SAPpeak-exercise – 
SAP post-exercise) was not a significant predictor of any class of mortality (Study II). (Table 5.) 
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Fig. 4. Systolic and diastolic blood pressures±standard deviations (SD) during peak exercise among 
survivors and non-survivors. The differences between the groups were statistically significant 
(p<0.01). (Study IV.) 
9.3 Heart rate variability during and after exercise 
We investigated the behaviour and prognostic power of HRV during and after the exercise test 
(Study I). As the exercise intensified, mean R-R interval and RMSSD decreased with a significant 
(p<0.01) trend, while the influence of the HF component increased and the influence of the LF band 
decreased (p<0.01) (Fig. 5).  
During the pre-exercise phase, log VLF power (HR 0.56, 95% CI 0.43–0.72), log LF power 
(HR 0.58, 95% CI 0.45–0.74), log LF power (n.u.) (HR 0.75, 95% CI 0.64–0.87), log HF power% 
(HR 1.44, 95% CI 1.09–1.88), pcSD2 (HR 0.61, 95% CI 0.43–0.86), and log RMSSD (HR 0.72, 
95% CI 0.56– 0.92) were significant (p<0.01) predictors of better prognosis after adjustment for 
coronary risk factors (age, BMI, MET, sex, smoking, use of β-blockers, diabetes, CHD, prior MI). 
(Table 5.) During the first minute of exercise, smaller log LF power (HR 0.70, 95% CI 0.55–0.94, 
p<0.01) was associated with increased risk of mortality. None of the HRV parameters were 
connected with mortality at peak exercise or during the recovery phase. (Table 5.) 
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Fig. 5. Log RMSSD and VLF, LF and HF frequency bands during the exercise test. (Study I.) 
HF=high frequency; LF=low frequency; RMSSD=square root of the mean squared differences in
 
N-
N intervals; VLF=very low frequency;  
9.4 T-wave alternans during and after exercise 
During maximum exercise, heightened TWA was found in 5.2% of 1,972 patients when we used the 
cut-off point of 60 µV (Study IV). Maximum TWA during exercise as a continuous variable in 
every precordial lead differed significantly (p=0.04) between survivors 35.8 (±21.8) µV and non-
survivors 39.9 (±23.3) µV (Study IV). After adjustment for coronary risk factors (sex, age, BMI, 
smoking, use of β-blockers, reached maximum heart rate, prior MI, CHD, diabetes and 
hypercholesterolemia), the HR of heightened TWA (≥60 µV) for all-cause mortality was 2.5 ( 95% 
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CI 1.4-4.5, p<0.01) and for cardiovascular mortality 5.8 ( 95% CI 3.1-11.1, p<0.01) (Study IV). 
After extending the study population to over 3,000 patients (Data 3), the TWA values of ≥46 µV 
were reread by a physician investigator and corrected if necessary or discarded based on noise or 
baseline wander. The analysis of every precordial lead separately yielded significant differences in 
leads V1 and V3-V6 between survivors (N=3367) and non-survivors (N=231) (Fig. 6) (Study V).  
In Data 3, maximum TWA during exercise in all precordial leads was a significant predictor 
for cardiovascular mortality and all-cause mortality (Table 4), but not for SCD (Study V). 
Analysing each precordial lead separately and in lead combinations, TWA in lead V5 exceeded all 
other single leads as well as combinations of leads for all-cause mortality. For cardiovascular death, 
combination of anterior and lateral precordial leads (V3-V6) yielded the greatest HR. Leads V3 and 
V5, as well as combinations of the leads V3, V4 and V5, were significant predictors of SCD.  
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Fig. 6. Maximum TWA (median and interquantile range) during exercise in precordial leads 
between survivors and non-survivors. The differences between these two groups were significant 
(p<0.05) in leads V1 and V3–V6. (Modified from Leino et al. 2011.) 
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During the recovery after the exercise, heightened TWA was found in 3.9% of patients when we 
used the cut-off point of 60 µV (Study IV). Lowering the cut-off point to 20 µV led 51.3% patients 
to be classified as abnormal. During the recovery phase, TWA was different between the survivors 
and the non-survivors (26.7±23.4 µV versus 31.3±19.5 µV, p=0.03). After adjustment for the 
previously mentioned covariates, TWA ≥60 µV during recovery was associated with all-cause 
mortality (HR 2.4, 95% CI 1.3-4.4, p<0.01) and cardiovascular mortality (HR 3.5, 95% CI 1.6-7.9, 
p<0.01) (Study IV). Using a TWA cut-off point of 20 µV, the association between TWA and 
mortality was not significant with regard to either all-cause or cardiovascular mortality (Study IV).  
 
 
 
Table 4. Statistically significant hazard ratios (HR) and 95% confidence intervals (CI) for T-wave 
alternans (TWA) in precordial leads using Cox multivariable regression analysis. Covariates in the 
multivariable analysis were sex, age, body-mass index (BMI), smoking, use of β-blockers, reached 
maximum heart rate, prior myocardial infarction (MI), coronary heart disease (CHD) and diabetes. 
(Study V.) 
 
 
 
  All cause death 
  
  HR 95 CI (lower) 95 CI (upper) p 
TWA in all precordial leads 1.011 1.001 1.021 0.026 
TWA in V5 1.015 1.004 1.020 0.006 
TWA in V2, V3, V4, V5 or V6 1.012 1.003 1.022 0.012 
TWA in V3, V4, V5 or V6 1.013 1.003 1.023 0.007 
TWA in V4, V5 or V6 1.012 1.002 1.022 0.019 
TWA in V5 or V6 1.014 1.003 1.025 0.010 
TWA in V4 or V5 1.012 1.002 1.021 0.021 
TWA in V3, V4 or V5 1.012 1.003 1.022 0.012 
 
    
 Cardiovascular death     
  HR 95 CI (lower) 95 CI (upper) p 
TWA in all precordial leads 1.020 1.006 1.034 0.005 
TWA in V5 1.022 1.007 1.038 0.004 
TWA in V2, V3, V4, V5 or V6 1.023 1.010 1.036 0.001 
TWA in V3, V4, V5 or V6 1.024 1.011 1.038 0.000 
TWA in V4, V5 or V6 1.022 1.009 1.036 0.001 
TWA in V5 or V6 1.023 1.008 1.038 0.003 
 TWA in V4 or V5 1.021 1.007 1.035 0.003 
TWA in V3, V4 or V5 1.022 1.009 1.036 0.001 
 
    
 
SCD 
 
  
  HR 95 CI (lower) 95 CI (upper) p 
TWA in V3 1.023 1.003 1.044 0.025 
TWA in V5 1.023 1.002 1.045 0.033 
TWA in V4 or V5 1.022 1.002 1.041 0.031 
TWA in V3, V4 or V5 1.021 1.002 1.041 0.029 
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9.5 PR interval before and after exercise 
The 135 (6.8%) patients who had first-degree AV block, 6.7% of whom faced cardiovascular death 
during follow-up, were significantly older (64 vs. 56 years, p<0.01) and more obese (BMI 29 vs. 
27, p<0.01). They were more often men (73 vs. 62%, p<0.01), non-smokers (84 vs. 72%, p<0.01) 
and users of β-blockers (81 vs. 40%, p<0.01). Furthermore, their heart rate during pre-exercise (65 
vs. 74 bpm, p<0.01), exercise (127 vs. 147 bpm, p<0.01) as well as two minutes after exercise (82 
vs. 99 bpm, p<0.01) was significantly lower than of those with no AV block. PR interval quintiles 
did not differed significantly between cardiovascular death patients and survivors when measured 
during the pre-exercise phase. During the recovery after the exercise the trend of cardiovascular 
mortality rates was significantly (p<0.01) higher toward the highest quintiles of PR interval (Fig. 7). 
According to Cox regression analysis after adjustment for typical risk factors (sex, age, BMI, use of 
β-blockers, heart rate, QRS-complex width, CHD and diabetes), first-degree AV block at the 
recovery phase was a significant predictor of cardiovascular mortality (HR 2.73, 95% CI 1.25-5.95, 
p=0.01). The adjusted PR interval as a continuous variable also predicted mortality significantly 
(HR 1.36, 95% CI 1.15-1.62, p<0.01). During the pre-exercise phase the PR interval did not predict 
mortality either as a continuous or a dichotomized variable. (Table 5.) (Study III.) 
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Fig. 7. Unadjusted incidence rate of cardiovascular mortality per 1,000 person-years among patients 
divided into quintiles based on PR intervals in the pre- and post-exercise phases. The range of PR 
intervals (ms) is given for each bin. The p-values for trends are calculated with Poisson regression. 
(Nieminen et al. 2010.) 
9.6 Combinations of exercise test variables 
9.6.1 Rate-pressure product 
The product of SAP and heart rate during the exercise (RPPpeak) was not significantly associated 
with an increased risk for either all-cause or cardiac mortality or SCD (Study II) (Table 5). The 
recovery of RPP after exercise (RPPrecovery) yielded the HRs of 0.85 for SCD (95% CI 0.73-0.98, 
p=0.02), 0.87 for cardiovascular death (95% CI 0.78-0.97, p=0.01) and 0.87 for all-cause mortality 
(95% CI 0.81-0.94, p<0.01). The prevalence of death was clearly higher in the quintile with the 
lowest RPPrecovery than the one with the highest. (Fig. 8.) 
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Fig. 8. Prevalence (%) of unadjusted all-cause and cardiovascular (CVD) mortality as well as 
sudden cardiac death (SCD) for the recovery of rate-pressure product (RPPrecovery) quintiles. 
(Nieminen et al. 2008.) 
9.6.2 Combination of heart rate recovery and T-wave alternans 
Heart rate recovery lower than 18 bpm one minute after the cessation of exercise, combined with 
TWA greater than 20 µV measured during the recovery, yielded the HRs of 3.0 for all-cause 
mortality (95% CI 1.6-5.5, p<0.01) and 5.2 for cardiovascular mortality (95% CI 1.8-14.4, p<0.01) 
(Table 5.). When only one of these variables was classified as abnormal, the HRs were 2.0 for all-
cause mortality (95% CI 1.2-3.5, p=0.01) and 3.5 for cardiovascular mortality (95% CI 1.3-9.1, 
p=0.01) (Table 5.). The cut-off point of 60 µV for TWA measured during the recovery as combined 
with abnormal heart rate recovery yielded an HR of 6.1 for all-cause mortality (95% CI 2.8-13.2, 
p<0.01) and 8.0 for cardiovascular mortality (95% CI 2.9-22.0, p<0.01) (Table 5.). When TWA was 
measured during the exercise, the cut-off point of 60 µV combined with abnormal heart rate 
recovery predicted all-cause mortality with an HR of 5.0 (95% CI 2.1-12.1, p<0.01) and 
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cardiovascular mortality with an HR of 12.3 (95% CI 4.3-35.3, p<0.01) (Table 5.). All these 
combinations exceeded the predictive power of ST segment deviation (0.1 mV) during the exercise. 
Survival curves for the exercise-based TWA ≥60 µV in combination with abnormal heart rate 
recovery are shown in Fig. 9.  
We also calculated the Harrell’s C indices for all parameters in combination with HRR and 
TWA. The Harrell’s C index is a generalisation of the area under the receiver-operating 
characteristic curve that allows for censored data. Of all the combinations tested, the highest C 
indices were yielded by exercise-based TWA ≥60 µV in combination with abnormal heart rate 
recovery, namely 0.677  for all-cause mortality (95% CI 0.631-0.723) and 0.713 for (95% CI 0.648-
0.777) cardiovascular mortality. (Study IV.) 
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Fig. 9. Adjusted survival curves by Cox regression for the exercise-based TWA ≥60 µV in 
combination with abnormal heart rate recovery. In the Cox regression analysis, the difference in 
survival between groups was statistically significant (p<0.01). Please note that the scale for the y-
axis is from 0.75 to 1.00. (Leino et al. 2009.) 
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Table 5. Hazard ratios and 95% confidence intervals for the exercise test parameters during pre-
exercise, peak exercise and recovery. All results are statistically significant (p<0.05).   
 
 
    Pre-exercise     
    All-cause death CVD SCD 
HRV (log) (VLF power) Study I 0.56 (0.43-0.72) 
 
  
HRV (log) (LF power) Study I 0.58 (0.45-0.74) 
 
  
HRV (log) (LF power n.u.) Study I 0.75 (0.64-0.87) 
 
  
HRV (log) (HF power %) Study I 1.44 (1.09-1.88) 
 
  
HRV (log) (RMSSD) Study I 0.72 (0.56-0.92) 
 
  
HRV (pcSD2) Study I 0.61 (0.43-0.86) 
 
  
PR interval (ms) Study III 
 
NS   
First-degree AV block Study III   NS   
 
 
 
 
 
 
 
 
 
 
 
    Peak exercise     
    All-cause death CVD SCD 
HRV (log) (VLF power) Study I NS 
 
  
HRV (log) (LF power) Study I NS 
 
  
HRV (log) (LF power n.u.) Study I NS 
 
  
HRV (log) (HF power %) Study I NS 
 
  
HRV (log) (RMSSD) Study I NS 
 
  
HRV (pcSD2) Study I NS 
 
  
SAP (mmHg) Study II 0.99 (0.98-1.00) NS NS 
TWA (µV) Study V 1.011 (1.001-1.021) 1.020 (1.006-1.034) NS 
TWA ≥60 µV Study IV 2.5 (1.4-4.5) 5.8 (3.1-11.1)   
TWA in lead V5 (µV) Study V 1.015 (1.004-1.020) 1.022 (1.007-1.038) 1.023 (1.002-1.045) 
TWA  ≥60 µV+ HRR ≤18 bpm Study IV 5.0 (2.1-12.1) 12.3 (4.3-35.8)   
RPP (1000 bpm mmHg) Study II NS NS NS 
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CVD=cardiovascular death; HF=high frequency; HRR=heart rate recovery; HRV=heart rate 
variability; LF=low frequency; NS=non significant; pcSD =standard deviation of Poincare plot; 
RMSSD=square root of the mean squared differences in
 
N-N intervals; RPP=rate-pressure product; 
SAP=systolic arterial pressure; SCD=sudden cardiac death; TWA=T-wave alternans; VLF=very 
low frequency;
    Recovery      
    All-cause death CVD SCD 
Heart rate recovery ≤18 bpm Study IV 2.5 (1.6-3.7) 2.3 (1.3-4.2)   
Heart rate recovery ≤18 bpm Study II 2.4 (1.6-3.6) 2.4 (1.3-4.3) NS 
HRV (log) (VLF power) Study I NS 
 
  
HRV (log) (LF power) Study I NS 
 
  
HRV (log) (LF power n.u.) Study I NS 
 
  
HRV (log) (HF power %) Study I NS 
 
  
HRV (log) (RMSSD) Study I NS 
 
  
HRV (pcSD2) Study I NS 
 
  
SAP (mmHg) Study II NS NS NS 
TWA ≥60 µV Study IV 2.4 (1.3-4.4) 3.5 (1.6-7.9)   
TWA ≥20 µV Study IV NS NS   
PR-interval (ms) Study III 
 
1.36 (1.15-1.62)   
First-degree AV block Study III 
 
2.73 (1.25-5.95)   
TWA  ≥60 µV+ HRR ≤18 bpm Study IV 6.1 (2.8-13.2) 8.0 (2.9-22.0)   
RPP (1000 bpm mmHg) Study II 0.87 (0.81-0.94) 0.87 (0.78-0.97) 0.85 (0.73-0.98) 
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10  DISCUSSION 
10.1 Requirements for estimating cardiovascular prognosis 
The background of cardiovascular health and prognosis is multifactorial. Therefore, screening high-
risk patients among large populations is challenging. Screening CHD patients who are at risk for an 
acute MI leading to SCD is only a single aspect in the risk stratification. Other cardiovascular 
endpoints besides SCD should also be taken into account. In addition to CHD, such factors as 
vulnerability to arrhythmias, anatomical abnormalities, electrolyte imbalances, genetic disturbances, 
valvular disturbances and many others could raise patient into the high-risk group.  
The risk for cardiovascular events is much more likely to be a continuum from low-risk to 
high-risk than a single cut-off point dividing patients into either group. Choosing the cut-off points 
has been considered a major problem in prognostic studies, because creating non-clinically based 
cut-off points has been suggested to generate false outcomes. A negative value of a parameter 
cannot relieve the patient from facing the investigated end-point in future. However, cut-off points 
can aid clinicians in decision-making and provide assistance when generating guidelines for further 
examinations and therapy. Choosing the cut-off points should be based on the study population’s 
pre-test possibility for cardiovascular events, and different cut-off points should be determined for 
different populations. Conventional dichotomy limits derived from or used in univariate analyses do 
not provide the best prediction of events when several predictors are combined. (Redwood et al. 
1997.) Therefore, optimal prediction of future cardiovascular events is obtained by changing these 
dichotomy limits when variables are combined. Optimal dichotomy limits are also influenced by the 
combination of variables used and by the clinical event selected. (Redwood et al. 1997.) 
With low-risk patients, the clinical focus in terms of cardiovascular diseases should be on 
primary prevention. High-risk patients should undergo further investigations, such as coronary 
angiography, if necessary. In some cases treatment could be commenced immediately. (Gibbons et 
al. 1997, Gibbons 2008, Miller 2008.) In the ideal test, the test protocol would be uniform between 
hospitals. Because cardiovascular death could be derived from several reasons, the ideal test would 
take account of all the possibilities for abnormal cardiovascular function, including the autonomic 
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function of the cardiovascular system, the mechanical function of the heart as well as anatomical 
abnormalities and possible origins for arrhythmias. 
10.2 Sudden cardiac death 
When the definition of one hour from the onset of symptoms is applied, the proportion SCDs in all 
natural deaths is
 
13%
 
(Zipes et al. 2006). In contrast, a community-wide study reported that more 
than 18% of all deaths were SCDs, using a 24-hour definition (De Vreede-Swagemakers et al. 
1997). The proportion of SCDs among all cardiovascular deaths has been shown to be over 60% 
(Zheng et al. 2001). The limit of 24 hours is likely to overestimate the true SCD incidence, while 
the limit of 1 hour after symptom onset might result in an underestimation (Adabag et al. 2010a). 
Approximately 25% of patients will be misclassified if time is the only criterion used (Greene et al. 
1989). The longer the follow-up, the smaller the proportion of SCDs among all deaths, indicating 
that a major amount of SCDs occur in the near future after the chain of events which have led to 
starting the follow-up. Because SCD occurs shortly after the onset of symptoms, there is little or no 
time for effective medical interventions. Therefore, effective and clinically useful markers of risk as 
prevention appear to be only the viable approach to decrease the incidence of SCD. 
In FINCAVAS we have used the 24-hour definition, and 1.4–1.9% of the study patients 
have faced SCD during the follow-up. This figure accounts for approximately 45–59% of all 
cardiovascular deaths and 20–34% of all deaths during the follow-up. This is parallel to the 
previous literature (Myerberg et al. 1993, Myerberg et al. 1997). The classification of deaths 
between SCD and other cardiovascular deaths is never clear-cut, and this classification is also not 
faultless in FINCAVAS. However, the mortality data was received from the Causes of Death 
Register which has been ascertained as a reliable source (Pajunen et al. 2005). The death certificates 
were assessed and classified into death classes by independent experts. Many of the causes of death 
were also confirmed by autopsy. The autopsy rate was approximately 40% for all deaths and 60% 
for SCD in Data 2 (Minkkinen et al. 2009).  
In the past, biological death was an immediate consequence of cardiac arrest, usually 
occurring within minutes. Because life-supporting systems have developed, patients may today 
remain biologically alive for a long period after the onset of a pathophysiological process that has 
caused irreversible damage. (Priori and Zipes 2006.) In these cases the death would be defined as a 
cardiovascular death due to the time limits, although the basic nature of death would be SCD. 
Patients with long-term and severe cardiovascular disease may also confuse the distribution 
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between SCDs and other cardiovascular deaths. These individuals have had a great risk for SCD, 
but another type of cardiovascular death – for example, heart failure – had caused the death first. 
Therefore, the death has been classified as a cardiovascular death, even though it might have been 
an SCD as well. However, the absolute diagnosis of SCD would require continuous ECG 
monitoring. Including only those patients who have had their ECG monitored during the last days 
before death in the study population would lead a marked work-up bias.  
The underlying factors behind SCD include a complex interplay between the anatomic and 
functional substrates,
 
modulated by the transient events that perturb the balance,
 
and the impact of 
the underlying potential arrhythmia
 
mechanisms of all hearts that precipitate SCD (Akhtar et al. 
1991, Myerburg et al. 1993, Zipes and Wellens 1998, Huikuri et al. 2001, Chugh et al. 2008, 
Buxton 2009) (Fig. 10). Any of these factors can interact with the others in almost endless 
permutations
 
and combinations. Usually, the interaction of two factors is insufficient to
 
produce 
SCD, unless the single abnormality
 
is extremely severe. (Zipes and Wellens 1998.) Combining a 
third factor to this process is much more likely to lead to SCD. Because of this multifactorial basis 
of SCD, and because many of the victims do not have symptoms or
 
signs identifying them as being 
at high risk before the event,
 
the prevention of SCD is complicated. (Adabag et al. 2010b.) 
Furthermore,
 
testing the effectiveness of primary preventive measures – such as abstinence from 
smoking, exercise, weight reduction as well as the controlling of blood
 
pressure and lipid 
abnormalities – in patients with no history of cardiovascular disease is impossible with satisfactory 
accuracy. Testing the effectiveness should include the randomisation of preventive versus non-
preventive measures as well as accurate categorizing of causes of death. (Zipes and Wellens 1998.) 
However, because
 
most cases of SCD occur in the population suffering from
 
CHD, it is logical that 
in recent years the
 
most attention has been given to secondary preventive therapy
 
in patients with 
proven CHD and especially
 
to survivors of an MI (Zipes and Wellens 1998, Zheng et al. 2001). 
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Fig. 10. Multifactorial basis of sudden cardiac death (SCD). (Myerburg et al. 1993, Zipes and 
Wellens 1998, Huikuri et al. 2001.) 
  
10.3 Major findings in the present study 
10.3.1 Haemodynamic parameters 
10.3.1.1 Heart rate recovery 
For abnormal heart rate recovery we used the cut-off point of 18 bpm one minute after the cessation 
of exercise. Abnormal heart rate recovery as a categorised variable was significantly associated with 
increased risk of cardiovascular and all-cause mortality, with HRs of 2.3–2.5 in our study with 
almost 2,000 patients (Studies II, IV), but for SCD it was not a significant predictor (Study II). Of 
the 122 deaths that occurred during the follow-up, only 33 were classified as SCDs, which may 
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have decreased the statistical significance of the results. In previous studies, abnormal heart rate 
recovery has been a significant predictor for all-cause and cardiovascular death as well as SCD, 
although the cut-off points and recovery protocols have varied substantially (Cole et al. 1999, Cole 
et al. 2000, Nishime et al. 2000, Jouven et al. 2005). Furthermore, many of the previous studies 
have used treadmill exercise which has been investigated to lead to abnormal heart rate recovery 
more frequently than bicycle exercise. Therefore, a direct comparison between the results is 
difficult.  
Heart rate recovery reflects the withdrawal of the sympathetic nervous system and the 
activation of the parasympathetic nervous system, offering an important component of risk 
stratification within the clinical exercise test. Abnormal interplay between these two has been 
proposed to be arrhytmogenic. Abnormal heart rate recovery can also reflect the patient’s poor 
physical fitness and aerobic capacity, which is associated with poorer prognosis. For instance, in 
our study heart rate recovery is usually determined as an absolute difference between heart rate at 
peak exercise and heart rate after the exercise. Because maximal heart rate during the exercise as 
well as at rest can vary greatly, absolute values might lead to similar results in very different 
physiological situations. Especially a too low level of exercise may lead to too low heart rate at 
peak exercise and therefore to too low heart rate recovery, although the recovery to the basic level 
would be normal. In our analysis heart rate recovery with the cut-off point of 18 bpm was 
associated with worse outcome among patients with high (>130 bpm) maximal heart rate as well 
among patients with low (≤130 bpm) maximal heart rate. Nevertheless, the prognostic power of 
heart rate recovery was greater among patients with low maximal heart rate, potentially indicating 
the greater relative influence of the same heart rate recovery values compared to the maximal heart 
rate. Therefore, heart rate response to exercise should be seen as a continuum from the resting level 
to peak exercise and, finally, to the recovery phase after the exercise.   
10.3.1.2 Blood pressure 
We were able to demonstrate that the higher the SAP during peak exercise, the lower the risk of all-
cause mortality (Study II). This reflects the fact the patients with an underlying heart disease are not 
able to generate elevated blood pressures. Underlying heart disease may also lead to a short total 
working time that does not allow enough time for the blood pressure to increase normally. In 
previous studies, exercise hypotension has been a sign of worse prognosis in patients with a 
previous MI and chronic heart failure (Hedberg et al. 2009, Nishiyama et al. 2010). Therefore, 
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abnormal SAP behaviour in any direction during the exercise should not be ignored, but it should be 
consireded in proportion to the patient’s cardiovascular background.  
The recovery of SAP after exercise did not predict any type of mortality (Study II). We 
defined blood pressure recovery as a difference between maximal SAP during the exercise and SAP 
4 minutes after the cessation of exercise. During the first few minutes of recovery, the changes in 
the autonomic nervous system are fast, enabling the autonomic nervous system to return to the 
normal level. Patients with only minor abnormality in shifting from the sympathetic to the 
parasympathetic tone may not be detactable after more than 4 minutes of recovery. However, the 
limit of 4 minutes is probably more specific than shorter time limits.  
The differences in maximal heart rate during the exercise might have an influence on the 
maximal blood pressure during the exercise. Therefore, we tested the difference in maximal SAP 
during the exercise between the patients with maximum heart rate ≤130 bpm (N=1,141) and the 
patients with maximal heart rate >130 bpm (N=3,427). Patients with maximum heart rate ≤130 bpm 
had significantly lower SAP levels (182±29 mmHg vs. 197±28 mmHg, p<0.01) during exercise 
than other patients and also the difference between maximum SAP during the exercise and the 
lowest SAP during the recovery was significantly lower (37±24 mmHg vs. 54±24 mmHg, p<0.01) 
than other patients (Data 3). However, our final data do not include SAP values obtained after 4 
minutes of recovery. We therefore did not compare the prognostic power of SAP during the 
recovery between these two groups.   
10.3.2 ECG parameters 
10.3.2.1 Heart rate variability 
Before the exercise, greater HRV in all frequency bands (HF, LF, VLF) and in the time-domain 
variable (RMSSD) was significantly associated with better prognosis, supporting the previous 
results (Study I). During the exercise, the influence of the HF band strengthens over the LF band. 
This is a compelling fact, noticed also in the previous literature (Perini and Veicsteinas 2003), 
because the HF band represents the vagal activity which is supposed to decrease as exercise 
intensity increases. One explanation might be the incapability of the sympathetic nervous system to 
control heart rate as swiftly and accurately as the parasympathetic nervous system, leading to HF 
band overdrive during the exercise. In support of a relationship between the HF and LF bands 
during the exercise, previous results have also shown that the influence of the HF band was lower in 
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the recovery period than in the last two minutes of exercise. (Freeman et al. 2006.) Because of these 
findings, HRV is considered to reflect the autonomic nervous system, but other, still unknown 
mechanisms also create a complex interplay with the autonomic nervous system. Atrial stretch, 
direct mechanical oscillations related to increased respirations, and metaboreflexes have proposed 
to interact with the autonomic nervous system in producing HRV. (Bernardi et al. 1990, Iellamo et 
al. 2006.) During maximum exercise, we did not find greater HRV to be a significant predictor of 
mortality. The shortening of R-R intervals during the exercise decreases the possibility for variation 
in heart rate. In the study by Dewey and colleagues (2007), greater HRV during exercise and 
recovery was associated with increased risk of death, which was discordant with the literature on 
HRV at rest. Our hypothesis was that these compelling results might due to different basic heart rate 
levels between patients. A broad range in R-R intervals makes the comparison between patients 
impossible, which leads to a misinterpretation of HRV changes. Therefore, we suggested heart rate 
correction before HRV analysis to make the HRV parameters comparable between patients.  For 
heart rate correction, we multiply every R-R interval with the square of the heart rate of the 
corresponding ECG segment. After this heart rate correction, HRV during peak exercise remained a 
non-significant predictor of death. During the recovery after the exercise, HRV was not associated 
with mortality in our study.  
 Our study confirms the previous result concerning attenuated resting HRV as a prognostic 
marker of increased risk of mortality. Though the prognostic power of HRV at rest has undoubtedly 
been stated, it seems that during the exercise it does not offer valuable information about a patient’s 
prognosis. Nevertheless, the pathophysiology of HRV is still unclear, particularly during physical 
exercise. More physiological studies are needed to fill this gap.  
10.3.2.2 PR interval 
A prolonged PR interval at pre-exercise, determined as PR interval >200 ms, was not associated 
with cardiovascular mortality in our study (Study III). This supports the earlier findings that first-
degree AV block at rest has not predicted cardiovascular outcomes during 10 years’ follow-up, even 
though the follow-up in FINCAVAS was shorter (Perlman et al. 1971, Mymin et al. 1986). To the 
best of our knowledge, a prolonged PR interval or first-degree AV block during the recovery after 
exercise has not been investigated earlier. We found first-degree AV block during the recovery 
phase to be significantly associated with cardiovascular mortality, with an HR of 2.73 (95% CI 
1.25-5.95, p=0.012) (Study III). The explanation and pathophysiology behind this finding are 
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unclear, but the most plausible explanation relates to intrinsic factors affecting the intracardiac 
conduction and, therefore, the PR interval. In our study PR interval was measured two minutes after 
the cessation of exercise. At that time point heart rate was markedly elevated in many patients, even 
though it was lower than during maximal exercise. Dysfunctional intrinsic AV node regulation may 
be manifested only at elevated heart rates, leading to prolonged PR interval. This dysfunctionality 
may be a precursor of a prolonged PR interval at rest, which will develop over the years. In a recent 
study, an association was demonstrated between prolonged PR interval and increased risk of 
cardiovascular events over a 20-year follow-up (Cheng et al. 2009), and based on these results it 
would be interesting to see how the PR interval will behave later on in the follow-up among the 
FINCAVAS study population. 
The PR interval is a valuable tool in risk stratification with a clinical exercise test, because it 
reflects both autonomic and electrophysiological properties of the cardiovascular system. Although 
first-degree AV block at rest hardly associates with an increased risk of cardiovascular events, the 
measurement of PR interval during the recovery from exercise may be more useful in clinical 
practice. Determining PR interval during recovery may identify patients who will develop an AV 
block at rest during the following years, and enhanced primary prevention could be directed at those 
patients.  
10.3.2.3 T-wave alternans 
TWA has proved to be associated with future cardiovascular events in many patient groups, 
including the FINCAVAS population. In our study with almost 2,000 patients, abnormal TWA (≥60 
µV) measured during peak exercise has prognostic power for future cardiovascular and all-cause 
mortality with an HR of 5.8 and 2.5, respectively. During the recovery, the prognostic power for 
cardiovascular mortality was slightly weaker (HR 3.5), while the risk of all-cause mortality remains 
almost the same (HR 2.4) (Study IV).  After expanding the study population to almost 4,000 
patients, the maximum TWA became a statistically significant predictor for all-cause mortality (HR 
1.01) and cardiovascular mortality (HR 1.02) but not for SCD (Study V). Despite the statistical 
significance, the clinical significance of HRs between 1.01 and 1.02 is questionable. The 
differences between the two sub-studies, with partly the same study population, are probably due to 
the following reasons. In Study IV we took account of TWA values at heart rates of <125 bpm, 
because at high heart rates TWA values may be influenced by noise. At the time of expanding the 
study population the TWA data was reread, meaning that TWA values of ≥46 µV were checked by 
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a physician investigator and corrected if necessary or discarded based on noise or baseline wander. 
After controlling noise by rereading, we abandoned the heart rate restriction.   
The prognostic power of TWA monitored in single and combined precordial leads had not 
been studied systematically prior to our study (Study V). In ambulatory ECG, TWA in leads V1, V3 
or V5 has been reported to be associated with increased risk of cardiovascular outcomes (Maeda et 
al. 2009, Sakaki et al. 2009). We found that during the exercise the greatest TWA values were 
measured from leads V1, V5 and V6. Lead V5 achieved the most powerful prediction for SCD as 
well as cardiovascular and all-cause mortality, indicating that restricting the assessment of TWA to 
lead V5 alone may perform better in risk stratification than using all precordial leads. Monitoring 
generalised elevations in TWA across the precordium did not offer an advantage in the prediction of 
mortality. TWA is thought to be a regionally specific phenomenon, the magnitude of which reflects 
the degree of heterogeneity of repolarisation.  
Our findings concerning the prognostic power of TWA for the study population of almost 
4,000 patients are modest. Compared to, for example, heart rate recovery or PR interval, TWA is a 
relatively new variable in prognosis estimation, and studies in different subpopulations are sporadic. 
According the current study, general elevations in TWA may not become a common risk marker for 
worse prognosis among the low-risk population, but the variable may provide helpful additional 
information about prognosis for selected patient populations. According to Bayes’ theorem, the 
positive accuracy of a test might be lost when dealing with low mortality rates, and the accuracy of 
a test may improve when changing from the general population to more specific groups. The 
advantage of TWA is its high specificity when compared to other risk markers, but more studies are 
still needed to investigate who are the patients who will benefit from TWA analysis. According to 
our findings, TWA is worth further investigations, and combinated to other prognostic variables, 
namely heart rate recovery in this study, it exceeds the prognostic power of single variables. 
. 
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10.3.3 Combinations of parameters; rate-pressure product and combination of 
heart rate recovery and T-wave alternans 
10.3.3.1 Rate-pressure product 
RPP has been reported to be a significant marker of mortality at rest and during peak exercise, but 
its significance during the recovery phase after exercise had not been studied earlier (Ciaroni et al. 
1993, Sadrzadeh Rafie et al. 2008). During peak exercise, RPP was not significantly associated with 
an increased risk of SCD or cardiovascular or total mortality, but RPPrecovery had an inverse relation 
with all three types of death with an HR of 0.85–0.87 (Study II). Both decreased heart rate recovery 
and SAPrecovery mainly reflect abnormal recovery of the autonomic nervous system, namely 
increased sympathetic activity which increases cardiac stress. Maximal heart rate during the 
exercise has an effect on both; heart rate recovery and SAPrecovery. Therefore, RPPrecovery is probably 
dependent on maximal heart rate during the exercise. In this study we did not tested the influence of 
maximal heart rate on RPPrecovery. In previous reports, a close correlation has been observed between 
RPP, myocardial oxygen consumption and coronary blood flow during exercise (Kitamura et al. 
1972). As a part of a clinical exercise test, RPPrecovery may be useful in identifying patients with 
underlying CHD. As RPPrecovery is simple to measure and interpret, it is worthy of more detailed 
investigations. More studies are needed also for determining abnormal values of RPPrecovery for 
different patient groups. 
10.3.3.2 Combination of heart rate recovery and T-wave alternans 
For enhancing the the sensitivity and specificity of the clinical exercise test, we hypothesised that 
heart rate recovery, reflecting the autonomic recovery of the cardiovascular system, and TWA 
reflecting an electrically unstable myocardium, could provide a picture of cardiovascular function 
by scoping it from two different perspectives. Abnormal heart rate recovery could indicate impaired 
vagus nerve activation and lessened capacity to withdraw sympathetic nerve tone, both of which are 
known to be arrhythmogenic. Therefore, the presence of both abnormal heart rate recovery and 
TWA would be suggested to be associated with a high risk of cardiovascular events. The prognostic 
power for all-cause and cardiovascular mortality of this combination exceeded the prognostic power 
of either variable alone as well as that of the traditionally used ST segment deviation.  Patients with 
abnormal values for both of these variables suffered from cardiovascular mortality significantly 
more often than patients with normal values.  (Study IV.)   
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 However, conventional dichotomy limits used in univariate analyses have been proposed to 
not provide the best prediction of events when several predictors are combined (Redwood et al. 
1997). The optimum cut-off points should be selected individually for each combination of 
variables and by the clinical event selected. Therefore, the prognostic power of the combination of 
heart rate recovery and TWA may be even higher than the results of the present study would 
suggest.   
10.3.4 Cardiovascular risk stratification and exercise test in future  
Cardiovascular risk stratification is based on the evaluation of patients’ current risk state and the 
probability that a given patient will progress to a higher-risk state in future. Factors representing the 
current risk state include the mechanical function of the left ventricle, the existence and severity of 
CHD, the electrical stability of the heart, evidence of a recent coronary plaque rupture indicating an 
increased short-term risk, and general health including non-coronary co-morbidity. (Gibbons et al. 
1997.) The probability for a given patient to progress to a higher risk state depends primarily on 
factors predisposing to the progression of an underlying atherosclerotic disease, such as smoking, 
hypercholesterolemia, diabetes and hypertension (Gibbons et al. 1997). The same factors are widely 
known in primary prevention for patients free from cardiac diseases. Exercise capacity has been 
suggested to be the most important marker of risk during exercise testing, but alone it describes 
only one aspect of cardiovascular prognosis (Gibbons et al. 1997, Fowler-Brown et al. 2004, Lauer 
et al. 2005).  
According to Bayes’ theorem, any test used in a low-risk population will provide poor 
positive accuracy. Because SCD can be the first signal of an underlying cardiovascular problem, 
screening the low-risk population is important. To increase the accuracy of the tests used, the future 
of cardiovascular risk stratification in the low-risk population will probably focus on multiple 
variables or risk scores, which will take into account the current risk and the progression of risk 
alike. Multiple variables have been shown to perform better than single variables for predicting 
future mortality and arrhythmic events (Redwood et al. 1997). Furthermore, in the current study, the 
prognostic power of combined variables exceeded single parameters. Combined parameters have 
not been adopted into wide clinical use yet, but the possibility to estimate the cardiovascular state 
from several different perspectives would offer a great addition to risk stratification. Although the 
multiple variables as well as cardiovascular risk scores have been under investigation during the last 
few decades, the optimal combinations of variables are yet to be determined.  
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More attention should be paid to the recovery phase after exercise. In addition to maximal 
exercise, recovery after exercise is also a challenge to the heart as it requires a change in the 
function of the autonomic nervous system and the mechanical function of the heart. Therefore, the 
exercise test provides two sequential challenges to the heart to change its function. Abnormal 
working order in either the autonomic nervous system or the heart may lead to abnormal recovery 
and the emergence of abnormalities that would not be visible during exercise. 
10.4 Bicycle exercise test versus treadmill exercise test 
All exercise tests in the FINCAVAS population were performed by bicycle. Due to less upper body 
motion, the blood pressure and ECG measurements are easier to assess with this testing modality. 
Moreover, some elderly or obese patients prefer the bicycle, where less coordination is required and 
the risk of falling is lower. (Wolber et al. 2005.) The heart rate response to exercise has been 
reported to be significantly lower in a bicycle exercise test than a treadmill test due to the lower 
workload achieved. At the same time, similar RPP values have been reported due to higher SAP 
values during the bicycle test. (Wicks et al. 1978.) Another study reported differences in RPP values 
due to a significant difference in heart rate, whereas the values for SAP did not differ (Hambrecht et 
al. 1992). The treadmill exercise test has proven more sensitive in diagnosing CHD in 
asymptomatic men, because of better sensitivity in inducing ischemia and ST segment changes 
(Hambrecht et al. 1992). However, the sensitivity of the bicycle exercise test has been demonstrated 
to exceed treadmill testing in patients with critical CHD, because a sizeable group of patients with 
critical CHD could not adequately perform an exercise treadmill test (Timmis et al. 1979). Bicycle 
exercise will probably perform at least equally to the treadmill test as a prognostic means due to the 
higher accuracy of blood pressure measurements and ECG tracings, although the treadmill test 
might be slightly superior in diagnosing CHD (Wicks et al. 1978, Rahimi et al. 2006). However, 
because of the different body positions in bicycle and treadmill exercise protocols, direct 
comparison between the test results is difficult.  Also, the results between different studies may not 
be compared because of various different exercise testing protocols and different patient 
populations.  
The reached exercise level is strongly dependent on the patient’s previous experience of the 
exercise mode. Subjects who are not experienced with the exercise mode usually stop exercise 
before reaching their maximum oxygen uptake. In Finland, bicycling is a very common mode of 
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exercise and the mode of the exercise has not been a problem in FINCAVAS. However, it is not 
possible to say what the results would have been had treadmill exercise been used.  
10.5 Application and limitations of FINCAVAS 
Worldwide, FINCAVAS is one of the largest clinical exercise test studies with continuous digital 
ECG. All patients in FINCAVAS were referred to a clinical exercise test at a university hospital. 
Exercise tests in Finland are performed in various healthcare provision facilities, including 
university hospitals. In addition to normal cardiovascular patients, the diagnosis and treatment of 
the most critical and challenging patients are centralised to university hospitals, which has raised a 
question concerning selection bias. Nevertheless, because of the low mortality rate among the 
FINCAVAS population, this population has been classified as a low-risk population and it probably 
reflects, in the best possible way, the variety of the population who are referred to exercise testing 
for clinical reasons. The heterogeneity of the patients referred to exercise testing has been 
ascertained as one of the strengths of FINCAVAS, but on the other hand, it makes the study settings 
challenging. Our study population consists of patients with a wide spectrum of ages, life styles, 
medications and histories of cardiac disease. The prognostic power of the parameters we have tested 
probably varies from one patient group to another. An investigated parameter may be a clear risk 
factor for one group of patients but not for others. The study does not separate different patient 
groups; in spite of the high total number of patients, dividing the population into subgroups led to 
an inadequately small number of outcomes for risk stratification. Because of various clinical 
indications for exercise testing, the exercise protocols varied from submaximal to maximal exercise. 
However, according to our original idea, including all patients with any clinical indication for 
exercise testing in our study is the optimal way to describe the large and varied population which 
performs exercise tests.   
The total number of patients is almost 5,000, 321 of whom died from any cause. Of these 
deaths, 138 were defined as cardiovascular and 63 as SCDs. The small number of end point events, 
especially with regard to Data 1 and 2, may have affected the statistical power of our results. 
Defining milder cardiovascular events, such as an MI or the necessity of a pacemaker, as end points 
might have increased the prognostic power of the variables we studied. On the other hand, death is 
more unequivocal to define.  
Cox regression analysis is a widely used method in risk stratification. In the multivariable 
Cox regression analysis, we used common cardiovascular risk factors as covariates, but the exact 
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combination of covariates differed between studies. Therefore, the direct comparison between the 
studies is difficult. Our purpose was to choose the most relevant covariates for every analysis. The 
Cox proportional regression model assumes that the effects of the predictor variables are constant 
over time, but as one of the limitations in FINCAVAS, we do not have information about the 
changes in the patients’ lifestyle or medications during the follow-up.      
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11 SUMMARY AND CONCLUSIONS 
This study provides evidence that the bicycle exercise test has prognostic potential when evaluating 
patients’ risk for future all-cause and cardiovascular mortality as well as for SCD. To enhance the 
prognostic power of the exercise test, the test should be taken as a continuum from rest to the 
recovery phase. Combinations of single parameters can increase the accuracy of the exercise test by 
reflecting cardiovascular health from several perspectives. However, more studies are needed 
before exercise testing recommendations for risk stratification can be constructed. The principal 
findings and conclusions are:  
 
I During the physical exertion or recovery phase after exertion, HRV does not have 
prognostic potential for future mortality. However, this study supports the previous notions 
that attenuated HRV at rest is a predictor of death.  
II RPPrecovery is a prognostic marker for all-cause and cardiovascular mortality as well as for 
SCD, exceeding the prognostic power of heart rate recovery or SAPrecovery alone. SAPrecovery 
measured alone is not a significant predictor of SCD or cardiovascular or all-cause 
mortality.  
III Prolonged PR interval as well as first-degree AV block measured during the recovery phase 
after physical exertion is a risk stratifier for cardiovascular mortality. However, neither of 
these two variables have prognostic power during the pre-exercise phase.  
IV Reduced heart rate recovery after exercise as combined with the heightened TWA during 
peak exercise powerfully predicts future all-cause and cardiovascular mortality. The 
prognostic power of this combination exceeds the prognostic power of either parameter 
alone or the commonly used ST segment deviation.  
V Maximum TWA monitored from the anterolateral precordial lead V5 is a predictor of all-
cause and cardiovascular mortality as well as of SCD during routine exercise testing. Peak 
TWA values rather than lower TWA elevations among several precordial leads should be 
employed for risk assessment.  
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Heart rate variability (HRV) or differences in beat-to-beat
interval (R–R interval) is believed to reflect the status and the
balance between the sympathetic and parasympathetic nervous
systems [1]. Previously, it has been shown that lower resting
HRV is associated with worse prognosis in many different
patient populations, including survivors of acute myocardial
infarction and patients without coronary heart disease (CHD)
[2]. In contrast to the results at rest, a recent study found that
greater HRV during an exercise treadmill test was linked to
increased risk of death [2]. Specifically, a greater root mean
square difference in R–R intervals (RMSSD) and several
frequency domain variables were associated with increased
risk of all-cause and cardiovascular death during peak exer-
cise and the recovery phase [2]. We analyzed whether HRV
parameters predict mortality in the patients of the Finnish
Cardiovascular Study (FINCAVAS).
All consecutive patients coming in for a clinically indicated
exercise test using a bicycle ergometer at Tampere University
Hospital and willing to participate in the study were recruited
between October 2001 and December 2004. The main indi-
cations for the exercise test were diagnosis of CHD (frequency
45%), testing vulnerability to arrhythmia during exercise (20%),
and evaluation of work capacity (18%) and adequacy of the
CHD treatment (16%). After excluding patients with insuffi-
cient recordings, marked arrhythmias or ectopic heartbeats, the
total data included 1876 patients, 1190 men and 686 women.
R–R interval data during the pre-exercise phase, the first and
last minute of exercise, as well as during the first 2 min of
recoverywere analyzed usingHRVAnalysis Software [3]. The
following time domain HRV variables were analyzed: mean
R–R, standard deviation in R–R (SDNN), the square root of
the mean squared differences in successive R–R intervals
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(RMSSD) and the Poincare plot analysis (pcSD1, pcSD2).
For the frequency domain HRV variables, the R–R interval
data was resolved into high frequency (HF, N0.15 Hz), low
frequency (LF, 0.04–0.15 Hz), and very low frequency (VLF
b0.04 Hz) components including absolute power of each
bandwidth (power), power in normalized units (power n.u.), and
percentage power (power%) using nonparametric fast Fourier
transform. Non-normally distributed HRV variables were log-
transformed prior to statistical analysis. A 2-sided P value
b0.05 was considered statistically significant in the comparison
of patient characteristics. Due to the large number of HRV
parameter comparisons, pb0.01 was considered an appropriate
threshold for significance in these analyses. The detailed
study protocol of FINCAVAS has been described earlier [4].
Baseline characteristics of the study population and exercise
test variableswere compared using 2-tailed t-tests (for normally
distributed continuous variables), Mann–Whitney U-tests (for
non-normally distributed continuous variables), or χ2 tests
(for categorical variables). Changes in exercise test variables
during different exercise periods were analyzed using one-way
analysis of variance (ANOVA). Prognostic power of HRV
variables were determined using Cox regression analysis.
Univariable Cox analysis was first run for each HRV variable
separately. Thereafter, the HRV variables with predictor effect
in univariable analyseswere evaluated in separatemultivariable
models with nine covariates: age, body mass index (BMI),
metabolic equivalent of task (MET), sex, smoking (no/yes), use
of β-blockers (no/yes), diabetes (no/yes), coronary heart
disease (no/yes), and previous myocardial infarction (no/yes).
There were 101 (5.4%) deaths during the follow-up of
47.5±12.8 months (mean±SD). Patients who survived were
significantly younger (56.0 years vs. 64.9 years, pb0.01), and
they were more often female (37.5% vs. 19.8%, pb0.01).
Smokers died significantly more often than non-smokers
(36.7% vs. 26.8%, p=0.03). Survivors were less frequently on
ACE inhibitors (22.7% vs. 31.7%, p=0.02) and β-blockers
(59.6% vs. 82.2%, pb0.01) than non-survivors. Also,
survivors were less likely to suffer from diabetes (11.5% vs.
18.8%, p=0.03), CHD (38.6% vs. 48.5%, p=0.05) and
valvular heart disease (2.9% vs. 6.9%, p=0.02). Patients who
died had exhibited significantly lower pre-exercise diastolic
arterial pressure (80 mmHg vs. 75 mmHg, pb0.01), shorter
duration of the test (7.7 min vs. 6.4 min, p=0.01), smaller
exercise capacity (7.4 MET vs. 5.5 MET, pb0.01), and lower
heart rate during exercise (148 bpm vs. 127 bpm, pb0.01).
In ANOVA, mean R–R interval (pb0.001) and RMSSD
(pb0.001) decreased as the exercise intensified. Of the spectral
components, the influence of HF component increased and the
influence of LF band decreased with the intensity of exercise
(pb0.001). In Cox multivariable analysis, log VLF power
(hazard ratio [HR] 0.56, 95%CI 0.43–0.72), logLFpower (HR
0.58, 95% CI 0.45–0.74), log LF power (n.u.) (HR 0.75, 95%
CI 0.64–0.87), log HF power% (HR 1.44, 95% CI 1.09–1.88),
pcSD2 (HR 0.61, 95% CI 0.43–0.86), and log RMSSD(HR
0.72, 95% CI 0.56–0.92) were significant predictors of better
prognosis (pb0.01) during the pre-exercise phase. During the
first minute of exercise, smaller log LF power (HR 0.70, 95%
CI 0.55–0.94, pb0.01) was associated with increased risk of
mortality. None of the HRV parameters were connected with
mortality at peak exercise or during the recovery phase.
Our results with an inverse association between
mortality and the resting HRV parameters are in unison
with the existing literature. The hazard ratios were
comparable to published results. Short-term HRV is most
probably caused by fluctuation in the parasympathetic
activity [1], which has a known ability for the beat-to-beat
regulation of HR [5]. In the beginning of exercise, heart rate
increases as vagal activity fades and the sympathetic system
takes the role of major controller. The changed physiolo-
gical state may be the background for no existing link
between HRV and mortality at peak exercise in the present
large study population. In contrast, a recent study [2]
showed prognostic value for HRV during exercise treadmill
test. The data analyzed in our study is from bicycle
ergometer tests, and the results may not directly be
extrapolated to treadmill tests. Also, the study populations
between these two studies have some differences, for
example, proportion of women was greater in our study.
These differences may have influence on results.
In conclusion, HRV does not seem to have prognostic
implications during physical exertion. However, our results
support the notion that decreased HRVat rest is a predictor of
death.
The authors of this manuscript have certified that they
comply with the Principles of Ethical Publishing in the
International Journal of Cardiology [6].
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We tested the hypothesis that the change from the
peak to recovery values of systolic arterial pressure
(SAPrecovery) and rate–pressure product (RPPrecovery) can
be used to predict all-cause and cardiovascular morta-
lity, as well as sudden cardiac death (SCD) in patients
referred to a clinical exercise stress test. As a part of the
Finnish Cardiovascular Study (FINCAVAS), consecutive
patients (n¼ 2029; mean age±SD¼ 57±13 years; 1290
men and 739 women) with a clinically indicated exercise
test using a bicycle ergometer were included in the
present study. Capacities of attenuated SAPrecovery,
RPPrecovery and heart rate recovery (HRR) to stratify the
risk of death were estimated. During a follow-up
(mean±s.d.) of 47±13 months, 122 patients died; 58
of the deaths were cardiovascular and 33 were SCD.
In Cox regression analysis after adjustment for the
peak level of the variable under assessment, age, sex,
use of b-blockers, previous myocardial infarction
and other common coronary risk factors, the hazard
ratio of the continuous variable RPPrecovery (in units
1000 mm Hgb.p.m.) was 0.85 (95% CI: 0.73–0.98) for
SCD, 0.87 (0.78–0.97) for cardiovascular mortality, and
0.87 (0.81 to 0.94) for all-cause mortality. SAPrecovery was
not a predictor of mortality. The relative risks of having
HRR below 18 b.p.m., a widely used cutoff point, were as
follows: for SCD 1.28 (0.59–2.81, ns), for cardiovascular
mortality 2.39 (1.34–4.26) and for all-cause mortality
2.40 (1.61–3.58). In conclusion, as a readily available
parameter, RPPrecovery is a promising candidate for a
prognostic marker.
Journal of Human Hypertension (2008) 22, 537–543;
doi:10.1038/jhh.2008.38; published online 29 May 2008
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Introduction
An abnormal response of the autonomic nervous
system during and after an exercise stress test is
believed to be a marker of increased risk of death.
Autonomic imbalance is reflected in, for example,
the heart rate (HR) profile during and after exercise,
which has been shown to associate with all-cause or
cardiac mortality during follow-up.1–4 Furthermore,
short-term regulation of blood pressure
(BHR stroke volumeperipheral resistance) is
dominated by the autonomic nervous system, and
the levels of and changes in systolic arterial pressure
(SAP) during the exercise have been found to
represent determinants of cardiovascular mortality
in several studies.5,6 Moreover, the recovery of SAP
(SAPrecovery) from the peak to the post-exercise level
might mirror changes in the autonomic balance. In
that case, SAPrecovery could also prove valuable in
predicting mortality during follow-up, but earlier
studies on this hypothesis have been scarce.7–9
Several computed parameters have been derived
with the idea that they would integrate several
(patho) physiological markers or phenomena into a
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single variable. Such markers have not yet, however,
broken through into wide-scale clinical use. Rate
pressure product (RPP¼HRSAP) is a simple
calculatory parameter based on two variables regu-
lated by the autonomic nervous system. RPP is used
as an indicator of myocardial oxygen uptake and
coronary blood flow in the exercise test.10 Moreover,
resting and peak RPP during exercise have been
linked to cardiovascular mortality,6,11–18 but the
prognostic value of the recovery of RPP (RPPrecovery)
from the peak to the post-exercise level is unknown.
As a part of the Finnish Cardiovascular Study
(FINCAVAS), we evaluated the hypothesis that the
recovery of two readily available variables, SAP and
RPP, can be used to predict all-cause and cardiovas-
cular mortality, as well as sudden cardiac death
(SCD) in patients referred to a clinical exercise stress
test.
Materials and methods
Study cohort
As described in the detailed study protocol of
FINCAVAS,19 all consecutive patients coming in
for a clinically indicated exercise stress test at
Tampere University Hospital and willing to partici-
pate in the study were recruited between October
2001 and December 2004. A total of 2029 patients
(1290 men and 739 women) with technically
successful storage of exercise test data were in-
cluded in the study (Tables 1 and 2). The main
indications for the exercise test were a diagnosis of
coronary heart disease (CHD, frequency 46%),
testing vulnerability to arrhythmia during exercise
(21%), evaluations of working capacity (18%) and
the adequacy of CHD treatment (16%), in addition to
obtaining an exercise test profile prior to an invasive
operation (13%) or after a myocardial infarction
(8%); some patients had more than one indication.
The study protocol was approved by the Ethical
Committee of the Tampere University Hospital
District (Finland), and all patients gave an informed
consent prior to the interview and measurements as
stipulated in the Declaration of Helsinki Principles.
Study flow
After an informed consent was signed, the medical
history of each patient was collected with a
computer-based questionnaire. Thereafter, the sub-
ject lay down in the supine position for 10 min. The
exercise test was performed using a bicycle ergo-
meter with electrical brakes.
During the test, HR was continuously recorded
with electrocardiography, whereas arterial pressure
was measured with a brachial cuff every 2 min. The
highest HR and SAP values during the exercise were
used in the calculation of RPPpeak. In the post-
exercise phase, HR and SAP in the sitting position
Table 1 Patient characteristics and exercise test variables for all participants according to the HRR cutoff point of 18 b.p.m. during the
first minute of recovery
HRRX18 b.p.m., n¼1498 HRRo18 b.p.m., n¼ 531 P-value
Mean s.d. Mean s.d.
Age (years) 55 13 63 12 0.00
BMI (kg/m2) 27 4 29 5 0.00
Weight (kg) 80 15 83 16 0.00
Height (cm) 171 9 171 9 0.05
HR at rest (b.p.m.) 63 11 66 13 0.00
HR at peak exercise (b.p.m.) 152 23 131 31 0.00
Reached HR of expected maximum (%) 81 13 73 16 0.00
HR at 4 min of the recovery (b.p.m.) 85 17 82 20 0.00
SAP at rest (mm Hg) 135 18 137 20 0.06
SAP at peak exercise (mm Hg) 197 28 180 29 0.00
SAP at 4 min of recovery (mm Hg) 141 21 144 21 0.02
Abbreviations: BMI, body mass index; HR, heart rate; HRR, heart rate recovery; SAP, systolic arterial pressure.
The P-values have been derived with the t-test for independent samples.
Table 2 Unadjusted percentage of women, frequency of b-blocker
use, as well as the prevalence of cardiovascular disease,
symptoms, risk factors and death for all participants according
to the HRR cutoff point of 18 b.p.m. during the first minute of
recovery
HRRX18 b.p.m. HRRo18 b.p.m. P-value
(%) (%)
Women 37 34 0.13
b-Blockers 53 72 0.00
Smoking 27 27 0.85
CHD 35 47 0.00
Prior MI 19 26 0.00
Hypercholesterolaemia 48 55 0.01
Diabetes 10 18 0.00
SCD 1 3 0.03
Cardiovascular death 2 6 0.00
All-cause death 4 13 0.00
Abbreviations: CHD, coronary heart disease; HRR, heart rate recovery;
MI, myocardial infarction; SCD, sudden cardiac death.
The P-values have been calculated with the w2 test.
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at 4 min post-exercise were used in the calcula-
tion of RPPpost-exercise. RPPrecovery was defined
as RPPpeakRPPpost-exercise. Similarly, SAPrecovery¼
SAPpeakSAPpost-exercise. HRR was calculated as an
HR difference at the peak level and 1 min after the
exercise.
Follow-up
Death certificates were received from the Causes of
Death Register maintained by Statistics Finland in
May 2007; this source has been proven reliable.20
The certificates included causes of death using the
10th revision of the International Classification of
Diseases (ICD-10). The diagnosis numbers and
certificate texts were used to classify the deaths
as all cause, cardiovascular and SCDs (defined
as a cardiac death within 24 h after the onset of
symptoms).
Statistical analysis
An HRR cutoff point of 18 b.p.m. within the first
minute has been suggested by several authors for
exercise tests with an abrupt end.4.We used the same
cutoff point in addition to handling HRR as a
continuous variable. Because no previous cutoff
points for the decline in SAP and RPP have been
published, we used SAPrecovery and RPPrecovery only as
continuous variables.
The t-test for independent samples was used to
compare continuous patient characteristics and
exercise test variables between those with normal
and abnormal recovery values (Table 1), and the w2
test was applied for dichotomous variables (Table 2).
The hazard ratios and relative risks implied by
recovery values with regard to all-cause and cardi-
ovascular deaths, as well as SCD were estimated
with a Cox proportional hazards model using the
following covariates: the peak level of the variable
under assessment, sex, age, body mass index (BMI),
daily smoking (no/yes), use of b-blockers (no/yes),
prior diagnoses of CHD (no/yes), myocardial infarc-
tion (no/yes), diabetes (no/yes) and hypercholester-
olaemia (no/yes). The statistical analyses were
performed with the SPSS release 14.0 for Windows
(SPSS Inc, Chicago, IL, USA). All statistical tests
were two-tailed and used an a-level of o0.05.
Results
During the follow-up period of 47±13 months
(mean±s.d.), there were 122 deaths (6.0% of the
population), 58 (2.9%) of which were classified
as cardiovascular deaths and 33 (1.6%) further as
SCD (Figure 1). Patient characteristics, exercise test
variables and the number of deaths for those with
HRR X18 b.p.m. (n¼ 1498) and HRR o18 b.p.m.
(n¼ 531) are given in Tables 1 and 2.
Mortality and recoveries in HR, SAP and RPP
In Cox regression with adjustments for the peak
level of the variable to be assessed, sex, age, BMI,
smoking, use of b-blockers, and prior diagnoses of
CHD, myocardial infarction, diabetes and hyperch-
olesterolaemia, the hazard ratios of the continuous
variable RPPrecovery (in units 1000 mm Hg b.p.m.)
were statistically significant for all the three cate-
gories of death (Table 3). The continuous variable
SAPrecovery did not predict any type of mortality
(Table 4).
The relative risks of HRR when applying the
cutoff point of 18 b.p.m. were 1.28 for SCD (95%
confidence interval 0.59–2.81, P¼ 0.53), 2.39 for
Table 3 Adjusted hazard ratios and relative risks for sudden cardiac, cardiovascular and all-cause death in the Cox regression models
with RPPrecovery
SCD Cardiovascular mortality All-cause mortality
RR 95% CI P-value RR 95% CI P-value RR 95% CI P
Lower Upper Lower Upper Lower Upper
RPPrecovery (1000 b.p.m. per mm Hg) 0.85 0.73 0.98 0.02 0.87 0.78 0.97 0.01 0.87 0.81 0.94 o0.001
RPPpeak (1000 b.p.m. per mm Hg) 1.03 0.91 1.16 0.64 1.01 0.92 1.10 0.86 1.02 0.96 1.08 0.51
Age (years) 0.99 0.96 1.03 0.60 1.02 0.99 1.05 0.13 1.04 1.02 1.06 0.00
Sex (M/F) 0.14 0.03 0.60 0.01 0.35 0.17 0.73 0.01 0.55 0.36 0.84 0.01
BMI (kg/m2) 0.95 0.87 1.03 0.21 0.94 0.88 1.00 0.05 0.94 0.89 0.98 0.00
Smoking (no/yes) 1.08 0.49 2.38 0.84 0.85 0.47 1.53 0.59 0.64 0.43 0.96 0.03
Diabetes (no/yes) 0.68 0.28 1.63 0.39 0.69 0.37 1.30 0.26 0.80 0.51 1.28 0.36
b-Blocker (no/yes) 0.49 0.15 1.58 0.23 0.51 0.23 1.17 0.11 0.83 0.52 1.33 0.43
CHD (no/yes) 1.02 0.36 2.88 0.97 1.09 0.51 2.34 0.82 1.66 0.98 2.81 0.06
Prior MI (no/yes) 0.57 0.22 1.46 0.24 0.56 0.28 1.12 0.10 0.60 0.35 1.02 0.06
Hypercholesterolaemia (no/yes) 0.88 0.42 1.85 0.73 1.43 0.84 2.42 0.18 1.22 0.84 1.75 0.29
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; F, female; RR, hazard ratio/relative risk; M, male; MI,
myocardial infarction; RPPpeak, peak rate–pressure product during exercise; RPPrecovery, recovery of rate–pressure product; SCD, sudden cardiac
death.
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cardiovascular mortality (1.34–4.26, P¼ 0.003) and
2.40 for all-cause mortality (1.61–3.58, Po0.001).
HRR as a continuous variable produced a significant
hazard ratio for all-cause mortality 0.971 (0.954–
0.988, Po0.001), but not for cardiovascular (0.987
0.961–1.013, P¼ 0.32) or sudden cardiac (0.981,
0.949–1.015, P¼ 0.27) mortality.
Discussion
The exercise stress test is a routine tool in the
diagnostics and follow-up of CHD, as well as in
determining cardiovascular status prior to a major
procedure. In addition, the merits of the exercise test
as a prognostic means have been increasingly
recognized during the last two decades.21 It remains
a continuous challenge to develop new approaches
and enhance the existing techniques to screen large
general cardiovascular patient populations—not
only those at a particularly high risk—for increased
risk of cardiac death. Because the exercise stress test
is a widespread and relatively inexpensive tool, it
will be of special interest if the applicability of the
test can be expanded from evaluating the prevailing
cardiovascular status to cardiovascular prognosis.
Several markers of vagal tone and autonomic
imbalance at rest have been connected to cardiovas-
cular events and mortality: elevated resting HR,
impaired HR variability, decreased baroreflex sensi-
tivity,22,23 and so on. During exercise, HR and SAP
increase steadily because of the gradual activation of
the sympathetic and concomitant deactivation of
parasympathetic nervous system. HRR after exercise
is considered to be a function of the reactivation of
the parasympathetic nervous system, which is
important primarily during the first minute after
exercise. HRR has been used as a predictor of overall
and cardiovascular mortality in studies with various
types of patients: healthy subjects and those with or
without CHD.1,3,8,24 Our unselected hospital popula-
tion that comprises consecutive patients coming in
for a clinically indicated clinical exercise test
repeated this finding when using the cutoff point
of 18 b.p.m. at 1 min after an abrupt discontinuation
of the exercise.
Poor decrease of SAP after the exercise has been
linked to CHD or the severity of myocardial
ischaemia,25,26 stroke27 and myocardial infarction,28
but the previous studies on mortality have yielded
conflicting results. In one of these previous studies,
abnormal post-exercise SAP response stratified the
all-cause mortality in patients (n¼ 217) after an
acute myocardial infarction.9 However, two other
studies, with either 12 379 low-risk7 or 2428 con-
secutive adult patients,8 did not support this
finding, which is consistent with our results: we
did not find an association between SAPrecovery and
overall, cardiovascular or sudden cardiac mortality.
Given the impact of the large studies, SAPrecovery
does not seem to be applicable in risk stratification.
The peak-level SAP reached significance for all-
cause mortality: the higher the peak SAP, the lower
the risk of death. This has also been found in earlier
reports,29 suggesting that better trained subjects
exhibit a higher SAP response to exercise.29
To the best of our knowledge, this is the first
report of the value of RPPrecovery in prognostics.
Because no previous cutoff points were available,
we used only RPPrecovery as a continuous variable.
This parameter had an inverse relation with all three
types of end points used: the greater the drop in
RPP, the lower the risk of death. This is clearly
supported by Figure 1, where the prevalence of
death is clearly higher in the quintile with lowest
than highest RPPrecovery. It deserves to be mentioned
Table 4 Adjusted hazard ratios and relative risks for sudden cardiac, cardiovascular and all-cause death in the Cox regression models
with SAPrecovery
SCD Cardiovascular mortality All-cause mortality
RR 95% CI P-value RR 95% CI P-value RR 95% CI P-value
Lower Upper Lower Upper Lower Upper
SAPrecovery (mm Hg) 0.99 0.97 1.01 0.28 0.99 0.97 1.00 0.15 0.99 0.98 1.00 0.21
SAPpeak (mm Hg) 0.99 0.97 1.01 0.21 0.99 0.97 1.00 0.08 0.99 0.98 1.00 0.01
Age (years) 1.00 0.97 1.04 0.86 1.03 1.01 1.06 0.01 1.05 1.03 1.07 0.00
Sex (M/F) 0.18 0.05 0.61 0.01 0.33 0.17 0.67 0.00 0.50 0.33 0.77 0.00
BMI (kg/m2) 0.98 0.90 1.06 0.58 0.96 0.90 1.02 0.20 0.95 0.91 0.99 0.03
Smoking (no/yes) 0.96 0.45 2.04 0.91 0.82 0.46 1.44 0.48 0.64 0.44 0.95 0.02
Diabetes (no/yes) 0.66 0.28 1.59 0.36 0.69 0.37 1.30 0.26 0.76 0.47 1.20 0.24
b-Blocker (no/yes) 0.44 0.14 1.38 0.16 0.46 0.20 1.02 0.05 0.78 0.49 1.23 0.28
CHD (no/yes) 0.99 0.36 2.72 0.98 1.08 0.51 2.29 0.83 1.59 0.94 2.69 0.08
Prior MI (no/yes) 0.61 0.24 1.58 0.31 0.58 0.29 1.18 0.14 0.62 0.37 1.06 0.08
Hypercholesterolaemia (no/yes) 0.87 0.41 1.81 0.70 1.47 0.88 2.46 0.15 1.25 0.87 1.80 0.22
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; F, female; RR, hazard ratio/relative risk; M, male; MI,
myocardial infarction; SAPpeak, peak systolic arterial pressure during exercise; SAPrecovery, recovery of systolic arterial pressure; SCD, sudden
cardiac death.
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that RPPrecovery emerged as the sole haemodynamic
parameter with a statistically significant hazard
ratio for SCD. There are many possible mechanisms
to explain why delayed decrease in RPP after the
exercise would be an indicator of increased mortal-
ity. Both HR and blood pressure are adjusted by
several mechanisms, but the autonomic nervous
system is the dominant regulator in acute changes.
Autonomic dysfunction or abnormalities in vasor-
eactivity may thus cause low RPPrecovery. Moreover,
RPPrecovery may reflect aerobic capacity and physical
fitness, which have been linked to prognosis.
Because we used no cutoff points for RPP or SAP,
the demographic data presented are divided by
HRR at 18 b.p.m. The groups with HRR of at least
18 b.p.m. and o18 b.p.m. differ from each other
regarding several known cardiovascular risk factors
(Tables 1 and 2). Therefore, we used many covariates
to clarify the importance of each of these risk factors
as determinants of poorer prognosis (Table 3). In the
models with RPPrecovery, sex and RPPrecovery were the
only statistically significant independent risk factor
for SCD and cardiovascular death, whereas BMI, age
and smoking status appeared as significant covari-
ates in addition to RPPrecovery and sex for all-cause
mortality. Surprisingly, age was a prognostic marker
only for all-cause mortality. This is probably due to
the duration of follow-up. Smoking and BMI had a
paradoxical negative association with all-cause
mortality; however, smoking and BMI had a positive
link to mortality if they were the only covariates in
the model.
One disparity between our study groups was the
use of b-blockers (Table 2). Medication with the
b-blockers causes reduced increase in HR and SAP,
and thus reduced maximal RPP. The medication
status upon the exercise test depends on the
indication the test is performed for. Our patients
with a clinically indicated exercise test were tested,
for example, to evaluate working capacity (18% of
the tests) and the adequacy of CHD treatment (16%).
These tests are performed with the prevailing
medications, whereas those tested for CHD diag-
nostics (46%) enter the test after discontinuing their
b-blockers for at least 5 days. We used the b-blocker
status as a covariate in the Cox regression analyses,
but it did not prove to be a significant risk factor in
any of the models.
The standard exercise stress test with a bicycle
has certain advantages compared with treadmill
tests.10,30 One of these is the easier measurement of
blood pressure during exertion. On the other hand,
the present study is subject to some limitations.
We included all patients scheduled for a clinical
exercise stress test at a university setting, and the
population comprises patients with a wide spec-
trum of ages, life styles, histories and statuses of
cardiac disease. The impact of the heterogeneity is
diminished if not eliminated by using several
covariates in the analysis.
In conclusion, the readily available parameter
RPPrecovery is a promising candidate for a prognostic
marker. The validity of this variable needs to be
tested further in other exercise stress test popula-
tions, before a more widespread clinical use of the
markers can be recommended. SAPrecovery does not
seem to serve as a prognostic tool.
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What is known about the topic
K Levels of and changes in systolic arterial pressure and heart
rate during an exercise test are associated with mortality.
K Suppressed heart rate recovery, an index of parasympathetic
re-activation after the exercise phase, is a predictor of
mortality.
K Peak rate–pressure product (heart rate systolic arterial
pressure) during exercise is a prognostic marker.
What this study adds
K Recovery of rate–pressure product after the exercise phase
is linked to cardiovascular and all-cause mortality, as well as
sudden cardiac death independently of traditional risk
factors.
K Recovery in systolic arterial pressure is not associated with
any of the three types of mortality.
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(ACKGROUND A prolonged electrocardiographic PR interval at
est has been considered a benign phenomenon until recently.
BJECTIVE We hypothesized that measurement of the PR interval
uring recovery from physical exertion could improve cardiovas-
ular mortality risk stratification because it would track the dy-
amic influences of homeostatic mechanisms controlling atrioven-
ricular (AV) conduction.
ETHODS A total of 1,979 consecutive patients (1,244 men and
35 women) with clinically indicated bicycle ergometer tests
nrolled in FINCAVAS (the Finnish Cardiovascular Study) were
ncluded in the study. The PR interval was measured at 1 min
efore and at 2 min after exercise.
ESULTS During the mean follow-up period of 47 months (inter-
uartile range: 37 to 59 months), 50 cardiovascular deaths (end
oint) were registered. The unadjusted hazard ratios (HR) in Cox
egression analyses were significant for both continuous PR inter-
al and first-degree atrioventricular (AV) block for pre- and post-i
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547-5271/$ -see front matter © 2010 Heart Rhythm Society. All rights reservednterval for 20-ms increments (HR: 1.17, P  .117) and first-
egree AV block (HR: 1.85, P  .138) during the pre-exercise
hase were not prognostic. However, during recovery from exer-
ise, prolonged AV conduction achieved significance both in con-
inuous (HR: 1.29, P  .006) and dichotomized analyses (HR:
.41, P  .045).
ONCLUSION The PR interval before exercise is not a robust risk
tratifier for cardiovascular death during 4-year follow-up. Post-
xercise assessment of AV conduction may offer improved predic-
ion because of functional abnormalities that become manifest
nly during this physiologic challenge to the heart.
EYWORDS Atrioventricular conduction; Exercise test; Cardiovas-
ular mortality; PR interval; Prognostics
BBREVIATIONS AV  atrioventricular; CI  confidence interval;
CG  electrocardiographic; HR  hazard ratio; NYHA  New
ork Heart Association
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xercise phases. After adjustment for standard markers, the PR All rights reserved.Conduction time of the electrical signal from the sinus
ode to the ventricles is clinically measured as electrocar-
iographic (ECG) PR interval. Deceleration of atrioventric-
lar (AV) conduction above the typical upper limit of 200
s, or first-degree AV block, is primarily due to excessive
elay in the AV node and, less frequently, in the His-
urkinje system, whereas conduction within the right atrium
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ears of age, 1% to 2%2–5 have a prolonged PR interval, and
he prevalence of first-degree AV block increases to 3% to
%3,5 by the age of 60 years.
Decelerated AV conduction has been considered a be-
ign, functional phenomenon for 5 decades. None of the
tudies during that period suggested a link between first-
egree AV block and mortality among healthy young2,6 or
iddle-age3 men, or in a community-based epidemiological
tudy.5 Three studies provided contradictory evidence of an
ssociation between first-degree AV block and coronary
eart disease among middle-age men.3,7,8
Recently, Cheng et al9 published results from the Fra-
ingham Heart Study showing an association between ab-
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797Nieminen et al Atrioventricular Conduction and Mortalityormal AV conduction at rest and the outcome measures of
ncident atrial fibrillation, pacemaker implantation, and all-
ause mortality. The importance of the recovery PR interval
as not been studied. We hypothesized that measurement
uring recovery from physical exertion could improve risk
tratification, as it would track the dynamic influences of
omeostatic mechanisms controlling AV conduction. There-
ore, we investigated the PR interval both at rest and also
uring the recovery phase of a clinical bicycle ergometer
est in FINCAVAS (the Finnish Cardiovascular Study). Our
ollow-up data include cardiovascular death as an end point,
hich is more specific than all-cause mortality for conduc-
ion abnormalities.
ethods
tudy cohort
ll consecutive patients referred for an exercise stress test at
ampere University Hospital between October 2001 and the
nd of 2004 and willing to participate in the FINCAVAS
rial10 were enrolled. This substudy included a total of 1,979
onsecutive patients (1,244 men and 735 women) with sinus
hythm, technically successful exercise tests, and a valid PR
nterval measurement during the pre-exercise phase. Due to
echnical reasons, 29 post-exercise PR interval values were
issing. A test was technically adequate if storing the he-
odynamic data and continuous digital ECG signal was
uccessful. The main indications for the exercise test were
uspicion of coronary heart disease (frequency 46%), test-
ng vulnerability to arrhythmia during exercise (21%), and
valuation of work capacity (18%) and adequacy of the
oronary heart disease treatment (15%), as well as obtaining
n exercise test profile prior to an invasive procedure (13%)
r after a myocardial infarction (MI) (8%); some patients
ad more than 1 indication. The study protocol was ap-
roved by the Ethics Committee of the Tampere University
ospital District, Finland, and all patients gave informed
onsent prior to the interview and measurements as stipu-
ated in the Declaration of Helsinki.
xercise test protocol
fter an informed consent was signed, the medical history
f each patient was collected on a computer-based ques-
ionnaire form. Thereafter, the subject maintained a supine
osition for 10 min. The pre-exercise ECG was recorded
hile the patient sat upright on the bicycle ergometer. The
pright routine exercise test was then performed using a
icycle ergometer with electrical brakes. The lead system
as the Mason-Likar modification of the standard 12-lead
ystem. The initial workload varied from 20 to 30 W, and
he load was increased stepwise by 10 to 30 W every
inute. The recovery phase after the physical stress lasted
or 4 to 6 min. Continuous ECGs were digitally recorded at
00 Hz with the CardioSoft exercise ECG system (version
.14, GE Healthcare). weasurement of ECG and clinical variables
he PR interval for the pre-exercise phase was measured at
min before the start of exercise. The post-exercise PR
nterval was assessed at 2 min after cessation of exercise.
he PR intervals were measured to the nearest millisecond
utomatically using the CASE Workstation (version 1.82,
E Healthcare). The software composes a spatial ECG
ector from the 12 standard ECG leads. An average com-
lex is calculated based on the normal cardiac cycles. In the
veraged cycle, P-onset and QRS-onset are defined. The
rst deflections from the 0 lines of the P wave and the QRS
omplex are used for measurement of the PR interval. All
xtreme PR interval values (250 ms or 90 ms) were
verread by a physician investigator and corrected if nec-
ssary. Manually and automatically measured PR intervals
t the pre-exercise and post-exercise phases were compared
n a subset of 100 randomly chosen ECGs. The PR intervals
n standard lead II were overread by a physician, and 3
andom measurements were averaged. Bias between manu-
lly and automatically derived values was defined as the
ean difference between the paired PR intervals, and limits
f agreement were calculated as bias 2 SD of the mea-
urement pairs.11 The bias for the pre-exercise phase was 4
s (limits of agreement 10 to 18 ms), and for the post-
xercise phase was 5 ms (17 to 26 ms).
ollow-up
eath certificates were received from the Causes of Death
egister, maintained by Statistics Finland, in May 2007;
his source has been shown to be reliable.12 The certificates
ncluded causes of death using the Tenth Revision of the
nternational Classification of Diseases (ICD-10). The diag-
osis numbers and certificate texts were used to classify the
eaths as all-cause or cardiovascular (end point applied in
he study).
tatistical analysis
he t test for independent samples and the 2 test were used
s applicable to compare parameters of patient characteris-
ics (Table 1) for those with and without first-degree AV
lock during the pre-exercise phase. Unadjusted cardiovas-
ular mortality rate for the pre- and post-exercise PR inter-
al quintiles are presented in Figure 1, with significance
etermined by Poisson regression. In Cox regression anal-
sis, we considered the PR interval both as a continuous
ariable and as dichotomized at the most commonly used
ut point of 200 ms for first-degree AV block. Cox regres-
ion analysis was performed both unadjusted and adjusted
ith several typical risk factors (Table 2) as covariates. The
ew York Heart Association (NYHA) score, a surrogate for
eart failure, was transformed into a dichotomous variable
y differentiating the classes with good (II or better) or poor
III) function. Results for continuous PR intervals are given
or increments of 20 ms.9 All covariates fulfilled the pro-
ortionality assumption based on correlations with survival
ankings with Schoenfeld residuals. Statistics were analyzed
ith the SPSS release 16.0 for Windows (SPSS, Inc., Chi-
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798 Heart Rhythm, Vol 7, No 6, June 2010ago, Illinois). All statistical tests were 2-tailed and used an
lpha level 0.05.
esults
atient characteristics and prevalence of
rst-degree AV block
atient characteristics according to the presence of first-
egree AV block at baseline are presented in Table 1. Most
f the continuous variables differed significantly between
he groups; only duration of the exercise test was similar.
ex, smoking, and use of -blockers were also different
etween the groups. Regarding the entire population, the
able 1 Patient characteristics according to the pre-exercise P
PR interval 200 m
Mean (SD)
ge (yrs) 56 (13)
ody mass index (kg/m2) 27 (4)
re-exercise assessment
Heart rate (beats/min) 74 (15)
Width of the QRS complex (ms) 98 (15)
PR interval (ms) 154 (21)
xercise assessment
Maximum heart rate (beats/min) 147 (26)
Length of the exercise (min) 7 (2)
ost-exercise assessment
Heart rate at 2 min (beats/min) 99 (21)
Width of the QRS complex (ms) 99 (15)
PR interval (ms) 144 (25)
emale 38%
moking 28%
eta-blocker use 60%
iabetes 13%
oronary heart disease 33%
yocardial infarction 21%
ew York Heart Association class III 8.1%
ardiovascular death 2.2%
igure 1 Unadjusted incidence rate of cardiovascular mortality per
,000 person-years among patients divided into quintiles based on PR
ntervals in the pre- and post-exercise phases. The range of PR intervals
ms) is given for each bin. The p values for trends are calculated with2oisson regression.R interval in the pre-exercise phase was 158  28 ms
mean  SD) and in the post-exercise phase 148  30 ms.
revalence of first-degree AV block in the age groups below
0 years, 40 to 59 years, and at least 60 years was 2.8%,
.9%, and 11.0%, respectively, in the pre-exercise phase
nd 1.9%, 3.1%, and 8.1% in the post-exercise phase.
ortality and the PR interval
he mean follow-up period was 47 months (interquartile
ange 37 to 59 months). A total of 107 deaths were regis-
ered, and 50 (2.5% of the population) of those were from
ardiovascular causes, the latter of which was the end point
sed. Therefore, cardiovascular mortality was 0.64%/year.
Cardiovascular mortality rates differed between patients
n the PR interval quintiles in the recovery phase but not in
he phase before physical stress (Figure 1). The unadjusted
azard ratio (HR) in Cox regression analyses was 1.31 (P
001, 95% confidence interval [CI]: 1.14 to 1.51) for each
0-ms increment in the pre-exercise PR interval, and simi-
arly, 1.47 (P .001, 95% CI: 1.27 to 1.69) for the recovery
R interval. The unadjusted HR for first-degree AV block
efore exercise was 3.04 (P  .003, 95% CI: 1.47 to 6.25),
nd for after exercise was 4.00 (P .001, 95% CI: 1.94 to
.22).
After adjustment for typical risk markers, the PR interval
HR: 1.17, P  .092, 95% CI: 0.97 to 1.18) and first-degree
V block (HR: 1.74, P  .170, 95% CI: 0.79 to 3.82)
Table 2) during the pre-exercise phase were not prognostic.
owever, during recovery from exercise, prolonged AV
onduction achieved significance both in continuous (HR:
.36, P .001, 95% CI: 1.15 to 1.62) and dichotomized
nalyses (HR: 2.73, P  .012, 95% CI: 1.25 to 5.95) (Table
val
1,844) PR interval 200 ms (n  135)
PMean (SD)
64 (12) .001
29 (5) .001
65 (13) .001
111 (26) .001
224 (27) .001
127 (31) .001
7 (2) .13
82 (20) .001
112 (24) .001
202 (34) .001
27% .01
16% .003
81% .001
12% .89
33% .85
22% .91
9.8% .51
6.7% .006R inter
s (n ). Survival curves for the adjusted first-degree AV block
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799Nieminen et al Atrioventricular Conduction and Mortalityre given in Figure 2. The change in PR interval from the
re- to post-exercise measurement was not prognostic.
iscussion
ur main finding is that the PR interval prolongation as-
essed during recovery from exercise contains prognostic
nformation, whereas its measurement at rest, prior to an
xercise test, is not prognostic in adjusted analyses (Figure
). Because our results differ from those of a recent study9
ut are in agreement with several earlier studies, it is of
articular importance to consider possible differences
mong the methodologies and study populations.
revious studies
he first estimation of the prognostic implications of the
rolonged PR interval was based on an investigation in
,000 United States Navy pilots and flight students between
0 and 30 years of age.2 Only 1 of these young men died of
ardiac causes during the follow-up of 10 years, rendering it
mpossible to detect potential differences in cardiovascular
ortality between those with a normal and an abnormal AV
onduction time. The Manitoba study recruited 3,983 Royal
able 2 Results of adjusted Cox regression models with first-
egree AV block for the pre- and post-exercise phases
Hazard
ratio
95%
confidence
interval
PLower Upper
re-exercise first-degree AV block
First-degree AV block (no/yes) 1.74 0.79 3.82 .170
Age (yrs) 1.05 1.02 1.08 .002
Sex (female/male) 2.62 1.20 5.73 .016
Body mass index (kg/m2) 0.93 0.86 1.00 .052
Coronary heart disease (no/yes) 1.16 0.63 2.12 .635
Diabetes (no/yes) 1.37 0.65 2.87 .406
Beta-blocker use (no/yes) 3.32 1.24 8.91 .017
Pre-exercise QRS complex width
(ms)
1.07 0.94 1.22 .298
Pre-exercise heart rate (beats/
min)
0.99 0.79 1.24 .935
ost-exercise first-degree AV block
First-degree AV block (no/yes) 2.73 1.25 5.95 .012
Age (yrs) 1.05 1.02 1.08 .003
Sex (female/male) 2.94 1.29 6.71 .010
Body mass index (kg/m2) 0.93 0.86 1.00 .060
Coronary heart disease (no/yes) 1.28 0.69 2.37 .426
Diabetes (no/yes) 1.41 0.67 2.95 .369
Beta-blocker use (no/yes) 2.94 1.08 8.05 .036
Post-exercise QRS complex
width (ms)
1.07 0.93 1.24 .317
Post-exercise heart rate (beats/
min)
0.99 0.83 1.18 .912
Hazard ratios for QRS width and heart rate are given for increments of
0. The covariates with no or yes as potential values have no as a reference
evel. The same applies for sex: the first parameter value (female) is the
eference level. Therefore, for example, being male is a considerable risk
actor.
AV  atrioventricular.anadian Air Force pilots in the late 1940s6 for a follow-up hf 30 years, but first-degree AV block did not predict isch-
mic heart disease or mortality even over this lengthy time
pan. These results suggested that first-degree AV block
oes not convey prognostic information among young
ealthy men. It is well known that first-degree AV block is
he most common ECG abnormality among amateur ath-
etes,13 arguably a reasonable comparison group for Air
orce pilots, and it has even been considered a normal
nding among highly trained athletes.14 This decelerated
V conduction in athletes stems from elevated vagal tone
ersus sympathetic excitation, which is typically considered
beneficial balance.
Regarding older age groups, neither cross-sectional as-
ociation between first-degree AV block and symptomatic
oronary heart disease nor the 5-year coronary heart disease
igure 2 Results of adjusted Cox regression analysis for cardiovascular
ortality among patients with (lower line) or without (upper line) first-
egree atrioventricular block (PR interval 200 ms) during pre-exercise
nd recovery phases. Note that the y-axis scale is not to 0. The covariates
means for the pre-exercise and recovery analyses, respectively) were age
56.5, 56.4 years), sex (0.63, 0.62), body mass index (27.5, 27.5 kg/m2),
iagnosis of coronary heart disease (0.33, 0.33) or diabetes (0.13, 0.13);
se of beta-blocker (0.61, 0.61), QRS complex width (98.7, 98.5 ms), and
eart rate (73.6, 73.6 beats/min).
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800 Heart Rhythm, Vol 7, No 6, June 2010ortality differed significantly between those with a pro-
onged (220 ms) or a normal PR interval among 18,000
ale civil servants ages 40 to 64 years.3 Erikssen and
tterstad7 recruited 1,832 men ages 40 to 59 years and free
rom coronary heart disease, among whom the incidence of
ll cardiovascular events during 7-year follow-up was mod-
rately but significantly even lower in men with a prolonged
R interval than among men with a PR interval 210 ms.
nly 1 study with 12,770 middle-age men observed an
nadjusted positive association between first-degree AV
lock and coronary heart disease over a 5-year follow-up.8
Two community-based epidemiologic studies pursued
he significance of the prolonged PR interval. Almost 4
ecades ago, a study with 4,678 adult men and women from
ecumseh, Michigan, found no excess incidence of cardio-
ascular disease or mortality among subjects with a pro-
onged PR interval (210 ms) during the mean follow-up
eriod of 4 years.5 These results were recently challenged
y an investigation in 7,575 individuals enrolled in the
ramingham Heart Study demonstrating a 1.44-fold risk of
ll-cause mortality, a 2.1-fold risk of atrial fibrillation, and
2.9-fold risk of pacemaker implantation associated with
rst-degree AV block (200 ms).9 The follow-up period in
he Framingham Heart Study was censored at 20 years,
oughly 5 times that of the Tecumseh study. Collectively,
hese findings indicate that a prolonged PR interval moni-
ored at rest is rarely an indicator of more severe conduction
isturbances during a follow-up period of 5 years.
urrent investigation
he results of our study, which had a 4-year follow-up, did
ot repeat the findings of Cheng et al9 for prolonged PR
ntervals monitored before the exercise test as a prognostic
arker (Table 2), which may be due to shorter follow-up.
owever, a prolonged PR interval during the post-exercise
eriod was a robust risk marker (Table 2, Figure 2). The
raditional risk factors of age and sex were prognostic co-
ariates, whereas coronary heart disease and diabetes were
learly nonsignificant in our relatively heterogeneous pop-
lation. QRS duration, a marker with an unclear role in risk
tratification,15 showed HRs suggestive of heightened risk
or increasing QRS duration, but the CIs clearly overlapped
ith the value 1.
In patients with clearly prolonged AV conduction, atrial
ystole begins too early in diastole, resulting in superimpo-
ition of atrial contraction on the early left ventricular filling
hase16 and an inefficient contribution of atrial systole to
entricular filling. The resulting decrease in cardiac output
s poorly tolerated in patients with congestive heart failure
r mitral regurgitation,16 among whom prolonged AV con-
uction is common. This mechanism does not explain the
xcess mortality among subjects with first-degree AV block
n our investigation, as the prevalence of remarkably pro-
onged PR intervals (300 ms) was small, affecting 3 and
patients during the pre- and post-exercise phases, respec-
ively.Short-term regulation of AV conduction is based on both
xtrinsic and intrinsic mechanisms.17,18 The extrinsic regu-
ation is mainly due to the autonomic nervous system.
rompt resumption of autonomic balance after exercise with
ecreased sympathetic tone and increased vagal activation,
hich slows AV conduction, is generally considered bene-
cial. Accordingly, these autonomic influences are unlikely
o account for the paradoxically deleterious effects of pro-
onged PR interval during recovery from exercise. An al-
ernative explanation relates to intrinsic factors affecting the
ynamic behavior of the AV node regarding recovery, fa-
ilitation, and fatigue.19 These factors are independent of
utonomic tone and can counteract PR shortening during
eriods of elevated heart rates.18,19,20 In the present study,
eart rates were substantially elevated at 2 min after cessa-
ion of exercise, the recovery measurement point of PR
nterval (Table 1). This was the case despite the fact that the
ecovery heart rate for patients with first degree AV block
as lower than for patients without prolongation because of
n even larger difference in peak heart rate between the 2
roups. Thus, a plausible explanation is that dysfunctional
ntrinsic AV node regulation, manifest only at elevated heart
ates, is a precursor of prolonged resting PR interval, which
ver the course of years or decades may increase risk of
eath or necessitate pacemaker implantation.9
tudy limitations
ur study is subject to certain limitations. First, we did not
ave records of nonmortality end points to confirm the
revious results regarding incident atrial fibrillation and
acemaker implantation. Neither do we have information on
hanges in parameters affecting mortality risk (e.g., smok-
ng, lifestyles, and medication) during follow-up.
onclusion
he PR interval prior to exercise is not a robust risk stratifier
or cardiovascular death during a follow-up of 4 years.
ost-exercise assessment of first-degree AV block may of-
er improved prediction because of functional abnormalities
hat become manifest only during this physiologic challenge
o the heart. These findings are consistent with growing
vidence that the recovery phase of clinical exercise testing
as considerable promise in the diagnosis of coronary heart
isease21,22 and risk stratification.23–26 Thus, a lengthened
R interval during the post-exercise phase should be added
o the set of potential noninvasive markers that may be
seful in predicting cardiovascular mortality.
cknowledgements
he authors thank the staff of the Department of Clinical
hysiology at the Tampere University Hospital for collect-
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(ACKGROUND Identification of individuals who are at risk for
ardiovascular death remains a pressing public health challenge.
erangements in autonomic function acting upon an electrically
nstable substrate are thought to be critical elements in trigger-
ng cardiovascular events.
BJECTIVE The purpose of this study was to analyze heart rate
ecovery (HRR) in combination with T-wave alternans (TWA) to
mprove risk assessment.
ETHODS The Finnish Cardiovascular Study (FINCAVAS) enrolled
onsecutive patients (N 1,972 [1,254 men and 718 women], age
7  13 years [mean  SD]) with a clinically indicated exercise
est using bicycle ergometer. TWA was analyzed continuously with
he time-domain modified moving average method. Maximum TWA
t heart rates 125 bpm was derived.
ESULTS During 48  13 months of follow-up (mean  SD), 116
atients died; 55 deaths were cardiovascular. In multivariable Cox
nalysis after adjustment for common coronary risk factors, high
xercise-based TWA (60 V) and low HRR (18 bpm) yielded
elative risks for all-cause mortality of 5.0 (95% confidence 2.1–c
i
o
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s
march 15, 2009; accepted August 12, 2009.)
547-5271/$ -see front matter © 2009 Heart Rhythm Society. All rights reservedonfidence interval 4.3–35.3, P .01). High recovery-based TWA
60 V) and low HRR (18 bpm) yielded relative risks for
ll-cause death of 6.1 (95% confidence interval 2.8 –13.2,
.01) and for cardiovascular mortality of 8.0 (95% confi-
ence interval 2.9 –22.0, P .01). Prediction by HRR and TWA,
oth singly and in combination, exceeded that of standard
ardiovascular risk factors.
ONCLUSION Reduced HRR and heightened TWA powerfully pre-
ict risk for cardiovascular and all-cause death in a low-risk pop-
lation. This novel approach could aid in screening of general
opulations during routine exercise protocols as well as improve
nsights into pathophysiology.
EYWORDS Exercise test; Heart rate recovery; Mortality; Progno-
is; T-wave alternans
BBREVIATIONS EF  ejection fraction; FINCAVAS  Finnish
ardiovascular Study; HRR  heart rate recovery; SCD  sudden
ardiac death; TWA  T-wave alternans
Heart Rhythm 2009;6:1765–1771) © 2009 Heart Rhythm Society.
2.1, P .01) and for cardiovascular mortality of 12.3 (95% All rights reserved.ntroduction
n abnormal autonomic nervous system response in terms
f heart rate recovery (HRR) during or after clinical exer-
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ampere, Finland. E-mail address: mika.kahonen@uta.fi. (Receivedise testing predicts all-cause and cardiovascular mortality
n a variety of relatively low-risk cohorts,1–7 including
urs.8 The reduction in heart rate during the first 30 to 60
econds after exercise appears to be caused principally by
eactivation of the parasympathetic nervous system but sub-
equently by withdrawal of sympathetic tone.9
T-wave alternans (TWA) is an ECG phenomenon indi-
ating an electrically unstable myocardial substrate.10 This
eat-to-beat alternation in the shape, amplitude, or timing of
he ST segment and the T wave has been found to predict
udden cardiac death (SCD) and cardiovascular and total
ortality independent of standard factors in relatively low-
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1766 Heart Rhythm, Vol 6, No 12, December 2009isk populations,11,12 including ours13,14 as well as in higher-
isk groups.15–19 We applied the time-domain modified
oving average method,20 which permits TWA measure-
ent during routine symptom-limited exercise.13,14
HRR and TWA reflect different pathophysiologic mech-
nisms. The aims of this study were to determine whether
he combined analysis of HRR and TWA during routine
xercise testing enhances their predictive power for cardio-
ascular and all-cause mortality over independent assess-
ent of either variable and to compare their predictive
trength to that of other standard risk factors.
ethods
tudy cohort
ll consecutive patients who were referred for an exercise
tress test at Tampere University Hospital between October
001 and the end of 2004 and were willing to participate in The
innish Cardiovascular Study (FINCAVAS)21 were recruited.
total of 1,972 patients (1,254 men and 718 women) with
echnically successful exercise tests were enrolled in the study.
test was considered technically adequate if storing the he-
odynamic data and continuous digital ECG signal was suc-
essful. Patients with atrial fibrillation (N 31) were excluded
ecause atrial fibrillation is an exclusion criterion in HRR
tudies.2,3 The main indications for the exercise test were
uspicion of coronary heart disease (frequency 45%); testing
ulnerability to arrhythmia during exercise (22%); evaluation
f work capacity (18%) and the adequacy of treatment of
oronary heart disease (16%); and obtaining an exercise test
rofile prior to an invasive procedure (13%) or after a myo-
ardial infarction (8%). Some patients had more than one
ndication. The study protocol was approved by the Ethics
ommittee of the Tampere University Hospital District, Fin-
and, and all patients gave informed consent prior to the inter-
iew and measurements as stipulated in the Declaration of
elsinki.
tudy flow
fter written informed consent was obtained, the medical
istory of each patient was collected via a computer-based
uestionnaire form. The exercise test then was performed.
xercise test protocol
he subject lay down in the supine position for 10 minutes,
nd the resting ECG was digitally recorded. The upright
outine exercise test then was performed using a bicycle
rgometer with electrical brakes. The lead system consisted
f the Mason-Likar modification of the standard 12-lead
ystem. The initial workload varied from 20 to 30 W, and
he load was increased stepwise by 10 to 30 W every
inute. Continuous ECGs were digitally recorded at 500 Hz
sing the CardioSoft exercise ECG system (version 4.14,
E Healthcare, Freiburg, Germany). During the test, heart
ate and ST segment deviation were continuously registered
n the ECG, while systolic arterial pressure and diastolic
rterial pressure were measured with a brachial cuff every 2
inutes. neasurement of HRR
RR was determined as the difference between maximum
eart rate during exercise minus heart rate during the first
inute following cessation of exercise. We used the HRR
utpoint of18 bpm, which has been suggested for exercise
ests with an abrupt end.22 Differences in recovery protocols
ave not negated the predictive strength of HRR.22
easurement of TWA
ssessing the relationship between TWA and mortality is
ne of the original goals of FINCAVAS.21 We used the
ime-domain, Food and Drug Administration–cleared mod-
fied moving average method because of its intrinsic flexi-
ility and demonstrated capacity to measure TWA accu-
ately under dynamic conditions, including changing heart
ates, myocardial ischemia, exercise, activity, and behav-
oral stress.11,13,14,16,19,23 In brief, the modified moving av-
rage algorithm reports TWA as the maximum difference in
-wave morphology between successive beats. It separates
dd from even beats, calculates average morphologies of
oth the odd and even beat streams separately, and contin-
ously updates the result by a weighting factor of 1/8 of the
ifference between the ongoing average and the new incom-
ng beat. The method performs at a resolution of 1 V and
as undergone extensive validation.20
TWA values were calculated automatically and contin-
ously by the released version of GE Healthcare’s modified
oving average algorithm during rest, exercise, and recov-
ry using all standard precordial leads (V1–V6). Maximum
WA values at heart rates 125 bpm were derived. TWA
alues at higher heart rates were excluded because inaccu-
acies in TWA measurement can result at heart rates ex-
eeding this range. Precordial leads have been shown to be
ptimum for TWA measurement.24,25 The exercise-based
WA cutpoint of 60 V, which yielded excellent Cox
egression results in our previous study,14 was used. Recov-
ry-based TWA values were analyzed according to cut-
oints 20 V and 60 V.14,26 TWA cutpoint of 20 V was
hosen because it has shown the highest sensitivities com-
ared with other cutpoints.26
eft ventricular ejection fraction
easurement of left ventricular ejection fraction (EF) is not
outine for patients referred for a clinical exercise test.
owever, EF was determined for 1,200 (55%) of the study
atients using echocardiography or isotope techniques
ithin 6 months of the exercise test. More than one fifth
N  408 [21%]) of the patients were examined with cor-
nary angiography.
ollow-up
eath certificates were received from the Causes of Death
egister, maintained by Statistics Finland, in May 2007, a
ource that has been shown to be reliable.27 The certificates
ncluded causes of death using the tenth revision of the
nternational Classification of Diseases (ICD-10). The diag-
osis numbers and certificate texts were used to classify the
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1767Leino et al Combined Heart Rate Recovery and T-Wave Alternans for Risk Stratificationeaths as all cause or cardiovascular. The investigators who
nalyzed TWA test results were blinded to events.
tatistical analysis
he t-test for independent samples was used to compare
ontinuous parameters of patient characteristics (Table 1)
nd exercise test variables (Table 2) for survivors and non-
urvivors. The Chi-square test was applied for dichotomous
ariables. P values were derived with the t-test and the
hi-square test for independent samples. Relative risks for
otal and cardiovascular mortality were analyzed for HRR,
WA, and their combinations as well as for ST-segment
eviation by Cox regression analysis after adjustment by
tandard covariates (Table 3). The proportionality assump-
ion for all covariates was checked by using correlations of
he survival rankings with the Schoenfeld residuals. All of
he covariates fulfilled the proportionality assumption. Harrell’s C
ndices also were calculated (Table 4). The calculations for
able 1 Patient characteristics of the study population
arameter
Survivors (N  1,8
Mean
ge (years) 56.5
eight (kg) 80.5
eight (cm) 171.0
ody mass index 27.5
N
ex: female 776
moking: yes 534
itrates 695
eta-blockers 1,174
ypercholesterolemia 1,024
iabetes 238
oronary heart disease 784
eft ventricular hypertrophy 91
istory of myocardial infarction 425
able 2 Exercise test variables of the study population
arameter
Survivors
Mean
uration of test (minutes) 7.5
ge-adjusted expected maximum HR (bpm) 176.8
eached maximum HR (bpm) 146.6
aximum SAP during the exercise (mmHg) 193.6
aximum DAP during the exercise (mmHg) 92.3
R at rest (bpm) 63.1
AP at rest (mmHg) 136.1
AP at rest (mmHg) 79.7
aximum TWA at rest before exercise (V) 19.4
aximum TWA during exercise (V) 35.8
aximum TWA during recovery (V) 26.7
aximum left ventricular ejection fraction 65.9
RR at 1 minute postexercise (bpm) 24.7
T-segment deviation during exercise (mV) 0.08DAP  diastolic arterial pressure; HR  heart rate; HRR  heart rate recoverombination variables were based on three categories: no pa-
ameter positive, either parameter positive, and both parame-
ers positive. Harrell’s C index is a generalization of the area
nder the receiver operator characteristic (ROC) curve for
urvival data with censored cases. Values above 0.5 show
etter than random prediction, and a value of one represents
erfect concordance between predicted and observed numbers.
Statistics were analyzed using SPSS release 14.0 for Win-
ows (SPSS, Inc., Chicago, IL, USA) and Stata 10.1 for Win-
ows (StataCorp LP, College Station, TX, USA). All statistical
ests were two-tailed and used an alpha level .05.
esults
aseline characteristics
uring the follow-up period of 48  13 months (mean 
D) in our study population of 1,972 consecutive patients
eferred for clinical exercise testing, there were 116 deaths
5.9% of the population), including 55 (2.8% of the popu-
Deaths (N  116)
P valueMean SD
65.1 11.3 .01
79.0 15.8 .27
171.6 9.3 .49
26.7 4.1 .07
N % P value
30 23.6 .01
41 32.3 .12
66 52.0 .01
99 78.0 .01
64 50.4 .91
23 18.1 .03
64 50.4 .01
7 5.5 .57
44 34.6 .01
,856) Deaths (N  116)
P valueSD Mean SD
2.1 6.2 2.0 .01
6.7 172.5 5.6 .01
26.4 127.0 29.6 .01
28.5 175.6 32.0 .01
11.9 85.1 13.4 .01
11.6 64.5 14.5 .19
18.6 135.2 25.8 .62
9.6 75.7 11.4 .01
11.5 25.5 17.2 .01
21.8 39.9 23.3 .04
23.4 31.3 19.5 .03
13.8 60.2 15.6 .01
11.5 18.2 13.8 .01
0.10 0.11 0.14 .0156)
SD
13.1
15.2
9.3
4.5
%
37.8
26.0
33.9
57.3
49.9
11.6
38.2
4.4(N  1y; SAP  systolic arterial pressure; TWA  T-wave alternans.
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1768 Heart Rhythm, Vol 6, No 12, December 2009ation; 47.4% of all deaths) that were classified as cardio-
ascular deaths. Thus, the cardiovascular mortality of the
resent patients was 0.7% per year. Patient characteristics
nd exercise test variables for survivors (N  1,856) and
onsurvivors (N  116) are given in Tables 1 and 2,
espectively.
ortality, HRR, and TWA
RR was abnormal in 29.5% (N  590) of the population.
xercise-based TWA 60 V was found in 5.2% (N 
07). During recovery, 51.3% (N  1,063 patients) had
WA 20 V, including 3.9% (N  81 patients) with
WA 60 V. Thus, the present approach classified the
ajority of the patients as low risk. Combined Cox propor-
ional hazard analysis of depressed HRR and heightened
xercise- or recovery-based TWA more than doubled the
rognostic capacity for total and cardiovascular mortality
fter adjustment for standard risk factors and exceeded
xercise-induced ST-segment deviation (Table 3). In addi-
ion to standard covariates, maximum left ventricular EF,
lood pressures at rest, maximum blood pressures during ex-
rcise, and resting heart rate were added to the multivariate
able 3 Results of Cox multivariable regression analysis (N  1
ortality
All-cause mo
RR
95%
Low
RR 18 bpm 2.5 1.6
xercise-based TWA 60 V 2.5 1.4
ecovery-based TWA 20 V 1.1 0.7
ecovery-based TWA 60 V 2.4 1.3
RR 18 bpm and exercise-based TWA 60 V 5.0 2.1
RR 18 bpm or exercise-based TWA 60 V 2.8 1.8
RR and recovery-based TWA 20 V 3.0 1.6
RR or recovery-based TWA 20 V 2.0 1.2
RR and recovery-based TWA 60 V 6.1 2.8
RR or recovery-based TWA 60 V 2.3 1.5
T-segment deviation (0.1 mV) during exercise 1.3 0.9
Results after adjustment for sex, age, body mass index, smoking (y
iagnoses of coronary heart disease (yes/no), history of myocardial infarc
CI  confidence interval; HRR  heart rate recovery; RR  relative ri
able 4 Harrell’s C indices for cardiovascular and all-cause mor
All-cause
death
RR 18 bpm 0.655
xercise-based TWA 60 V 0.539
ecovery-based TWA 20 V 0.555
ecovery-based TWA 60 V 0.526
RR 18 bpm and/or exercise-based TWA 60 V 0.677
RR 18 bpm and/or recovery-based TWA 20 V 0.655
RR 18 bpm and/or recovery-based TWA 60 V 0.661
T-segment deviation (0.1 mV) in exercise test 0.558
Calculations for combination variables were based on three categories
CI  confidence interval; HRR  heart rate recovery; TWA  T-wave alternannalysis with the combination of HRR and TWA. None of
hese factors exceeded the predictive power of the combination
f HRR and TWA. Incidence rates of all-cause and cardiovas-
ular deaths in subgroups are shown in Figure 1.
Harrell’s C indices were calculated for all single and
ombination parameters as well as for ST-segment devia-
ion (Table 4). For the single parameters, HRR provided the
ighest C index for both total and cardiovascular mortality.
dding exercise-based TWA 60 V to reduced HRR
ielded highest C index for all-cause and cardiovascular
ortality, although confidence intervals overlapped with
RR alone.
Survival curves depict events across 4 years of follow-up
or the combined analysis of reduced HRR and elevated
WA during exercise (Figure 2) and recovery (Figure 3).
iscussion
ur study is the first to demonstrate that the presence of
igh levels of TWA during exercise or recovery adds sig-
ificantly to the prognostic power of poor HRR for all-cause
nd cardiovascular mortality. Because both markers are
utomated and widely used parameters that can be moni-
of relative risks for all-cause mortality and cardiovascular
Cardiovascular mortality
P value RR
95% CI
P valueUpper Lower Upper
3.7 .01 2.3 1.3 4.2 .01
4.5 .01 5.8 3.1 11.1 .01
1.6 .73 1.5 0.8 2.5 .18
4.4 .01 3.5 1.6 7.9 .01
12.1 .01 12.3 4.3 35.3 .01
4.3 .01 3.4 1.8 6.6 .01
5.5 .01 5.2 1.8 14.4 .01
3.5 .01 3.5 1.3 9.1 .01
13.2 .01 8.0 2.9 22.0 .01
3.5 .01 2.2 1.2 4.2 .01
1.9 .18 1.8 1.0 3.0 .04
use of beta-blockers (yes/no), reached maximum heart rate, and prior
es/no), diabetes (yes/no), and hypercholesterolemia (yes/no).
 T-wave alternans.
5% CI
Cardiovascular death
95% CI
ower Upper Lower Upper
.609 0.702 0.650 0.583 0.718
.507 0.570 0.594 0.535 0.653
.508 0.601 0.606 0.544 0.668
.499 0.553 0.550 0.535 0.653
.631 0.723 0.713 0.648 0.777
.608 0.702 0.691 0.633 0.749
.614 0.709 0.671 0.602 0.740
.510 0.606 0.580 0.511 0.649
or 2 parameters positive).,972)
rtality
CI
er
es/no),
tion (ytality
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1769Leino et al Combined Heart Rate Recovery and T-Wave Alternans for Risk Stratificationored in conjunction with routine exercise testing, their
ombination may serve as a new risk stratification tool for
creening low-risk patient populations.
revious studies
he significant influence of autonomic nervous system ac-
ivity on cardiovascular and total mortality has been amply
igure 2 Adjusted survival curves by Cox regression for subjects with
xercise-based T-wave alternans (TWA) 60 V and heart rate recovery
HRR) 18 bpm (top curve in both panels), TWA 60 V or HRR 18
pm (middle curve in both panels), and TWA60 V and HRR18 bpm
bottom curve in both panels) for all-cause mortality (A) and cardiovascu-
igure 1 Incidence rate of all-cause and cardiovascular mortality per
000 person-years among patients according to exercise-based T-wave
lternans (TWA) and heart rate recovery (HRR).sar mortality (B). Note that the scale for the y-axis is from 0.75 to 1.00.emonstrated, most recently by baroreceptor sensitivity
BRS)28 and noninvasive assessment with heart rate vari-
bility,28,29 heart rate turbulence,30 and HRR.1–8 The latter
s a strong predictor of cardiovascular mortality in asymp-
omatic patients5,7,8 and in broad populations4 as well as of
CD.1 Importantly, impaired HRR is not attributable to
schemic burden3 or lipid abnormalities.6 Treadmill exercise
cores strongly predict mortality among intermediate- to
igh-risk patients if HRR is abnormal.6
The accuracy and utility of exercise-based TWA in predict-
ng arrhythmic events and death have been investigated.12–15
ost TWA studies have been performed in high-risk popula-
ions, such as patients with heart failure,15,17–19 cardiomyopa-
hies,15,18 or history of myocardial infarction.11,12,15–19 We
reviously reported in approximately 2,000 FINCAVAS pa-
ients that TWA analyzed with the modified moving average
ethod is a strong predictor of all-cause and cardiovascular
ortality as well as of SCD in this low-risk population.14
specially high specificity when compared with other car-
iovascular parameters has characterized the prognostic
alue of elevated TWA,13 suggesting suitability to confirm
igure 3 Adjusted survival curves by Cox regression for subjects with
ecovery-based T-wave alternans (TWA) 60 V and heart rate recovery
HRR) 18 bpm (top curve in both panels), TWA 60 V or HRR 18
pm during recovery (middle curve in both panels), and TWA60 V and
RR18 bpm during recovery (bottom curve in both panels) for all-cause
ortality (A) and cardiovascular mortality (B). Note that the scale for the
-axis is from 0.75 to 1.00.uspected risk.
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1770 Heart Rhythm, Vol 6, No 12, December 2009The potential to improve prediction of cardiovascular
nd total mortality by combining TWA with the ambulatory
CG-based autonomic marker of heart rate turbulence was
ecently confirmed in a high-risk population of postmyocar-
ial infarction patients with left ventricular dysfunction.16
he present study, which enrolled a 6.9-fold larger, lower-
isk population of almost 2,000 patients, demonstrated fur-
her improvements in odds ratio.
urrent investigation
he present study confirms and extends the findings of our
revious investigations of TWA13,14 and HRR8 in the low-
isk FINCAVAS patient population. When analyzed to-
ether, TWA and HRR provide high relative risk ratios for
ll-cause death and for cardiovascular mortality after adjust-
ent for standard risk factors (Table 3), indicating a marked
ndependent prognostic capacity and exceeding the predic-
ive value of either parameter alone or ST-segment devia-
ion. The combinations of reduced HRR with heightened
WA were superior to exercise-induced ST-segment devi-
tion in our low-risk population using Cox proportional
azards models (Table 3) and Harrell’s C indices (Table 4).
he incidence rate of all-cause as well as cardiovascular
eaths was clearly higher among patients with reduced HRR
nd heightened TWA compared to patients with normal
alues (Figure 1).
The mechanistic basis for the improvement in prediction
esulting from combined analysis of HRR and TWA is
nclear. A plausible explanation is that a more complete
icture of underlying pathophysiologic factors is rendered
y information regarding both autonomic function and car-
iac electrical instability. As HRR is thought to reflect the
ynamic interplay between sympathetic and parasympa-
hetic nerve activity as influenced by changes in barorecep-
or gain,1 a reduced HRR may indicate autonomic imbal-
nce as a basis for cardiovascular events. Moreover, HRR
ay reflect aerobic capacity and physical fitness, which
ave been linked to prognosis.31 The independent associa-
ion between increased risk for all-cause and cardiovascular
ortality and TWA13,14 is consistent with the finding that
WA indicates increased heterogeneity of repolariza-
ion.10,32 Although the incidence of SCD was not evaluated
n the current investigation, because both TWA13,14 and
educed HRR1 have been independently associated with
CD in low-risk populations, it is possible that a number of
he cardiovascular deaths were arrhythmic in origin. Ath-
rosclerotic heart disease, typical of 29 (48%) of patients
ho died of cardiovascular causes, predisposes to ventric-
lar fibrillation and SCD.33 Accordingly, reduced HRR
ould indicate impaired vagus nerve activation and lessened
apacity to withdraw sympathetic nerve tone, both influ-
nces known to be arrhythmogenic.27,34 Thus, the presence
f both abnormal HRR and elevated TWA, reflecting de-
angements in autonomic function as well as in cardiac
lectrical instability, would be expected to be associated
ith the highest risk for cardiovascular events, as demon-trated in the present study.tudy limitations
e do not have information on changes in parameters
ffecting mortality risk (e.g., smoking, lifestyles, medica-
ion) during follow-up. In addition, data on EF were not
vailable for 45% of patients. It is likely that patients in
hom no need was found for EF determinations had even
etter cardiovascular health than did those with EF mea-
urement. EF is an arrhythmia risk stratifier only when EF
evels are below normal.35
onclusion
broad implication of the study finding is that routine
xercise testing discloses increased risk for cardiovascular
s well as all-cause death among patients with both de-
ressed HRR and abnormal TWA who are not identified by
tandard risk factors. In addition to improving predictivity,
he combined assessment of HRR and TWA may be helpful
n gaining insight into the pathophysiologic mechanisms on
n individual patient basis that could help to guide therapy.
n particular, patients with markedly depressed HRR could
e directed toward an exercise training regimen that im-
roves vagus nerve tone, BRS, and long-term prognosis.31
WA results reflective of an unstable cardiac substrate
ould signal the need for antiarrhythmic therapy. Finally,
articularly as the measurements can be performed nonin-
asively during routine exercise testing in the typical flow
f clinical care, these parameters can readily be incorpo-
ated, either singly or in combination, into routine risk
ssessment paradigms.
cknowledgements
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pImportance of regional specificity of T-wave alternans in
assessing risk for cardiovascular mortality and sudden cardiac
death during routine exercise testing
Johanna Leino, MD,* Richard L. Verrier, PhD,† Mikko Minkkinen, BMS,* Terho Lehtimäki, MD, PhD,*‡
Jari Viik, PhD,§ Rami Lehtinen, PhD,*¶ Kjell Nikus, MD,# Tiit Kööbi, MD, PhD,*¶
Väinö Turjanmaa, MD, PhD,*¶ Mika Kähönen, MD, PhD,*¶ Tuomo Nieminen, MD, PhD†**
From the *Medical School, University of Tampere, Finland, †Harvard Medical School, Beth Israel Deaconess Medical
Center, Boston, Massachusetts, ‡Department of Clinical Chemistry, Tampere University Hospital, §Department of
iomedical Engineering, Tampere University of Technology, ¶Department of Clinical Physiology, Tampere University
ospital, Tampere Polytechnic University of Applied Sciences, #Heart Centre, Department of Cardiology, Tampere
University Hospital, and **Department of Pharmacological Sciences, Medical School, University of Tampere, and
Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland.BACKGROUND T-wave alternans (TWA) indicates increased risk
for life-threatening arrhythmias. However, the regional distribu-
tion and predictivity of TWA among precordial leads remain un-
known.
OBJECTIVE We analyzed the magnitude and prognostic power of
TWA in precordial leads separately and in combination during
routine exercise stress testing in the largest TWA study conducted
to date.
METHODS The Finnish Cardiovascular Study (FINCAVAS) enrolled
consecutive patients (n  3,598, 56  13 [mean  standard
deviation] years old, 2,164 men, 1,434 women) with a clinically
indicated exercise test with bicycle ergometer. TWA was analyzed
with the time-domain modified moving average method.
RESULTS During a follow-up of 55 months (interquartile range of
35–78 months), 231 patients died; 97 deaths were cardiovascular,
and 46 were classified as sudden cardiac deaths (SCDs). In Cox
analysis after adjustment for common coronary risk factors, each
20-V increase in TWA in leads V1–V6 multiplied the hazard ratio
or cardiovascular mortality by 1.486-fold (95% confidence inter-
al [CI] 1.127–1.952; P  .005). Each 20-V increase in TWA ind
s
m
r
r
University Hospital, Paavo Nurmi Foundation, Paulo Foundation, Emil
1547-5271/$ -see front matter © 2011 Published by Elsevier Inc. on behalf of H1.545 (95% CI 1.150–2.108; P .004) and for SCD by 1.576 (95%
CI 1.041–2.412; P  .033).
CONCLUSIONS Maximum TWA monitored from anterolateral pre-
cordial lead V5 is the strongest predictor of cardiovascular mor-
tality and SCD during routine exercise testing in our analysis.
Higher TWA values indicate greater cardiovascular mortality and
SCD risk, supporting the concept that quantification of TWA should
receive more attention.
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SCD sudden cardiac death; SD standard deviation; TWA T-wave
alternans
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lead V5 amplified the hazard ratio for cardiovascular mortality by behalf of Heart Rhythm Society.Introduction
T-wave alternans (TWA) is an electrocardiographic (ECG)
phenomenon indicating an electrically unstable myocardial
substrate.1,2 This beat-to-beat alternation in the shape, am-
litude, or timing of the ST segment and the T wave has
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tion, Tampere University Foundation, Medical Research Fund of Tampereemonstrated utility in predicting ventricular arrhythmias,
udden cardiac death (SCD), and cardiovascular and total
ortality independent of standard factors in relatively low-
isk populations,3,4 including ours,5,6 as well as in higher
isk groups.7–17 Especially high specificity and negative
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386 Heart Rhythm, Vol 8, No 3, March 2011predictive value characterize the prognostic strength of el-
evated TWA compared with other cardiovascular parame-
ters.5
TWA is a regionally specific phenomenon that occurs in
the ischemic zones of the heart and is linearly projected to
the precordium.18 Usefulness of TWA in limb leads is also
limited by higher noise levels than in the precordial leads.6
Therefore, TWA studies have generally used precordial
leads, and limb leads are often excluded.6,18–21 However,
he regional distribution of TWA in the precordial leads is
till poorly understood. Does a single precordial lead or
ombination of several precordial leads offer greater prog-
ostic power than others? Also, it remains unknown
hether peaks in TWA in selected leads indicate greater
isk than wider but lower elevations in TWA values among
everal leads. This, the largest TWA study thus far, inves-
igates the distribution and the prognostic value of TWA in
ingle precordial leads as well as in the combinations of
everal precordial leads during routine clinical exercise
esting.
Materials and methods
Study cohort
All consecutive patients who were referred for an exercise
test at Tampere University Hospital between October 2001
and December 2008 and who were willing to participate in
the Finnish Cardiovascular Study (FINCAVAS)22 were re-
cruited. A total of 3,598 patients (2,164 men, 1,434 women)
with technically successful exercise tests were enrolled in
the study. A test was considered technically adequate if
storing the hemodynamic data and continuous digital ECG
signal was successful. Patients with atrial fibrillation (n 
209) were excluded. The main indications for the exercise
test were suspicion of coronary heart disease (CHD; fre-
quency 47%), evaluation of work capacity (26%), testing
vulnerability to arrhythmia during exercise (25%), and ad-
equacy of CHD treatment (13%), as well as obtaining an
exercise test profile before an invasive procedure (9%) or
after a myocardial infarction (MI; 8%); some patients had
more than one indication. The study protocol was approved
by the Ethics Committee of the Tampere University Hos-
pital District, Finland, and all patients gave informed con-
sent before the interview and measurements as stipulated in
the Declaration of Helsinki.
Study flow
After an informed consent was signed, the medical history
of each patient was collected with a computer-based ques-
tionnaire form. Thereafter, the subject lay down in the
supine position for 10 minutes, and the resting ECG was
digitally recorded. The upright routine exercise test was
performed using a bicycle ergometer with electrical brakes.
The Mason-Likar modification of the standard 12-lead sys-
tem was used. The initial workload was varied from 20 to 30
W, and the load was increased stepwise by 10 to 30 W every
minute. Continuous ECGs were digitally recorded at 500 Hz
with the CardioSoft exercise ECG system (Version 4.14,GE Healthcare, Freiburg, Germany). During the test, heart
rate was continuously registered on the ECG, while systolic
(SAP) and diastolic (DAP) arterial pressures were measured
with a brachial cuff every 2 minutes.
Measurement of TWA
Assessing the relationship between TWA and mortality is
one of the original goals of FINCAVAS.21 We employed
he time-domain modified moving average (MMA) method
ecause of its intrinsic flexibility and demonstrated capacity
o measure TWA accurately under dynamic conditions in-
luding changing heart rates, myocardial ischemia, exercise,
ctivity, and behavioral stress.3,5,6,13,14,16,22–24 In brief, the
MMA algorithm reports TWA as the maximum difference
in T-wave morphology between successive beats. It sepa-
rates odd from even beats, calculates average morphologies
of both the odd and even beat streams separately, measures
the difference between the average morphologies, and con-
tinuously updates the result by a weighting factor of 1/8 of
the difference between the ongoing average and the new
incoming beat.25 TWA values were calculated automati-
ally and continuously by the released version of GE
ealthcare’s MMA algorithm during routine exercise test-
ng using all standard precordial leads (V1–V6), which have
een shown to provide improved prediction over limb leads
r other configurations.6,18–20,26 Peak TWA values were
nalyzed without regard to exercise heart rate. TWA values
46 V were overread by a physician investigator and
corrected if necessary or discarded based on noise or base-
line wander.
Follow-up
Death certificates were received from the Causes of Death
Register maintained by Statistics Finland; this source has
been shown to be reliable.27 The certificates included causes
f death using the tenth revision of the International Clas-
ification of Diseases. The diagnosis numbers and certificate
exts were used to classify the deaths as all-cause, cardio-
ascular, or SCD, which was defined as a cardiac death
ithin 24 hours after the onset of symptoms. The investi-
ators who analyzed TWA test results were blinded to
vents.
Statistical analysis
The Student’s t-test for independent samples was used to
compare continuous parameters of patient characteristics
and exercise test variables for survivors and nonsurvivors,
and the 2-test was applied for dichotomous variables. The
P-values were derived with the t-test and the 2-test for
independent samples. The Mann-Whitney U-test was used
to compare maximum TWA values in every precordial lead
between survivors and nonsurvivors. Rates of mortality by
quintiles of TWA in lead V5 are presented with the signif-
icance determined by Poisson regression. Relative risks for
maximum TWA were analyzed for all precordial leads, for
each precordial lead separately, and for combinations of
precordial leads using Cox regression analysis after adjust-
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387Leino et al Precordial distribution of TWAment by standard risk factors for cardiovascular events,
specifically, sex, age, body mass index (BMI), smoking,
CHD, diabetes, use of -blockers, and prior MI. The com-
ination lead data were derived by choosing the highest
WA value among the leads. Also, we tested the prognostic
ower of widespread TWA (TWAsum), calculated by adding
aximum TWA values in every precordial lead at each
oint in time and using Cox regression analysis after ad-
ustment for standard risk factors. The endpoints in all
nalyses were all-cause, cardiovascular, and SCD. All of the
ovariates fulfilled the proportionality assumption by using
orrelations of the survival rankings with the Schoenfeld
esiduals. Statistics were analyzed with the SPSS release
6.0 for Windows (SPSS Inc., Chicago). All statistical tests
ere two tailed and used an alpha level .05.
Results
Baseline characteristics
Patient characteristics and exercise test variables separated
according to all-cause mortality are shown in Table 1. The
age of the 3,598 patients was 55.6  12.9 years (mean 
tandard deviation [SD]). Most of the patients (71.5%) were
ategorized as New York Heart Association (NYHA) class
, while other classes included 21.6% (NYHA II) and 6.9%
NYHA III) of the patients. During the follow-up period of
5 months (interquartile range from 35 to 78 months), there
ere 231 deaths (6.4% of the population), including 97
2.7% of the population; 42.0% of all deaths) that were
lassified as cardiovascular deaths and 46 (1.3% of the
opulation; 19.9% of all deaths) that were classified as
Table 1 Baseline characteristics and exercise test variables sep
Age
BMI, kg/m2
uration of test, minutes
eached maximum heart rate of age-related expected value, %
eart rate at rest, bpm
AP at rest, mmHg
AP at rest, mmHg
eart rate recovery at 1 minute postexercise, bpm
erformance in metabolic equivalents (MET)
ex: female
moking: yes
se of nitrates: yes
se of beta-blockers (or pause 48 hours before the test): yes
ypercholesterolemia: yes
iabetes: yes
HD: yes
VH: yes
istory of MI: yesCD.TWA magnitude in precordial leads
The maximum TWA achieved during exercise testing in
each precordial lead is shown in Figure 1. Leads V1 and
V3–V6 exhibited significant differences in maximum TWA
values between survivors and nonsurvivors. The trend in
incidence of cardiovascular and all-cause mortality as well
SCD showed an increase from the lower to the higher
quintiles of TWA in lead V5 (Figure 2).
Prognostic power of TWA in precordial leads
We tested the prognostic power of maximum TWA in each
precordial lead separately for all-cause and cardiovascular
mortality as well as for SCD using multivariable Cox re-
gression analysis (Table 2). Maximum TWA in all precor-
dial leads was a significant predictor of cardiovascular and
for survivors (n  3,367) and nonsurvivors (n  231)
Survivors (n 
3,367) Nonsurvivors (n 231)
Mean SD Mean SD P
55.1 12.8 63.7 11.4 .001
27.5 4.6 27.9 4.6 .159
8.2 2.0 6.7 2.0 .001
85.3 13.3 75.0 16.1 .001
63.4 11.3 65.3 12.7 .025
136.7 18.8 136.6 22.6 .915
80.2 9.6 77.9 11.2 .003
25.1 11.1 16.9 11.1 .001
7.9 2.9 5.5 2.4 .001
n % n % P
1,367 40.6 67 29.0 .001
760 22.6 72 31.2 .003
919 27.4 107 46.3 .001
1,656 49.3 172 74.5 .001
864 49.4 111 59.7 .008
356 10.9 39 17.0 .005
947 28.1 94 40.7 .001
167 5.0 14 6.1 .461
603 17.9 69 29.9 .001
0
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Survivors 15.0 12.0 11.0 13.0 15.0 15.0
All-cause death 17.0 13.0 13.0 15.0 19.0 17.0
V1 V2 V3 V4 V5 V6
Figure 1 Maximum exercise-induced TWA (median  interquartile
range) in precordial leads of survivors and nonsurvivors. The distributionaratedof TWA values differed significantly in leads V1 and V3–V6.
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388 Heart Rhythm, Vol 8, No 3, March 2011all-cause mortality but not for SCD. Maximum TWA in lead
V5 significantly predicted SCD and cardiovascular and all-
cause mortality, while maximum TWA in lead V3 was
significant only for SCD. TWA in leads V1, V2, V4, or V6
was not significant for any classes of mortality. Hazard
ratios (HRs) increased by 55% and 58% for each 20-V rise
n TWA for cardiovascular mortality and SCD, respectively,
n lead V5. For prediction of all-cause death, TWA in lead
5 exceeded all other single leads as well as all combina-
ions of leads.
We also tested the prognostic power of TWA in combi-
ations of precordial leads. Maximum TWA in the higher
ead of certain combinations, namely, in V2–V6, V3–V6,
4–V6, V5–V6, V4–V5, or V3–V5, yielded significant
rediction for cardiovascular and all-cause mortality in Cox
ultivariable regression analysis (Table 2). Excluding lead
1 markedly improved the prediction of cardiovascular and
ll-cause mortality.
Figure 2 Rates of total and cardiovascular mortality as well as SCD at
given in parentheses.
Table 2 HRs and 95% CIs for each 20-V increase in TWA in p
SCD
HR
95% CI
(lower)
95% CI
(upper) P
ax TWA in all precordial leads 1.269 0.818 1.952 0.2
ax TWA in V1 1.173 0.678 2.149 0.6
ax TWA in V2 1.173 0.710 1.952 0.5
ax TWA in V3 1.576 1.062 2.366 0.0
ax TWA in V4 1.457 0.961 2.191 0.0
ax TWA in V5 1.576 1.041 2.412 0.0
ax TWA in V6 0.980 0.544 1.771 0.9
ax TWA in V2, V3, V4, V5, or V6 1.321 0.869 1.990 0.1
ax TWA in V3, V4, V5, or V6 1.220 0.942 2.108 0.0
ax TWA in V4, V5, or V6 1.401 0.923 2.108 0.1
ax TWA in V5 or V6 1.374 0.887 2.191 0.1
ax TWA in V4 or V5 1.545 1.041 2.234 0.0
ax TWA in V3, V4 or V5 1.515 1.041 2.234 0.0
WAsum 1.083 0.818 1.196 0.1Note: Statistically significant results are presented in boldface type.Prognostic power of widespread TWA
A further aim of this study was to investigate whether or not
high peak values of TWA indicate greater risk than general
elevations in TWA values across the precordium. For this
purpose we calculated a new variable, TWAsum  TWAV1
 TWAV2  TWAV3  TWAV4  TWAV5  TWAV6. In
Cox regression analysis after adjustment with standard car-
diovascular risk factors, TWAsum did not show significant
prognostic power for SCD or cardiovascular mortality but
was significant for all-cause mortality.
Discussion
The aim of this study, the largest TWA study to date with
almost 3,600 patients enrolled, was to investigate the re-
gional distribution of TWA in assessing risk for total and
cardiovascular mortality as well as SCD. TWA is a widely
investigated phenomenon with promising risk stratification
potential.3–17,23,24,28 However, the prognostic value of
rs by quintile of TWA in lead V5. Number of deaths in each category is
al leads using Cox multivariable regression analysis
rdiovascular deaths All-cause deaths
R
95% CI
(lower)
95% CI
(upper) P HR
95% CI
(lower)
95% CI
(upper) P
486 1.127 1.952 0.005 1.245 1.020 1.515 0.026
.980 0.641 1.545 0.949 1.173 0.905 1.545 0.237
.150 0.802 1.671 0.434 1.150 0.905 1.457 0.255
.269 0.923 1.737 0.157 1.220 0.980 1.515 0.071
.295 0.942 1.737 0.104 1.173 0.942 1.429 0.147
545 1.150 2.108 0.004 1.347 1.083 1.486 0.006
.321 0.905 1.878 0.146 1.269 1.000 1.607 0.058
576 1.220 2.029 0.001 1.269 1.062 1.545 0.012
607 1.245 2.108 0.000 1.295 1.062 1.576 0.007
545 1.196 2.029 0.001 1.269 1.041 1.545 0.019
576 1.173 2.108 0.003 1.321 1.062 1.639 0.010
515 1.150 1.990 0.003 1.269 1.041 1.515 0.021
545 1.196 2.029 0.001 1.269 1.062 1.545 0.012
.062 1.000 1.150 0.067 1.062 1.000 1.105 0.0244.6 yearecordi
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389Leino et al Precordial distribution of TWATWA monitored from single and multiple precordial leads
has not been studied before this investigation.
Previous studies
Prediction by TWA in precordial leads has been stated for
ambulatory ECGs, but no systematic analysis for individual
leads has been reported for exercise-induced TWA. Sakaki
et al16 found that TWA 65 V in either lead V1 or V5
during Holter recording predicted cardiac mortality (HR
17.1; 95% CI 6.3–46.6; P.001) and SCD (HR 22.6; 95%
CI 2.6–193.7; P.005) with 1-year follow-up in a Japanese
population with ischemic and nonischemic cardiomyopathy.
Maeda et al11 reported that TWA 65 V in either lead V1
or V5 was a statistically significant predictor of life-threat-
ening ventricular arrhythmias (HR 6.1; 95% CI 1.1–34.0;
P .041) but not of all-cause mortality among patients with
n old MI. In the EPHESUS study,14 the prognostic power
f TWA in lead V1 was nearly the same (HR for SCD 5.2;
5% CI 1.8–14.6; P .002) as in lead V3 (HR 5.5; 95% CI
.2–13.8; P.001) among high-risk acute post-MI patients;
rognosis was improved based on the higher TWA value in
ither lead. ATRAMI researchers3 demonstrated that the
prediction by TWA in modified lead V5 (odds ratio 7.9;
95% CI 1.9–33.1; P  .005) is superior to that in lead V1
odds ratio 4.2; 95% CI 1.1–16.3; P  .04) in ambulatory
ECGs. Nearing et al18 determined that lead V5 showed
reater resolution than lead II in detecting TWA in the study
f 61 chloralose-anesthetized dogs. Furthermore, maximum
WA during angioplasty of the left anterior descending coro-
ary artery in seven patients was detected in leads V2–V4,
hich overlay the ischemic zone.18 Martinez and coworkers26
elegantly demonstrated the regional specificity of TWA during
angioplasty of the right and left coronary arteries.
Current investigation
We tested the prognostic power of TWA in single precordial
leads and lead combinations using Cox multivariable re-
gression analysis. Restricting the analysis to specific single
leads or lead groups improved prognosis over using all
precordial leads.
Our data concur with previous findings with the MMA
method,3,6,11,13,14,16 complex demodulation method,18
and Laplacian likelihood ratio method,26 that TWA mag-
nitude is elevated in anterolateral precordial leads in
subjects who either died or had coronary artery occlusion
compared with controls (Table 2, Figure 1). Similar to
previous studies,6,13,14,28 we noted that increases in TWA
magnitude detected mainly in lead V5 were associated
with increased incidence of SCD and cardiovascular and
total mortality during the 4-year follow-up (Figure 2).
This finding underscores the value of quantifying TWA
rather than analyzing single cut points to assess risk.
Although TWA achieved relatively high values in lead
V1, the prognostic power of TWA in this lead during ex-
ercise was null. This finding contrasts with several TWA
studies using ambulatory ECGs.3,11,14,16 A potential expla-
nation is that poor signal-to-noise ratio in the exercise en-vironment lessens the predictive capacity of lead V1, par-
ticularly if T-wave amplitude is relatively low in this lead.
We found that monitoring generalized elevations in
TWA across precordium offered no advantage in prediction
of SCD or cardiovascular mortality. A potential explanation
lies in the facts that TWA is regionally specific and that its
magnitude reflects the degree of heterogeneity of repolar-
ization, which underlies cardiac electrical instability and
risk for ischemia- and reperfusion-induced ventricular fi-
brillation.29
Limitations
The current analysis is not without limitations. We do not
have information on changes in parameters affecting mor-
tality risk (e.g., smoking, lifestyles, and medication) during
follow-up. Also, our analysis contained a relatively high
number of statistical comparisons, which may produce
false-positive results. Data with borderline significance
should be interpreted with caution. It is unclear why TWA
monitored in all the precordial leads did not predict SCD,
although it predicted cardiovascular and all-cause mortality.
Potentially, patients with long-term and severe cardiovas-
cular disease, who were at a great risk for SCD, died from
other precipitating factors, for example, heart failure. There-
fore, their deaths were classified as cardiovascular. Most of
the SCDs in FINCAVAS were out-of-hospital, unwitnessed
cardiac deaths that occurred within 24 hours after the onset
of symptoms. The widely accepted definition of SCD is
unexpected, witnessed death that occurs within 1 hour after
the start of symptoms or, when death is unwitnessed, within
24 hours of being seen alive and well.30 The limit of 24
hours is likely to overestimate the true SCD incidence,
while the limit of 1 hour after symptom onset might under-
estimate the SCD incidence.30 Approximately 25% of patients
ill be misclassified if time is the only criterion used.31
Conclusions
Maximum TWA monitored from the lateral precordial lead
V5 is the main predictor of SCD and cardiovascular and
total mortality during routine exercise testing. These find-
ings support the concept that quantification of TWA is
important in addition to using the marker in a dichotomous
formulation. Higher TWA values indicate greater cardio-
vascular mortality and SCD risk, with 55% and 58% in-
creases in HRs per each 20-V change, respectively, in lead
5. Peak TWA values rather than lower TWA elevations
mong several precordial leads should be used for risk
ssessment.
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